<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6473071</article-id><article-id pub-id-type="pmcid-ver">PMC6473071.1</article-id><article-id pub-id-type="pmcaid">6473071</article-id><article-id pub-id-type="pmcaiid">6473071</article-id><article-id pub-id-type="pmid">31031776</article-id><article-id pub-id-type="doi">10.3389/fimmu.2019.00805</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>IgG and Fc&#947; Receptors in Intestinal Immunity and Inflammation</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Castro-Dopico</surname><given-names initials="T">Tomas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/683597/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clatworthy</surname><given-names initials="MR">Menna R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/587883/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Department of Medicine, University of Cambridge</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><sup>2</sup><institution>NIHR Cambridge Biomedical Research Centre</institution>
<addr-line>Cambridge</addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><sup>3</sup><institution>Cellular Genetics, Wellcome Sanger Institute</institution>, <addr-line>Hinxton</addr-line>, <country>United Kingdom</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Mark S. Cragg, University of Southampton, United Kingdom</p></fn><fn fn-type="edited-by"><p>Reviewed by: Venkat Reddy, University College London, United Kingdom; Rostyslav Bilyy, Danylo Halytsky Lviv National Medical University, Ukraine</p></fn><corresp id="c001">*Correspondence: Menna R. Clatworthy <email>mrc38@cam.ac.uk</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>4</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">328186</issue-id><elocation-id>805</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>3</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>26</day><month>04</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-22 16:25:22.473"><day>22</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2019 Castro-Dopico and Clatworthy.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Castro-Dopico and Clatworthy</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-10-00805.pdf"/><abstract><p>Fc&#947; receptors (Fc&#947;R) are cell surface glycoproteins that mediate cellular effector functions of immunoglobulin G (IgG) antibodies. Genetic variation in Fc&#947;R genes can influence susceptibility to a variety of antibody-mediated autoimmune and inflammatory disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). More recently, however, genetic studies have implicated altered Fc&#947;R signaling in the pathogenesis of inflammatory bowel disease (IBD), a condition classically associated with dysregulated innate and T cell immunity. Specifically, a variant of the activating receptor, Fc&#947;RIIA, with low affinity for IgG, confers protection against the development of ulcerative colitis, a subset of IBD, leading to a re-evaluation of the role of IgG and Fc&#947;Rs in gastrointestinal tract immunity, an organ system traditionally associated with IgA. In this review, we summarize our current understanding of IgG and Fc&#947;R function at this unique host-environment interface, from the pathogenesis of colitis and defense against enteropathogens, its contribution to maternal-fetal cross-talk and susceptibility to cancer. Finally, we discuss the therapeutic implications of this information, both in terms of how Fc&#947;R signaling pathways may be targeted for the treatment of IBD and how Fc&#947;R engagement may influence the efficacy of therapeutic monoclonal antibodies in IBD.</p></abstract><kwd-group><kwd>Fc&#947; receptor</kwd><kwd>IgG</kwd><kwd>inflammatory bowel disease</kwd><kwd>intestinal immunity</kwd><kwd>mucosal infections</kwd><kwd>neonatal immunity</kwd></kwd-group><counts><fig-count count="5"/><table-count count="0"/><equation-count count="0"/><ref-count count="298"/><page-count count="23"/><word-count count="19507"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>The gastrointestinal (GI) tract comprises a series of organs whose primary functions are digestion, absorption, excretion, and to host a vast and diverse community of microbial commensals. The stomach and small intestine contribute to physical and chemical digestion and absorption, while the colon is primarily involved in the desiccation and compaction of waste (<xref rid="B1" ref-type="bibr">1</xref>). To aid these functions, the human GI tract is colonized by trillions of microorganisms that together form the microbiome, including at least 1,000 species of bacteria, the major component of the commensal flora. Microbial colonization increases progressively along the GI tract, with the colon harboring 10<sup>10</sup>-10<sup>12</sup> organisms per gram of luminal contents and elevated species diversity. In the lower GI tract of healthy individuals, anaerobes dominate, including <italic toggle="yes">Bacteroides</italic>, bifidobacterial, fusobacteria, and peptostreptococci, while aerobes, such as enterobacteria, are present at lower densities (<xref rid="B2" ref-type="bibr">2</xref>).</p><p>A state of mutualism exists between the host and the commensal microbiota, whereby bacteria benefit from the energy-rich sources of food, and the host salvages essential compounds from indigestible nutrients, such as dietary polysaccharides. In this scenario, the host immune system has an essential role in maintaining on-going symbiosis by limiting tissue invasion by resident microbes and keeping detrimental inflammatory responses at bay. This is achieved by dynamic cross-talk between microbes, intestinal epithelial cells (IECs), and tissue-resident leukocytes (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>) and includes the production of anti-microbial peptides and mucus by IECs, the induction and secretion of immunoglobulin (Ig)A by intestinal plasma cells, and the dominance of an anti-inflammatory milieu that suppresses damaging responses to luminal microbes. In return, the microbiota interacts with and educates the intestinal immune system, with consequences for both local and system inflammation.</p><p>While classically associated with systemic pro-inflammatory responses, recent studies have demonstrated that constitutive production of GI anti-microbial IgG is a feature of adult homeostasis with roles in immune cell maturation, defense against infection, and maternally-acquired neonatal immunity (<xref rid="B5" ref-type="bibr">5</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>). Furthermore, historical observations of <italic toggle="yes">de novo</italic> anti-microbial and autoreactive IgG in patients with inflammatory bowel disease (IBD) (<xref rid="B9" ref-type="bibr">9</xref>&#8211;<xref rid="B11" ref-type="bibr">11</xref>) have been brought into renewed focus by the identification of a polymorphism in the activating receptor Fc&#947;RIIA that alters susceptibility to ulcerative colitis (UC) (<xref rid="B12" ref-type="bibr">12</xref>&#8211;<xref rid="B14" ref-type="bibr">14</xref>), with subsequent studies demonstrating the pathogenic role of anti-microbial IgG in colitis. In this review, we will address the role that IgG and subsequent Fc&#947; receptor (Fc&#947;R) engagement by local GI-resident immune cells plays in intestinal immunity and inflammation, and the consequence of this interaction for defense against infection, immune maturation, detrimental inflammatory disease, and cancer.</p></sec><sec id="s2"><title>IgG Subclasses and Effector Function</title><p>IgG antibodies are the most abundant immunoglobulin isotype in human serum and extracellular tissue fluid, accounting for 10&#8211;20% of all plasma protein and 70&#8211;75% of total Ig (<xref rid="B15" ref-type="bibr">15</xref>). IgG subclasses exhibit diverse effector functions, including the ability to activate complement via the binding and activation of C1q, the engagement of Fc&#947;Rs on immune cells, and the direct neutralization of toxins and microbes (<xref rid="B16" ref-type="bibr">16</xref>). With pleiotropic roles in immunity, detrimental IgG-driven immune responses are associated with several inflammatory and autoimmune disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>), but IgG antibodies are also key effector molecules that contribute to anti-microbial immunity. Generally, IgG antibodies are known for their high antigen affinity, driven by somatic hypermutation, and are key molecules involved in immunological memory, although these functions vary depending on IgG subclass.</p><p>Fc&#947;Rs are cell surface glycoproteins that bind to the Fc portion of IgG antibodies (<xref rid="B19" ref-type="bibr">19</xref>). They are widely expressed across cells of the immune system and are responsible for mediating the cellular effector functions of IgG, including immune cell migration and maturation, the production of inflammatory mediators, and the elimination of opsonized microbes (<xref rid="B20" ref-type="bibr">20</xref>). There are several activating Fc&#947;Rs (Fc&#947;RI, Fc&#947;RIIA, Fc&#947;RIIIA, and Fc&#947;RIIIB in humans; Fc&#947;RI, Fc&#947;RIII, and Fc&#947;RIV in mice) and a single inhibitory receptor, Fc&#947;RIIB, in both humans and mice, with most exhibiting low-to-medium affinity for IgG (<xref ref-type="fig" rid="F1">Figure 1</xref>). The neonatal Fc receptor (FcRn) and the intracellular tripartite motif-containing protein 21 (TRIM21) also bind to immunoglobulins following their internalization (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B21" ref-type="bibr">21</xref>). FcRn is a major histocompatibility complex (MHC) class I-like molecule that binds to the Fc domain of IgG in a 2:1 stoichiometry with micro- to nanomolar affinity at pH 6.5 within acidic endosomes (<xref rid="B22" ref-type="bibr">22</xref>). As well as protecting IgG from degradation with endothelial and myeloid cells, FcRn plays a key role in the active bidirectional transport of IgG across barrier surfaces. It is expressed by murine IECs until weaning and throughout life in the human GI tract. This allows the retrieval of IgG and IgG-antigen immune complexes from the gastrointestinal lumen for phagocytes within the lamina propria, as well as mediating the secretion of IgG (<xref rid="B23" ref-type="bibr">23</xref>&#8211;<xref rid="B26" ref-type="bibr">26</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Human and murine Fc&#947; receptors. Schematic of human <bold>(A)</bold> and murine <bold>(B)</bold> classical Fc&#947; receptors embedded in the plasma membrane. Activating receptors contain intracellular ITAMs on the intracellular domain of the &#945; chain or in the associated common &#947;-chain (&#947;<sup>2</sup>; encoded by <italic toggle="yes">FCER1G</italic>). Activating Fc&#947;Rs are shaded in blue and inhibitory Fc&#947;RIIB is shaded in red. IgG affinity-altering variants are highlighted beneath the respective human Fc&#947;R, with the low- and high-binding variants and associated IgG affinities colored in purple and orange, respectively, in the table. Binding affinities are indicated as <italic toggle="yes">K</italic><sub><italic toggle="yes">A</italic></sub> (M<sup>&#8722;1</sup>). ITAM, immunoreceptor tyrosine-based activating motif; ITIM, immunoreceptor tyrosine-based inhibitory motif.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-00805-g0001.jpg"/></fig><p>For classical Fc&#947;Rs on the cell surface, productive signaling is initiated by the cross-linking of several receptors into signaling synapses on the cell surface through high-avidity antigen:antibody immune complexes (IC), aggregated IgG, or IgG-opsonized cells and surfaces (<xref ref-type="fig" rid="F2">Figure 2</xref>). Upon cross-linking, phosphorylation of immunoreceptor tyrosine-based activating motifs (ITAMs) located on the intracellular domain of activating Fc&#947;Rs or on the associated common &#947;-chain (also known as Fc&#1013;RI&#947;/FcR&#947;) occurs. ITAM phosphorylation activates signaling cascades via SRC family kinases and spleen tyrosine kinase (SYK), resulting in downstream activation of phosphatidylinositol3-kinase (PI3K) and phospholipase-C&#947;. Fc&#947;RIIB contains an intracellular immunoreceptor tyrosine-based inhibitory motif (ITIM), which becomes phosphorylated upon cross-linking with activating Fc&#947;Rs or the B cell receptor, initiating the recruitment of inositol phosphatases, most notably SHIP1, to the signaling synapse to dampen IgG-mediated responses (<xref rid="B18" ref-type="bibr">18</xref>). Activating and inhibitory Fc&#947;Rs are co-expressed on many immune cells, and their relative expression and activity determines the activation threshold of cells upon encounter of ICs or opsonized targets.</p><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Effector functions of IgG antibodies and Fc&#947;Rs. <bold>(A)</bold> IgG-opsonized antigens and cells can engage the classical complement pathway via binding to C1q. <bold>(B)</bold> IgG immune complexes, aggregated, or deposited IgG can bind to activating or inhibitory Fc&#947;Rs on the surface of immune cells, particularly those of the innate immune system. Activating Fc&#947;Rs (aFc&#947;R) can also bind to pentraxins, such as CRP, linking to cellular responses to innate humoral immunity. <bold>(C)</bold> Specific glycosyl variants of IgG can bind to C-type lectin receptors, such as Dectin-1 and SIGN-R1, to mediated activating Fc&#947;R-independent immune function.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-00805-g0002.jpg"/></fig><p>While IgG is the dominant ligand for Fc&#947;Rs, they can also signal in response to binding to other soluble effectors, such as pentraxins, including C reactive protein (CRP) and serum amyloid P (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). In particular, CRP mediates Fc&#947;RIIA-dependent internalization of damaged cells, self-antigens and microbes by human monocytes and neutrophils, via binding to phosphorylcholine moieties, chromatin, and histones (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>).</p><p>There are four IgG subclasses in humans (IgG1-4) and mice (IgG1, IgG2a/c, IgG2b, and IgG3). Human IgG1 is the most abundant and predominantly targets soluble protein antigens and membrane proteins (<xref rid="B15" ref-type="bibr">15</xref>). The generation of IgG1 is largely T cell dependent and it exhibits potent effector function (<xref rid="B31" ref-type="bibr">31</xref>). As such, IgG1 is frequently exploited in pharmaceutical settings for the production of therapeutic monoclonal antibodies (<xref rid="B32" ref-type="bibr">32</xref>). In mice, the effector profile of IgG2a and IgG2b is most similar to human IgG1 and show the greatest effector function <italic toggle="yes">in vivo</italic> in several settings (<xref rid="B17" ref-type="bibr">17</xref>). Human IgG2 responses (IgG3 in mice) are almost completely restricted to T cell-independent bacterial capsular carbohydrates, although anti-carbohydrate IgG antibodies of other subclasses do exist (<xref rid="B33" ref-type="bibr">33</xref>). IgG2 and IgG4 antibodies have a short, rigid hinge region compared to IgG1 and 3, resulting in impaired antibody flexibility, and this dictates to a certain extent the affinity of these molecules for Fc&#947;Rs and C1q. Human IgG3 antibodies are the most effective subclass in terms of their activating effector functions, with enhanced binding to C1q and increased affinity for Fc&#947;Rs, but they exhibit a blunted half-life due to impaired recycling via the FcRn (<xref rid="B34" ref-type="bibr">34</xref>). Finally, IgG4 is associated with induction by allergens following repeated or long-term exposure to antigen in a non-infectious setting, as well as in immune responses to parasitic infections (<xref rid="B15" ref-type="bibr">15</xref>). Given its relatively high affinity for the inhibitory receptor Fc&#947;RIIB, an ability to spontaneously dissociate and form bispecific antibodies (<xref rid="B35" ref-type="bibr">35</xref>), and the capacity to compete with IgE for allergens, IgG4 is often seen as an inhibitor of effector responses (<xref rid="B36" ref-type="bibr">36</xref>).</p><p>Beyond subclass, IgG effector functions can be fine-tuned through post-translational modification, most notably via <italic toggle="yes">N-</italic>linked glycosylation, which alters antibody stability, Fc&#947;R affinity and complement activity (<xref rid="B37" ref-type="bibr">37</xref>&#8211;<xref rid="B40" ref-type="bibr">40</xref>). Each IgG heavy chain carries a single covalently attached biantennary <italic toggle="yes">N-</italic>glycan at the highly conserved asparagine 297 residue in each of the Fc fragment C&#947;2 domains, with over 900 IgG glycoforms possible (<xref rid="B41" ref-type="bibr">41</xref>). Biantennary complexes can contain additional bisecting <italic toggle="yes">N-</italic>acetylglucosamine (GlcNAc), core fucose, galactose and sialic acid residues (<xref rid="B42" ref-type="bibr">42</xref>).</p><p>Defucosylated IgG exhibits enhanced Fc&#947;RIIIA affinity (<xref rid="B43" ref-type="bibr">43</xref>), while sialylation promotes anti-inflammatory functions of IgG by reducing Fc&#947;R affinity and promoting binding to the C-type lectin receptor, SIGN-R1 (DC-SIGN in humans) (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Indeed, sialylation is required for some of the protective functions of intravenous immunoglobulin (IVIg). Agalactosylated IgG, with two oligosaccharide chains ending in GlcNAc rather than galactose/sialic acid, is termed G0 (no galactose) (<xref rid="B19" ref-type="bibr">19</xref>). G0 IgG can activate complement via binding to mannose binding lectin and can bind the mannose receptor on phagocytes (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>).</p><p>In summary IgG antibodies are powerful effector molecules that can mediate tissue inflammation by complement activation, engagement of classical Fc&#947;Rs and C-type lectin receptors (<xref ref-type="fig" rid="F2">Figure 2</xref>). They are the dominant circulating antibody in humans and mice, with documented roles in defense and autoimmunity but their contribution to immunity in the gastrointestinal tract is much less well-defined.</p></sec><sec id="s3"><title>Immunity in the Gastrointestinal Tract</title><p>The frontline barrier between the external environment in the lumen of the GI tract and host tissues is the intestinal epithelium. This physical and biochemical barrier consists of an outer-most layer of thick secreted mucus, a single-cell layer of IECs, and the underlying non-epithelial mucosal cells, including a network of leukocytes found within the lamina propria, muscularis layers, and organized lymphoid follicles (<xref rid="B48" ref-type="bibr">48</xref>).</p><p>The largest mucosal barrier in the human body, the intestinal epithelium is continuously renewed by pluripotent intestinal epithelial stem cells located in the base of the crypts in a manner regulated by the local stem cell niche (<xref rid="B49" ref-type="bibr">49</xref>). Although absorptive enterocytes are the most abundant cell subset, IECs form a heterogeneous network of cells with distinct functions. For example, secretory Paneth cells and goblet cells produce anti-microbial peptides and mucins, respectively, while M cells transcytose antigens across the intestinal epithelium to the Peyer's patches beneath. Enterocytes also produce a restricted repertoire of anti-microbial peptides throughout the GI tract, such as the C-type lectin regenerating islet-derived protein III-&#947; (REGIII&#947;). The ability of IECs to form an effective barrier depends on their ability to act as frontline sensors of microbial stimuli through their expression of pattern recognition receptors (PRRs), including Toll-like receptor (TLR)5 and nucleotide-binding oligomerization domain (NOD)-like receptors (<xref rid="B50" ref-type="bibr">50</xref>&#8211;<xref rid="B52" ref-type="bibr">52</xref>). In turn, IEC-derived cytokines play essential roles in shaping the microbial structure of the GI tract, as well as the activation state of local immune cells during both homeostasis and inflammation (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). For example, interleukin (IL)-18 (<xref rid="B50" ref-type="bibr">50</xref>), IL-25 (<xref rid="B55" ref-type="bibr">55</xref>), thymic stromal lymphopoietin (<xref rid="B56" ref-type="bibr">56</xref>), and B cell-stimulating factors, including a proliferation-inducing ligand (APRIL) (<xref rid="B57" ref-type="bibr">57</xref>), are induced by PRR signaling in IECs and act to regulate local immunity. The importance of the epithelium in intestinal health is illustrated by genetic polymorphisms linking epithelial health and effector function with susceptibility to IBD and systemic inflammatory diseases, as shall be discussed later (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>).</p><p>Beneath the epithelium, the intestinal mucosa and submucosa houses a range of innate and adaptive immune cells (<xref ref-type="fig" rid="F3">Figure 3</xref>). Tissue-resident macrophages and dendritic cells (DCs) promote tolerance to intestinal commensal via anti-inflammatory cytokine production (including IL-10, and TGF&#946;, see section below). In addition, there are substantial populations of intestinal T cells, and the balance between regulatory T cells (Tregs) and T helper (Th)17 cells plays a fundamental role in determining whether there is mutualism with commensals or if their presence provokes inflammation. This is of particular interest, given the association of dysregulated IL-23/type 17 responses in the pathology of IBD and their role in defense against enteropathogens, such as <italic toggle="yes">Citrobacter rodentium</italic> (<xref rid="B60" ref-type="bibr">60</xref>&#8211;<xref rid="B65" ref-type="bibr">65</xref>).</p><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Schematic of major leukocyte populations in the intestine during homeostasis and their expression of Fc&#947;Rs. Migratory DCs promote B cell IgA class-switching and T cell polarization in GALT and MLNs, including regulatory T cells (Treg) and Th17 cells. The balance of Tregs and Th17 cells is critical for maintaining intestinal homeostasis and suppressing excessive responses to the microbiota. CD11b<sup>+</sup> cDC2s have an A:I ratio skewed toward Fc&#947;RIIB expression, as observed in DCs in other organs. Fc&#947;R-expressing DCs and monocyte-derived macrophages within the lamina propria support T cell and ILC3 activation via commensal-dependent production of cytokines, including IL-1&#946; and IL-23. Tissue-resident macrophages are dependent on IL-10 for their suppressive function. APRIL and BAFF production by DCs and macrophages supports local plasma cell survival. Macrophage A:I ratio is skewed toward activating Fc&#947;Rs and tuneable to the local milieu. Plasma cells and B cells express Fc&#947;RIIB, regulating survival and BCR activation threshold in these cells, respectively. Blue receptor, activating Fc&#947;R; red receptor, inhibitory Fc&#947;RIIB; S-IgA, secretory IgA; MLN, mesenteric lymph node; GALT, gut-associated lymphoid tissue; DC, dendritic cell; APRIL, a proliferation-inducing ligand; BAFF, B cell activating factor; IESC, intestinal epithelial stem cell; ILC3, group 3 innate lymphoid cell.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-00805-g0003.jpg"/></fig><p>IL-17A production by Th17 cells, &#947;&#948; T cells and group 3 innate lymphoid cells (ILC3s) at epithelial barriers sites can play a central role in intestinal inflammation (<xref rid="B66" ref-type="bibr">66</xref>&#8211;<xref rid="B69" ref-type="bibr">69</xref>). IL-17 promotes neutrophil recruitment to tissues via the induction of CXCL1, CXCL2, and CXCL8, while IL-17A-induced granulocyte-macrophage colony-stimulating factor (GM-CSF) and matrix metalloprotease can sustain neutrophil activation and survival (<xref rid="B70" ref-type="bibr">70</xref>&#8211;<xref rid="B72" ref-type="bibr">72</xref>). IL-17 can also induce expression of anti-microbial peptides (<xref rid="B73" ref-type="bibr">73</xref>) and promotes the maintenance of the intestinal epithelial barrier (<xref rid="B74" ref-type="bibr">74</xref>&#8211;<xref rid="B76" ref-type="bibr">76</xref>), therefore IL-17 has both pro-inflammatory and homeostatic roles. The IL-17-inducing cytokine IL-23 can also stimulate interferon (IFN)&#947; secretion by inflamed colonic lamina propria cells (<xref rid="B77" ref-type="bibr">77</xref>), which in turn contributes to inflammation through the activation of tissue-resident macrophages, apoptosis of IECs, and augmentation of antigen processing (<xref rid="B63" ref-type="bibr">63</xref>). Studies utilizing IFN&#947;-deficient mice or IFN&#947;-depletion confirm its contribution to intestinal inflammation in murine models (<xref rid="B78" ref-type="bibr">78</xref>&#8211;<xref rid="B80" ref-type="bibr">80</xref>).</p><p>IL-10 is the prototypical anti-inflammatory cytokine. Most classically associated with Foxp3<sup>+</sup> Tregs, IL-10 functions to suppress lymphocyte and myeloid immunity through a variety of mechanisms. Within the GI tract, the critical role of this cytokine is acutely illustrated by associations between <italic toggle="yes">IL10R</italic> single nucleotide polymorphisms (SNPs) and UC, as well as the widespread use of the <italic toggle="yes">Helicobacter hepaticus</italic> infection model: the presence or absence of IL-10R signaling dictates whether an otherwise tolerated bacterium induces colitis (<xref rid="B81" ref-type="bibr">81</xref>&#8211;<xref rid="B83" ref-type="bibr">83</xref>). Beyond Tregs and macrophages, regulatory B cells and epithelial cells also contribute to the intestinal IL-10 pool (<xref rid="B84" ref-type="bibr">84</xref>&#8211;<xref rid="B86" ref-type="bibr">86</xref>). Indeed, Rosser et al. demonstrated that microbiota-dependent IL-6 and IL-1&#946; production was sufficient to induce IL-10-producing B cells within mesenteric lymph nodes (MLNs) that contain systemic inflammation (<xref rid="B85" ref-type="bibr">85</xref>), while adoptive transfer of these cells is sufficient to suppress intestinal inflammation (<xref rid="B86" ref-type="bibr">86</xref>).</p></sec><sec id="s4"><title>Antibodies in the Gastrointestinal Tract</title><sec><title>IgA in the GI Tract</title><p>While constituting only 10&#8211;15% of total serum Ig, IgA is the major antibody isotype at mucosal surfaces (<xref rid="B87" ref-type="bibr">87</xref>). Of the two major isoforms in humans (IgA1 and 2), IgA2 is associated with mucosal sites and has enhanced resistance to proteolysis. The intestinal epithelium has the capability of transporting of Ig into the lumen via expression of the polymeric immunoglobulin receptor (pIgR). Following pIgR binding and internalization at the basolateral IEC surface, dimeric IgA is released at the apical membrane by proteolytic cleavage of the secretory component of pIgR, forming secretory IgA. Once within the lumen, secretory IgA participates in the maintenance of mutualism through mechanisms collectively known as <italic toggle="yes">immune exclusion</italic>. This includes the ability to neutralize toxins and pathogens in the absence of complement fixation (<xref rid="B88" ref-type="bibr">88</xref>), the anchoring and agglutination of microbes within the mucus layer (<xref rid="B89" ref-type="bibr">89</xref>), as well as the recently described ability to &#8220;enchain&#8221; dividing bacterial daughter cells to limit microbial colonization and evolution, and promote elimination from the body (<xref rid="B90" ref-type="bibr">90</xref>). Natural or low-affinity IgA can also deliver antigens to M cells for transport into Peyer's patches for the induction of adaptive immune responses (<xref rid="B91" ref-type="bibr">91</xref>).</p><p>Gut-draining MLNs, gut-associated lymphoid tissues (GALT), including Peyer's patches and isolated lymphoid follicles, and the intestinal lamina propria itself have been proposed to be sites for IgA generation, with the mode of IgA generation differing across tissues (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B92" ref-type="bibr">92</xref>). Local IgA production within the lamina propria and isolated lymphoid follicles is thought to be largely T cell-independent, given the absence of abundant T cell zones, instead relying on B cell-intrinsic TLR signaling and secretory factors released by DCs and non-haematopoietic cells (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B93" ref-type="bibr">93</xref>). The MLNs, caecal patch, and Peyer's patches can support both T cell-dependent and -independent IgA induction, with the former linked to invasive species of commensals and pathobionts (<xref rid="B94" ref-type="bibr">94</xref>&#8211;<xref rid="B97" ref-type="bibr">97</xref>).</p></sec><sec><title>IgG in the GI Tract</title><p>IgG1<sup>+</sup> and IgG2<sup>+</sup> plasma cells are present in the human gut. Both polyreactive and antigen-specific responses have been identified that target both foreign (commensals and enteropathogens) and self-antigens (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B98" ref-type="bibr">98</xref>). All antibodies show evidence of antigen-mediated selection and somatic hypermutation, with little difference in antigen reactivity between IgG isotypes, and no evidence of clonal relation between IgG and IgA responses within donors.</p><p>IgG2b and IgG3-producing B cell populations were also identified in the Peyer's patches and MLN of healthy adult mice, consistent with human observations. Murine IgG was elicited primarily by commensal-driven TLR signaling on B cells in a T cell-independent manner. Despite the relatively lower concentration of mucosal IgG compared with IgA, intestinal IgG responses exhibit broad microbial reactivity. Furthermore, most commensals bound by IgA antibodies in the murine gut also engage serum IgG2b and IgG3, while certain species of commensal microbes are uniquely opsonized by IgG3 across bacterial phyla (<xref rid="B7" ref-type="bibr">7</xref>).</p><p>The signals that lead to the local generation of IgG within the gastrointestinal tract have not been completely defined. However, <italic toggle="yes">Escherichia coli</italic> LPS has been shown to induce the B cell enzyme activation-induced cytidine deaminase (AID) and T cell-independent class-switch recombination to IgG2b and IgG3 in mice through dual B cell receptor (BCR)/TLR4 signaling (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>), and this may contribute to IgG generation in GALT. Indeed, a subset of IgG3- and IgG2b-expressing B cells within the Peyer's patches and MLN express the B1 cell marker CD43, a B cell subclass specializing in T cell-independent IgG production (<xref rid="B7" ref-type="bibr">7</xref>). T cell-dependent IgG responses have also been reported from B2 and follicular B cells in the GI tract, although the nature of the signals dictating T cell dependency remains to be determined. Higher affinity T cell-dependent responses may be reserved for invasive or epithelium-adherent species, in a manner analogous to IgA (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B101" ref-type="bibr">101</xref>) and consistent with the role of immune IgG in protection from enteropathogens (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B102" ref-type="bibr">102</xref>). Natural antibodies of the IgG3 subclass have also been described in mice and shown to interact with ficolins and mannose binding lectin that bind to bacteria, leading to Fc&#947;R-mediated phagocytosis by monocytes and inflammatory cytokine production (<xref rid="B103" ref-type="bibr">103</xref>).</p></sec><sec><title>Fc&#947; Receptors and Their Expression in Immune Cells in the GI Tract</title><p>Fc&#947;Rs are expressed by a number of immune cells within the GI tract, conferring the ability to respond to local IgG IC, and we will consider each cell type in turn:</p><sec><title>Intestinal Macrophages</title><p>Macrophages play a central role in tissue homeostasis and inflammation, with increasingly appreciated non-immune roles in tissue function. Within the GI tract, macrophages are found throughout the lamina propria, the connective tissue that underlies the intestinal epithelium, as well as between the circular and longitudinal muscle layers (<xref rid="B104" ref-type="bibr">104</xref>&#8211;<xref rid="B106" ref-type="bibr">106</xref>). Here, they are continuously exposed to microbial stimuli and play a central role as key guardians of the homeostatic milieu through their potent phagocytic capacity and ability to produce an array of cytokines and chemokines.</p><p>Elegant studies by Bain et al. demonstrated that adult intestinal macrophages are largely derived from CCR2-dependent Ly6C<sup>hi</sup> monocyte recruitment, a process dependent on the microbiota (<xref rid="B107" ref-type="bibr">107</xref>). Although intestinal macrophage numbers are unaltered in germ-free mice (<xref rid="B108" ref-type="bibr">108</xref>), commensal microbes influence macrophage activation state (<xref rid="B109" ref-type="bibr">109</xref>), for example via the production of short chain fatty acids (SCFAs) (<xref rid="B110" ref-type="bibr">110</xref>).</p><p>In homeostasis, intestinal macrophages are skewed toward anti-inflammatory functions, including the basal production of IL-10 (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B112" ref-type="bibr">112</xref>). Indeed, macrophage-derived IL-10 can dampen IL-23-mediated colitis and promote regulatory T differentiation <italic toggle="yes">in vitro</italic> (<xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B113" ref-type="bibr">113</xref>).</p><p>During colitis, infiltrating monocytes are redirected toward a more pro-inflammatory macrophage phenotype (<xref rid="B112" ref-type="bibr">112</xref>, <xref rid="B114" ref-type="bibr">114</xref>), with elevated production of IL-1&#946;, IL-23, and tumor necrosis factor (TNF). These, in turn, promote Th1/Th17 and innate lymphoid cell (ILC) activation. Thus, inflammatory macrophages are the principle mediators of tissue inflammation in several murine models of intestinal pathology (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B115" ref-type="bibr">115</xref>&#8211;<xref rid="B119" ref-type="bibr">119</xref>).</p><p>Intestinal macrophages express a number of cell surface receptors, including TLRs, C-type lectin receptors, NOD-like receptors, and Fc&#947;Rs (<xref rid="B120" ref-type="bibr">120</xref>). Indeed, Fc&#947;RI (CD64) is often used to discriminate between macrophages (Fc&#947;RI<sup>+</sup>) and dendritic cells (Fc&#947;RI<sup>&#8722;</sup>) in the GI tract (<xref rid="B121" ref-type="bibr">121</xref>). Studies in human monocyte-derived macrophage and murine bone marrow derived macrophages demonstrate expression of all canonical Fc&#947;Rs, and expression is tuneable to the local environment: Th2 cytokines, such as IL-4, upregulate the expression of Fc&#947;RIIB and decrease the so-called activating/inhibitory ratio on macrophages (<xref rid="B122" ref-type="bibr">122</xref>&#8211;<xref rid="B124" ref-type="bibr">124</xref>). Generally, however, Fc&#947;R expression is skewed in favor of activating signaling (<xref rid="B125" ref-type="bibr">125</xref>, <xref rid="B126" ref-type="bibr">126</xref>). A comprehensive analysis of Fc&#947;R expression in human gastrointestinal macrophages, across different anatomical regions of the gut, and in health and disease has yet to be performed.</p><p>Fc&#947;R cross-linking <italic toggle="yes">in vitro</italic> induces a potent macrophage inflammatory response, characterized by the production of IL-1&#946;, IL-6, IL-10, IL-12, and TNF-&#945;, as well as chemokines including CXCL8 (<xref rid="B127" ref-type="bibr">127</xref>). Interestingly, several studies have highlighted a link between TLR and Fc&#947;R co-stimulation and the induction of a Th17 polarizing macrophage phenotype. Stimulation of human M2 macrophages and DCs with IgG-opsonized bacteria induces IL-1&#946; and IL-23 expression (<xref rid="B128" ref-type="bibr">128</xref>&#8211;<xref rid="B130" ref-type="bibr">130</xref>). Given the role of these same macrophage-derived cytokines in intestinal pathology, Fc&#947;R cross-linking by anti-commensal IgG signaling could contribute to Th17 cell activation and inflammation in the human gut. However, some murine studies suggest that IgG immune complexes can inhibit LPS-induced IL-1&#946; and TNF production in BMDMs, a phenomenon at least partly dependent on prostaglandin E2 (PGE2) production (<xref rid="B131" ref-type="bibr">131</xref>, <xref rid="B132" ref-type="bibr">132</xref>). Therefore, further work is needed to understand whether <italic toggle="yes">in vitro-</italic>derived macrophages accurately reflect tissue macrophage activation by IgG immune complexes <italic toggle="yes">in vivo</italic>, particularly in the complex environment of the gastrointestinal tract.</p></sec><sec><title>Intestinal Dendritic Cells</title><p>DCs sit at the interface of innate and adaptive immunity, their primary function being the transport of antigen from peripheral sites to draining lymph nodes in a CCR7-dependent manner for MHC-dependent presentation to T cells. Additionally, DC-derived cytokines play key roles in shaping innate and adaptive immune responses, including T cell polarization, B cell class-switch recombination, and innate lymphoid cell activation (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref rid="B105" ref-type="bibr">105</xref>, <xref rid="B133" ref-type="bibr">133</xref>).</p><p>There are two main subsets of classical or conventional DCs (cDCs) derived from DC-specific precursors: BATF3-dependent cDC1s and IRF4-dependent cDC2s (<xref rid="B134" ref-type="bibr">134</xref>). In the murine intestine, several DC subsets have been characterized that variably express CD11b and CD103, with unique functions in health and disease (<xref rid="B105" ref-type="bibr">105</xref>). CD103<sup>+</sup> CD11b<sup>&#8722;</sup> cDC1s predominantly reside within GALT and are specialized in cross-presentation, while CD103<sup>+</sup> CD11b<sup>+</sup> cDC2s are found within the lamina propria and migrate to the MLN for presentation of exogenous antigens to CD4<sup>+</sup> T cells and promote humoral immunity. CD103<sup>+</sup> CD11b<sup>+</sup> cDCs are essential for IL-6-dependent Th17 generation in the small intestine and colon (<xref rid="B135" ref-type="bibr">135</xref>) and necessary for the generation of IgG- and IgA-class-switched B cell responses to flagellin in MLNs (<xref rid="B136" ref-type="bibr">136</xref>). CD11b<sup>+</sup> CD103<sup>&#8722;</sup> DC subsets have also been described with the capacity to induce IL-17A and IFN&#947; production by T cells (<xref rid="B137" ref-type="bibr">137</xref>, <xref rid="B138" ref-type="bibr">138</xref>). CD103<sup>+</sup> DCs have also been identified as major sources of IL-23 in the context of <italic toggle="yes">Citrobacter rodentium</italic> infection, a widely used model of human attaching-effacing <italic toggle="yes">Escherichia coli</italic> infection (<xref rid="B139" ref-type="bibr">139</xref>&#8211;<xref rid="B141" ref-type="bibr">141</xref>). CD103<sup>+</sup> DCs are also essential for the maintenance of tolerance via the induction of gut-homing CCR9<sup>+</sup> FoxP3<sup>+</sup> Tregs and IgA<sup>+</sup> plasma cells, both within MLNs and GALT (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B142" ref-type="bibr">142</xref>).</p><p>DCs express Fc&#947;RI and Fc&#947;RIIA in humans, and Fc&#947;RIII in mice, although Fc&#947;R expression is skewed toward inhibitory Fc&#947;RIIB in immature DCs. Indeed, Fc&#947;RIIB blockade leads to spontaneous DC maturation and the induction of a cytokine programme characterized by TNF, IL-6, CXCL8, and IL-12p70 production (<xref rid="B127" ref-type="bibr">127</xref>, <xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B144" ref-type="bibr">144</xref>), although as with macrophage studies, these data are generated on <italic toggle="yes">in vitro</italic> differentiated DCs. Analysis of Immgen consortium datasets on <italic toggle="yes">in vivo</italic> differentiated DCs identifies Fc&#947;R expression with cDC2s (<xref rid="B126" ref-type="bibr">126</xref>). This expression is tightly regulated, with maturation signals, such as LPS or IFN&#947;, down-regulating Fc&#947;RIIB to allow for IgG-induced cell activation via activating Fc&#947;R ligation. DCs efficiently process Fc&#947;R-internalized antigen and upregulate MHC and co-stimulatory molecules for robust antigen presentation to T cells (<xref rid="B145" ref-type="bibr">145</xref>&#8211;<xref rid="B147" ref-type="bibr">147</xref>). Furthermore, Fc&#947;R cross-linking on DCs induces CCR7 and matrix metalloprotease expression that facilitates their migration from inflamed peripheral sites to local draining lymph nodes (<xref rid="B148" ref-type="bibr">148</xref>). As well as its role in IgG recycling, FcRn has also been demonstrated to mediate the presentation of immune complexed antigens by DCs; FcRn engagement by immune complexes protects antigens from degradation following Fc&#947;R-mediated internalization, preserving them for presentation and cross-presentation to CD4 and CD8 T cells, respectively (<xref rid="B149" ref-type="bibr">149</xref>). Therefore, classical Fc&#947;Rs and FcRn play a key role in DC antigen presentation to T cells through a variety of mechanisms.</p><p>As with macrophages, comprehensive information on Fc&#947;R expression in human gastrointestinal DCs across different anatomical regions of the gut is currently lacking.</p></sec><sec><title>Intestinal Neutrophils</title><p>The most abundant circulating leukocyte, neutrophils are first line inflammatory responders specializing in anti-microbial defense. This includes microbial internalization and killing, the release of proteases and reactive oxygen species, cytokine production, and the formation of neutrophil extracellular traps (NETs) (<xref rid="B150" ref-type="bibr">150</xref>). These functions are critical for defense following barrier breach, but their potent pro-inflammatory capability inevitably means that neutrophils may also contribute significantly to collateral tissue damage during inflammatory responses. Beyond microbicidal activity, neutrophils can shape adaptive immunity, for example via the production of APRIL and B cell activating factor (BAFF) in the marginal zone of the spleen (<xref rid="B151" ref-type="bibr">151</xref>), and may even be able to present antigen to T cells (<xref rid="B152" ref-type="bibr">152</xref>&#8211;<xref rid="B154" ref-type="bibr">154</xref>) identifying neutrophils as a more versatile immune subset than previously appreciated.</p><p>Neutrophils have long been associated with inflammation in patients with IBD and in defense against enteropathogens, rapidly recruited to the mucosa by resident and inflammatory mononuclear phagocytes (MNPs) (<xref rid="B155" ref-type="bibr">155</xref>, <xref rid="B156" ref-type="bibr">156</xref>). However, their role in intestinal inflammation remains enigmatic, exhibiting both detrimental and protective functions in a context-dependent manner (<xref rid="B157" ref-type="bibr">157</xref>&#8211;<xref rid="B159" ref-type="bibr">159</xref>), including the production of barrier-protective IL-22 (<xref rid="B160" ref-type="bibr">160</xref>). The extravasation of neutrophils into the intestine is also observed during homeostasis, where their engulfment by resident MNPs suppresses <italic toggle="yes">Il23a</italic> induction (<xref rid="B161" ref-type="bibr">161</xref>).</p><p>Neutrophils constitutively express Fc&#947;RIIA and Fc&#947;RIIIB in humans, and Fc&#947;RIII and Fc&#947;RIV in mice, with low levels of Fc&#947;RIIB in both species (<xref rid="B162" ref-type="bibr">162</xref>&#8211;<xref rid="B164" ref-type="bibr">164</xref>). Fc&#947;R cross-linking has profound effects on neutrophil function, as expected of cells acutely poised to respond to stress. This includes NET formation (<xref rid="B165" ref-type="bibr">165</xref>), cytokine production, such as IBD-associated TNF and oncostatin M (<xref rid="B166" ref-type="bibr">166</xref>, <xref rid="B167" ref-type="bibr">167</xref>), endothelial cell adhesion (<xref rid="B168" ref-type="bibr">168</xref>), phagocytosis (<xref rid="B169" ref-type="bibr">169</xref>), and reactive oxygen species production (<xref rid="B170" ref-type="bibr">170</xref>). Unsurprisingly, therefore, polymorphisms affecting Fc&#947;R function have consequences for the IgG-mediated activation of neutrophils. Most notably, three variants of Fc&#947;RIIIB exist (NA1, NA2, SH) that exhibit differential activity. NA1 is associated with enhanced uptake of IgG-opsonized erythrocytes (<xref rid="B171" ref-type="bibr">171</xref>), while SH enhances surface Fc&#947;RIIIB expression (<xref rid="B172" ref-type="bibr">172</xref>). Furthermore, copy number variation in <italic toggle="yes">FCGR3B</italic> correlates with Fc&#947;RIIIB surface levels, IC uptake, and soluble serum Fc&#947;RIIIB (<xref rid="B164" ref-type="bibr">164</xref>).</p></sec><sec><title>B Cell Response</title><p>As well as being the source of antibodies, B cells are also themselves regulated by IgG via expression of Fc&#947;RIIB, where it cross-links to the BCR to increase the cellular activation threshold and suppress antibody production (<xref rid="B18" ref-type="bibr">18</xref>). Furthermore, direct cross-linking of Fc&#947;RIIB on the surface of mature B cells and bone marrow-resident plasma cells can directly mediate apoptosis, thereby limiting the peripheral pool of antibody-producing cells (<xref rid="B173" ref-type="bibr">173</xref>, <xref rid="B174" ref-type="bibr">174</xref>). As such, Fc&#947;RIIB has a critical role in maintaining humoral tolerance. Whether local IgG-IC engagement of Fc&#947;RIIB in GALT similarly regulates B cells in the gastrointestinal tract is currently undetermined.</p></sec><sec><title>Innate Lymphocytes</title><p>ILCs are a recently identified class of immune cells that are enriched at mucosal sites, such as the GI and respiratory tracts (<xref rid="B175" ref-type="bibr">175</xref>). ILCs subsets mirror those seen for T cells. Natural killer (NK) cells represent the innate cytotoxic equivalent of CD8<sup>+</sup> T cells, whereas non-cytotoxic <italic toggle="yes">helper</italic> ILCs resemble CD4<sup>+</sup> T helper cells. All helper ILCs, hereafter referred to simply as ILCs, express IL-2R&#945; and IL-7R&#945;, but unlike T cells and B cells, they do not express somatically-rearranged antigen-specific receptors (<xref rid="B176" ref-type="bibr">176</xref>). Helper ILC subsets are divided into ILC1s, ILC2s, and ILC3s that largely mirror the transcription factor-dependence and cytokine effector profile of Th1, Th2, and Th17 cells, respectively.</p><p>Given the importance of Th17 biology in the gut, it is unsurprising that the GI tract represents one of the major sites of ILC colonization. Mature NKp46<sup>+</sup> ILC3s reside primarily in the intestinal mucosa and require ROR&#947;t for their development (<xref rid="B177" ref-type="bibr">177</xref>&#8211;<xref rid="B179" ref-type="bibr">179</xref>). Lymphoid tissue inducer (LTi) cells primarily reside within SLOs and represent a distinct ILC3 subset that develops partly independently of other helper ILCs (<xref rid="B180" ref-type="bibr">180</xref>). They contribute to lymphoid organogenesis and regulate local immunity through MHC-II expression and cytokine production (<xref rid="B181" ref-type="bibr">181</xref>&#8211;<xref rid="B184" ref-type="bibr">184</xref>). Through their production of IL-22, ILC3s play a critical role in the reinforcement of the intestinal epithelial barrier. Early studies demonstrated that <italic toggle="yes">C. rodentium</italic> infection induced innate intestinal IL-22 production that was dependent on IL-23 and the microbiota (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B185" ref-type="bibr">185</xref>). Subsequently, several studies have shown that IL-22R signaling mediates REG family AMP production, IEC fucosylation, and epithelial stem cell proliferation (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B186" ref-type="bibr">186</xref>&#8211;<xref rid="B191" ref-type="bibr">191</xref>). ILC3s are also an important source of GM-CSF, a key regulator of tissue immunity. In complementary studies, ILC3-derived GM-CSF was shown to orchestrate monocyte and granulocyte recruitment to the inflamed large intestinal lamina propria in anti-CD40 and <italic toggle="yes">H. hepaticus</italic> models of colitis (<xref rid="B192" ref-type="bibr">192</xref>&#8211;<xref rid="B194" ref-type="bibr">194</xref>).</p><p>Fc&#947;R expression has not been extensively investigated in ILCs. Their cytotoxic counterparts, NK cells, express activating Fc&#947;RIIC and Fc&#947;RIIIA in humans, and Fc&#947;RIII in mice, but not Fc&#947;RIIB (<xref rid="B195" ref-type="bibr">195</xref>, <xref rid="B196" ref-type="bibr">196</xref>). Fc&#947;R signaling on NK cells stimulates the targeted release of cytotoxic molecules to kill opsonized cells, a process known as antibody-dependent cell-mediated cytotoxicity (ADCC), as well as IFN&#947; and TNF-&#945; release (<xref rid="B197" ref-type="bibr">197</xref>, <xref rid="B198" ref-type="bibr">198</xref>). Several lines of evidence suggest that Fc&#947;R signaling may impact ILC function, either directly or indirectly. Firstly, Fc&#947;R signaling on MNPs may drive ILC3 activation through the production of type 17-inducing cytokines, such as IL-1&#946; and TL1A (<xref rid="B129" ref-type="bibr">129</xref>, <xref rid="B199" ref-type="bibr">199</xref>, <xref rid="B200" ref-type="bibr">200</xref>). Secondly, Fc&#947;RIII expression has been identified in murine ILC3s in global transcriptomic studies (<xref rid="B201" ref-type="bibr">201</xref>, <xref rid="B202" ref-type="bibr">202</xref>). Therefore, Fc&#947;R expression may be a common feature of cytotoxic and helper ILC subsets.</p></sec></sec></sec><sec id="s5"><title>Intestinal IgG in Health and Pathogen Defense</title><sec><title>Neonatal Immunity</title><p>The acquisition of maternally-derived secretory antibodies <italic toggle="yes">in utero</italic> and through breast milk provides neonates with an important source of immunity prior to the development of the host immune system (<xref rid="B203" ref-type="bibr">203</xref>). Mucosal pathogens are a major cause of death in children below the age of 5, with epidemiological data indicating that breastfeeding confers a 20-fold reduction in infant mortality from diarrhea. In this setting, maternally-derived IgG plays a key role in the maintenance of mutualism between the neonate and microbiome, tolerance toward innocuous dietary and environmental antigens, and systemic protection from pathogenic challenge (<xref rid="B5" ref-type="bibr">5</xref>&#8211;<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B204" ref-type="bibr">204</xref>, <xref rid="B205" ref-type="bibr">205</xref>).</p><p>Koch et al. demonstrated that in the absence of intestinal FcRn-mediated IgG uptake, neonates exhibited enhanced bacterial translocation to the MLN and compensatory mucosal inflammatory responses, most prominently exacerbated T follicular helper responses and germinal center B cell activation (<xref ref-type="fig" rid="F4">Figure 4</xref>) (<xref rid="B7" ref-type="bibr">7</xref>). This response was subsequently superseded by <italic toggle="yes">de novo</italic> anti-microbial IgG generation after weaning. Similarly, maternally-derived intestinal IgG was demonstrated to mediate protection against <italic toggle="yes">Heligmosomoides polygyrus</italic>, both through luminal delivery via milk and FcRn-mediated epithelial transport from the circulation (<xref rid="B206" ref-type="bibr">206</xref>). In a model of commensal colonization, Macpherson and colleagues further demonstrated the requirement for maternal IgG antibodies in the development of tissue-resident immune cells in neonates. Neonatal expansion of small intestinal NKp46<sup>+</sup> ILC3s and IL-22-dependent genes, such as REGIII&#947;, was IgG-dependent, driven by the retention and subsequent transfer of microbe-derived metabolites to offspring as immune complexes (<xref rid="B5" ref-type="bibr">5</xref>) (<xref ref-type="fig" rid="F4">Figure 4</xref>). Strikingly, this included ligands for AHR, a key transcription factor mediating ILC3 development (<xref rid="B178" ref-type="bibr">178</xref>, <xref rid="B207" ref-type="bibr">207</xref>). Consequently, offspring to colonized dams were better able to control intestinal microbial challenge and suppress systemic dissemination of bacteria.</p><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>IgG in intestinal homeostasis. FcRn-mediated placental and epithelial transport contributes to the neonatal anti-microbial IgG repertoire in early life, mediating protection against opportunistic mucosal invasion. Maternally-derived IgG contributes to protection from allergic responses through FcRn-mediated antigen presentation by DCs to T cells for regulatory T cell induction. IgG-mediated transfer of microbial molecules, such as SCFAs, also supports appropriate immune cell development. In adult humans and mice, anti-microbial IgG is generated throughout life in GALT, contributing to systemic protection from infection through engagement of Fc&#947;Rs on myeloid cells. In humans, FcRn is continuously expressed within the intestinal epithelium, allowing for bidirectional trafficking of IgG and immune complexes between the intestinal lumen and lamina propria for antigen delivery to local Fc&#947;R-expressing myeloid cells. SCFA, short-chain fatty acids; ILC3, group 3 innate lymphoid cell; FcRn, neonatal Fc receptor; AHR, aryl hydrocarbon receptor.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-00805-g0004.jpg"/></fig><p>Beyond microbial recognition, intestinal IgG plays a key role in tolerance to innocuous antigens. In a recent elegant study, Ohsaki et al. demonstrated that epicutaneous sensitization of pregnant mothers with model allergens resulted in suppressed allergic responses in offspring subsequently challenged with the same antigen (<xref rid="B8" ref-type="bibr">8</xref>). Lower allergen-specific IgE titres, impaired mucosal and systemic Th2 activation, and reduced anaphylaxis was attributed to intestinal FcRn-mediated allergen:IgG immune complex uptake and presentation within MLNs by tolerogenic DCs which, in turn, induced protective mucosal Tregs. Indeed, given the roles for Fc&#947;R signaling in DC activation, this suggests IgG-mediated trafficking and presentation may be a common mechanism of immune complex-mediated immune responses in DCs across tissues (<xref rid="B148" ref-type="bibr">148</xref>). Whether similar mechanisms exist for the induction of microbe-induced Tregs remains to be established. Furthermore, how DC presentation of IgG-opsonized antigens may be altered during mucosal inflammation, and whether this induces pro-inflammatory T cell responses that promote microbial elimination has yet to be explored.</p></sec><sec><title>Intestinal and Systemic Infection</title><p>In healthy adult mice, microbe-specific IgG is largely excluded from the intestinal lumen, suggesting that its major site of action is in the intestinal wall, where it combats invasive microbial species, and in protection from systemic challenges. For example, IgG responses induced by gram negative bacterial antigens have been demonstrated to confer Fc&#947;R-mediated protection against systemic <italic toggle="yes">E. coli</italic> and <italic toggle="yes">Salmonella</italic> challenge (<xref rid="B205" ref-type="bibr">205</xref>). Indeed, murine IgG2b is known to effectively engage Fc&#947;Rs and complement receptors, suggesting a role in the activation of mucosal phagocytes (<xref rid="B208" ref-type="bibr">208</xref>). A striking aspect of this response is its inherent flexibility, tuneable to fluctuations in microbial loads and to genetically-determined variation in the strength of the mucosal innate immune system. For example, defective TLR signaling or oxidative burst production augments gut T cell-dependent microbial IgG titres that act to preserve mutualism <italic toggle="yes">in vivo</italic> (<xref rid="B204" ref-type="bibr">204</xref>). Therefore, IgG-mediated anti-commensal responses represent an essential and plastic mechanism required to maintain host-microbe mutualism and mediate protection from systemic pathogen spread.</p><p>The context of antigen delivery to GALT is a critical determinant of subsequent humoral immune responses. Antigen presentation in inflamed or infected mucosae, or from high antigenic loads, induces potent antibody responses due to alterations in adjuvant-derived signals, leading to high-avidity T cell-dependent antibodies that contribute to specific elimination of the inductive bacterial species (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B209" ref-type="bibr">209</xref>). As well as being induced continuously in GALT largely independently of T cells, <italic toggle="yes">de novo</italic> T cell-dependent IgG has been identified in models of intestinal infection, where it has been shown to make essential contributions to sterilizing immunity.</p><p>In murine models, B cells are required for clearance of <italic toggle="yes">C. rodentium</italic>, although this was independent of secretory IgA and IgM (<xref rid="B102" ref-type="bibr">102</xref>). Although initial disease activity and bacterial containment was equivalent between B cell-sufficient and deficient mice at 2 weeks post-infection, B cell-deficient mice exhibited enhanced mucosal inflammation and severe crypt hyperplasia with ulceration at 6 weeks, consistent with defective infection control. Disease susceptibility was rescued only by passive transfer of IgG-replete immune serum (<xref rid="B210" ref-type="bibr">210</xref>). Anti-<italic toggle="yes">C. rodentium</italic> IgG titres are diminished in CD4<sup>+</sup> T cell-deplete mice, which are highly susceptible to <italic toggle="yes">C. rodentium</italic>, suggesting a critical role for T cell-dependent antibody responses (<xref rid="B211" ref-type="bibr">211</xref>). Adequate IgG responses to <italic toggle="yes">C. rodentium</italic> are also dependent on NOD2-mediated bacterial sensing within the intestinal epithelium. Impaired local adaptive immune activation is observed in <italic toggle="yes">Nod2-</italic>deficient mice, attributed to reduced CCL2-mediated monocyte recruitment (<xref rid="B212" ref-type="bibr">212</xref>). Monocyte-derived IL-12 was required for induction of Th1 cells (<xref rid="B213" ref-type="bibr">213</xref>), with IFN&#947; being an effective driver of IgG class-switching (<xref rid="B214" ref-type="bibr">214</xref>, <xref rid="B215" ref-type="bibr">215</xref>), suggesting a possible mechanism for this effect. As well as complement-fixing activity (<xref rid="B216" ref-type="bibr">216</xref>), the contribution of Fc&#947;Rs to IgG-mediated protection in this model was investigated using Fc receptor common gamma chain (FcR&#947;)-deficient mice, which lack productive signaling from activating Fc&#947;Rs (<xref rid="B217" ref-type="bibr">217</xref>). FcR&#947;-deficient mice phenocopy B cell-deficient mice, succumbing more rapidly to infection, with increased bacterial burden and mucosal inflammation. In the absence of Fc&#947;R signaling, MNP-mediated <italic toggle="yes">C. rodentium</italic> phagocytosis, cellular maturation, and inflammatory cytokine production was impaired, as was antigen presentation to T cells. In an elegant study, Kamada et al. demonstrated the specific targeting of virulence factors on invasive strains of <italic toggle="yes">C. rodentium</italic> by mucosal IgG, consistent with their ability to adhere to the intestinal epithelium and elicit inflammation (<xref rid="B6" ref-type="bibr">6</xref>). In contrast, non-virulent strains and commensals residing predominantly within the lumen remained untargeted. Both MNPs and neutrophils are required for Fc&#947;R-mediated protection, with neutrophils shown to directly access opsonized bacteria within the intestinal lumen (<xref rid="B6" ref-type="bibr">6</xref>). Furthermore, more recent work from Caballero-Flores et al. has demonstrated that this IgG-mediated protection against <italic toggle="yes">C. rodentium</italic> can be vertically transmitted to offspring via breast milk (<xref rid="B218" ref-type="bibr">218</xref>).</p><p>In humans, FcRn expression is not limited to a brief developmental window, allowing the entry and retrieval of IgG from the intestinal lumen throughout health and disease. The importance of this was demonstrated in transgenic murine experiments with forced expression of human FcRn in murine IECs (<xref rid="B26" ref-type="bibr">26</xref>). This bidirectional transport allowed the secretion of IgG into the lumen, the subsequent uptake of opsonized bacteria, and the induction of local antigen-specific CD4<sup>+</sup> T cell responses required for clearance. Therefore, cross-talk between CD4<sup>+</sup> T cells and IgG-expressing B cells appears to be required for effective intestinal pathogen clearance. FcRn-mediated protection has also been demonstrated in a mouse model of <italic toggle="yes">Helicobacter pylori</italic> infection, with reduced IgG levels in gastric juice of challenged FcRn-deficient animals, with increased bacterial penetrance and activated lymphoid follicles compared to controls (<xref rid="B219" ref-type="bibr">219</xref>).</p><p>Beyond models of murine bacterial challenge, several studies in non-human primates have also identified roles for IgG in anti-viral mucosal immunity. Passive administration of anti-HIV neutralizing IgG can prevent mucosal viral transmission in rhesus macaques following oral administration (<xref rid="B220" ref-type="bibr">220</xref>, <xref rid="B221" ref-type="bibr">221</xref>). The Fc domain of anti-HIV broadly neutralizing antibodies was required for anti-viral activity <italic toggle="yes">in vivo</italic> (<xref rid="B222" ref-type="bibr">222</xref>) and could be further enhanced through Fc domain engineering to augment Fc-mediated activating Fc&#947;R engagement (<xref rid="B222" ref-type="bibr">222</xref>). Fc domain modification to increase FcRn binding also increased the serum half-life of the antibody and enhanced mucosal tissue localization (<xref rid="B223" ref-type="bibr">223</xref>). In a recent study, it was demonstrated that the site of immunization influences the dominant protective mechanisms of elicited Igs (<xref rid="B224" ref-type="bibr">224</xref>). Intramuscular vaccination induced an IgG-dominated response, with protection correlating most strongly with Fc&#947;R-mediated viral phagocytosis by monocytes. In contrast, mucosal vaccination via aerosol elicited an IgA-skewed response that correlated with neutrophil-mediated phagocytosis. Protection via mucosal vaccination also correlated significantly with Fc&#947;RIIA binding, suggesting that mucosal vaccine-specific IgA and IgG may cooperate to drive neutrophil-mediated viral clearance <italic toggle="yes">in vivo</italic>. Despite these differences in mechanism, both routes were equally effective in suppressing viral infection. Similarly, passive transfer of serum rotavirus-specific IgG has been shown to suppress oral rotavirus infection in na&#239;ve pigtailed macaques (<xref rid="B225" ref-type="bibr">225</xref>).</p></sec></sec><sec id="s6"><title>IgG, Fc&#947;Rs, and Intestinal Inflammation</title><sec><title>Inflammatory Bowel Disease</title><p>Inflammatory bowel disease is a chronic relapsing inflammatory disorder of the GI tract that causes considerable morbidity and is associated with an increased risk of colonic cancer (<xref rid="B156" ref-type="bibr">156</xref>, <xref rid="B226" ref-type="bibr">226</xref>, <xref rid="B227" ref-type="bibr">227</xref>). There are two main subtypes, Crohn's disease (CD), and UC, that differ in their clinical and pathological presentations. CD may affect any part of the GI tract and is associated with transmural inflammation affecting the entire mucosa and the formation of granulomas. In contrast, in UC, lesions are localized to the large bowel, resulting in continuous superficial mucosal inflammation and ulceration of the intestinal wall, with micro-abscess formation and neutrophil infiltration within the lamina propria common.</p><p>GWA studies (GWAS) have contributed significantly toward the understanding of the pathogenesis of IBD, with the immune system and its interaction with the microbiome lying at the core of disease susceptibility. Disease is driven by a genetic predisposition to aberrant mucosal immune responses toward the microbiota in the context of poorly-defined environmental factors, with unique and shared genetic traits between CD and UC (<xref rid="B156" ref-type="bibr">156</xref>). Furthermore, many disease-associated mechanistic pathways in IBD are shared with other extra-intestinal diseases, including ankylosing spondylitis and psoriasis (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B228" ref-type="bibr">228</xref>). A pathway implicated by genetic studies in both UC and CD is the IL-23/IL-17 cytokine axis (<xref rid="B61" ref-type="bibr">61</xref>). A SNP associated with an amino acid substitution in the cytoplasmic domain of IL-23R conferred significant protection against IBD. Several murine studies also support a pathogenic role for IL-23 in the intestine, ascribed to its ability to drive Th17-mediated inflammation (<xref rid="B229" ref-type="bibr">229</xref>&#8211;<xref rid="B231" ref-type="bibr">231</xref>). In human studies, antibodies against the common p40 subunit of IL-12 and IL-23 led to increased rates of clinical response in CD compared with placebo.</p><p>More generally, innate cytokine production is dysregulated in IBD, including TNF and IL-1&#946; (<xref rid="B63" ref-type="bibr">63</xref>). This is notably reflected in the efficacy of anti-TNF IgG monoclonal antibodies in the treatment of human disease (<xref rid="B156" ref-type="bibr">156</xref>, <xref rid="B232" ref-type="bibr">232</xref>). Furthermore, clinical trials are underway for the use of Anakinra (IL-1Ra), an IL-1&#946; antagonist, in the treatment of severe treatment-resistant UC (IASO trial) (<xref rid="B233" ref-type="bibr">233</xref>, <xref rid="B234" ref-type="bibr">234</xref>). In addition to its role in mediating neutrophil inflammatory responses (<xref rid="B235" ref-type="bibr">235</xref>), IL-1&#946; has important roles in type 17 immunity in concert with IL-23, particularly in the expansion and maintenance of Th17 cells within inflamed tissues (<xref rid="B236" ref-type="bibr">236</xref>). Strikingly, Ghoresch et al. demonstrated that combined stimulation of na&#239;ve T cells with IL-23, IL-1&#946;, and IL-6, in the absence of TGF&#946;, was sufficient to induce a pathogenic subset of Th17 cells (<xref rid="B237" ref-type="bibr">237</xref>), while dual IL-23 and IL-1&#946; stimulation has been shown to bypass the requirement for CD28-mediated co-stimulation for the induction of human Th17 cells (<xref rid="B238" ref-type="bibr">238</xref>). Despite the advances in our understanding of how these cytokines drive T cell-mediated pathology in the gut, therapeutic targeting of the downstream effector cytokines has proved unsuccessful, or even detrimental, in the treatment of IBD, as observed with monoclonal antibodies targeting IFN&#947; or IL-17A (<xref rid="B63" ref-type="bibr">63</xref>).</p><p><italic toggle="yes">De novo</italic> IgG generation has long been associated with chronic intestinal inflammation in IBD patients (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B239" ref-type="bibr">239</xref>) (<xref ref-type="fig" rid="F5">Figure 5</xref>). IBD-associated IgG appears to be directed against components of the commensal microbiome, particularly flagellin (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B239" ref-type="bibr">239</xref>). A significant proportion of UC patients also develop of auto-antibodies. Perinuclear anti-neutrophil cytoplasmic antibodies (pANCA) are observed in two thirds of UC patients (<xref rid="B240" ref-type="bibr">240</xref>&#8211;<xref rid="B242" ref-type="bibr">242</xref>), while antibodies against colonic goblet cells have been observed in some subjects (<xref rid="B243" ref-type="bibr">243</xref>). CXCR4<sup>+</sup> IgG plasmablasts have been described in the inflamed colonic mucosa of patients with IBD (<xref rid="B200" ref-type="bibr">200</xref>), suggesting local IgG production. However, despite these reports, a systematic characterization of the IBD-associated IgG repertoire and the identification of the cellular mechanisms by which IgG might contribute to IBD pathogenesis has been lacking.</p><fig id="F5" position="float" orientation="portrait"><label>Figure 5</label><caption><p>Involvement of IgG in intestinal inflammation. <bold>(A)</bold> There are multiple lines of evidence for the involvement of IgG and Fc&#947;R signaling in the pathogenesis in IBD. In genetic studies, the low-affinity Fc&#947;RIIA-R131 variant is associated with protection from UC in several independent cohorts. Systemic and local induction of <italic toggle="yes">de novo</italic> anti-commensal IgG and auto-antibodies, such as pANCA, is observed in human IBD, while IgG<sup>+</sup> plasma cells and Fc&#947;R-expressing cells are enriched in mucosal biopsies from IBD patients with active disease. In murine studies, <italic toggle="yes">de novo</italic> IgG production is observed, and passive transfer of anti-flagellin IgG to na&#239;ve animals exacerbates DSS-induced colitis. Fc&#947;R signaling strength determines the magnitude of intestinal inflammation in this model. In humans, IgG immune complex stimulation of intestinal LPMCs drives inflammatory cytokine production, including IL-1&#946;. <bold>(B)</bold> IgG and Fc&#947;R in intestinal inflammation: Inflammation is characterized by an increase in the generation of local anti-commensal IgG. These immune complexes cross-link Fc&#947;R on colonic MNP, leading to NLRP3 and ROS-dependent IL-1&#946; production. IL-1&#946;, in turn drives Th17 immunity propagating inflammation. ROS, reactive oxygen species; MNP, mononuclear phagocyte; LPMCs, lamina propria mononuclear cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-10-00805-g0005.jpg"/></fig><p>Genetic studies in IBD support the thesis that IgG play a role in UC pathogenesis (<xref ref-type="fig" rid="F5">Figure 5</xref>). A variant of Fc&#947;RIIA was initially associated with protection from UC in a Japanese case control study (<xref rid="B13" ref-type="bibr">13</xref>), and this was confirmed in a metanalysis of GWAS that included data from more than 70,000 patients. The Fc&#947;RIIA variant encodes a histidine or arginine at position 131 (H/R131) within the second Ig-like domain, resulting in variable ligand affinity (<xref rid="B244" ref-type="bibr">244</xref>, <xref rid="B245" ref-type="bibr">245</xref>), with reduced binding affinity for IgG1 and IgG2 in the R131 variant receptor compared to the H131 receptor (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B246" ref-type="bibr">246</xref>), the major IgG isotypes detected in the human gut (<xref rid="B10" ref-type="bibr">10</xref>). In UC, homozygous R/R131 individuals are protected from disease (odds ratio = 0.63; <italic toggle="yes">P</italic> = 1.56 &#215; 10<sup>&#8722;12</sup>) (<xref rid="B13" ref-type="bibr">13</xref>), suggesting that IgG plays a pathogenic role within the gut rather than being merely a bystander of inflammation. Of note, the Fc&#947;RIIA H/R131 SNP has been associated with susceptibility to a number of other autoimmune and inflammatory conditions. For example, the high-affinity H131 polymorphism is associated with Kawasaki disease and systemic vasculitis (<xref rid="B247" ref-type="bibr">247</xref>).</p><p>To further investigate the role of IgG in UC, we first assessed the extent to the fecal microbes were opsonized by IgA or IgG. In contrast to household controls, where &lt;10% of luminal bacteria were bound by IgG, up to 80% of commensal microbes were IgG-opsonized in UC patients (<xref rid="B248" ref-type="bibr">248</xref>). In support of local production of this anti-commensal IgG, we found a marked increase in both heavy chain <italic toggle="yes">Ig</italic> gene transcripts within UC mucosal biopsies, as well as enrichment of several Fc&#947;R gene transcripts and associated signaling pathways. To investigate the pathological significant of these observations, we used dextran sodium sulfate (DSS)-induced colitis to interrogate the impact of IgG and Fc&#947;R cross-linking of intestinal inflammation. Kobayashi et al. previously demonstrated that exposure to DSS leads to <italic toggle="yes">de novo</italic> production of anti-flagellin IgG, a dominant IgG-targeted antigen in human IBD (<xref rid="B249" ref-type="bibr">249</xref>). We confirmed this and demonstrated a more widespread IgG response against multiple bacterial species, including both commensals and pathobionts. This was driven in part by the <italic toggle="yes">de novo</italic> emergence of IgG-producing B cells and plasma cells within the colonic mucosa and GALT, in line with previous observations (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B200" ref-type="bibr">200</xref>). Immune cell profiling identified CX3CR1<sup>+</sup> monocytes and macrophages as the major Fc&#947;R-expressing colonic cell types, including expression of the risk receptor Fc&#947;RIIA in humans. Furthermore, these cell subsets represent the dominant source of IL-1&#946; production, one of the dominant inflammatory cytokines in human and murine colitis. Passive transfer of anti-flagellin IgG was sufficient to augment pro-IL-1&#946; expression by colonic MNPs in mice exposed to DSS and enhance disease severity in a manner analogous to experiments by Kobayashi et al., whereby na&#239;ve mice exposed to anti-flagellin IgG exhibited enhanced weight loss and pathology scores. To assess the contribution of MNP Fc&#947;R signaling to this disease augmentation, we made use of transgenic mice with different Fc&#947;R A:I ratio through manipulation of the inhibitory receptor, Fc&#947;RIIB. <italic toggle="yes">Fcgr2b</italic><sup>&#8722;/&#8722;</sup> mice exhibited elevated MNP pro-IL-1&#946; expression both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>, leading to exacerbated colonic type 17 T cell responses, and impaired recovery from DSS exposure, effects mitigated by IL-1&#946; blockade. In contrast, macrophage-intrinsic Fc&#947;RIIB over-expression imparted protection to DSS-induced colitis over non-transgenic littermate controls, demonstrating that MNP-intrinsic Fc&#947;R signal strength determines the magnitude of intestinal inflammation.</p><p>Our demonstration of the cellular and molecular mechanisms by which IgG-commensal immune complexes might drive inflammation in UC raise several additional questions. Genetic susceptibility studies in IBD to date have focused on <italic toggle="yes">FCGR2A</italic>, but variants in other Fc&#947;Rs, particularly <italic toggle="yes">FCGR2B</italic>, may be of relevance to disease pathogenesis. For example, Fc&#947;RIIB-T232 (rs1050501) results in an isoleucine-to-threonine substitution in the receptor transmembrane domain of the receptor leading to exclusion of the receptor from sphingolipid rafts (<xref rid="B250" ref-type="bibr">250</xref>&#8211;<xref rid="B252" ref-type="bibr">252</xref>). Fc&#947;RIIB-T232 is associated with susceptibility to SLE (<xref rid="B253" ref-type="bibr">253</xref>, <xref rid="B254" ref-type="bibr">254</xref>), and at a cellular level, with exacerbated pro-inflammatory responses to IgG immune complexes in macrophages and DCs (<xref rid="B255" ref-type="bibr">255</xref>). Conversely, the Fc&#947;RIIB-T232 genotype is associated with enhanced protection against some infections, including malaria (<xref rid="B254" ref-type="bibr">254</xref>). The activating Fc&#947;RIIIA-V158 variant, encoding a valine rather than a phenylalanine at position 158, exhibits enhanced affinity for all IgG subclasses (<xref rid="B31" ref-type="bibr">31</xref>) and is associated with susceptibility to rheumatoid arthritis (<xref rid="B256" ref-type="bibr">256</xref>, <xref rid="B257" ref-type="bibr">257</xref>) and immune-mediated thrombocytopenic purpura. These SNPs in inhibitory Fc&#947;RIIB and activating Fc&#947;RIIIA have profound effects on IgG-mediated inflammation, and certainly have the potential to influence susceptibility to, or progression of, intestinal inflammatory disease. A comprehensive genetic profiling of <italic toggle="yes">FCGR</italic> polymorphisms in IBD will be required to address this question, but has previously been technically challenging due to the sequence similarity between the Fc&#947;R genes (that have arisen by gene duplication), and to the copy number variation at this locus (<xref rid="B258" ref-type="bibr">258</xref>).</p><p>A further interesting question raised by our study is whether abnormalities in the IgG glycome may be present in patients with IBD, and the extent to which these may influence the pathogenicity of anti-commensal IgG. Aberrations in IgG glycome have been described in several autoimmune disorders, and in individuals with impaired responses to infectious agents, such as <italic toggle="yes">Mycobacterium tuberculosis</italic>. The development of widescale IgG profiling via so-called &#8220;systems serology&#8221; by Alter and colleagues has further implicated distinct IgG glycosylation patterns with IgG functionality and immune reactivity in various disease settings (<xref rid="B259" ref-type="bibr">259</xref>&#8211;<xref rid="B261" ref-type="bibr">261</xref>). Increased agalactosylated IgG has been observed in patients with RA and SLE, a state which favors IgG binding to activating Fc&#947;Rs, as well as a reduction in IgG sialylation (<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B262" ref-type="bibr">262</xref>, <xref rid="B263" ref-type="bibr">263</xref>). In IBD, abnormal patterns of IgG glycosylation have also been described, with increased agalactosylated IgG in both UC and CD (<xref rid="B264" ref-type="bibr">264</xref>), and decreased IgG sialylation detectable in CD (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B265" ref-type="bibr">265</xref>). Sialylated IgG is associated with increased binding to non-classical Fc receptors, such as DC-SIGN (<xref rid="B45" ref-type="bibr">45</xref>), the induction of Fc&#947;RIIB on effector cells (<xref rid="B122" ref-type="bibr">122</xref>), reduced complement-dependent cytotoxicity (<xref rid="B266" ref-type="bibr">266</xref>), and is an essential component of IVIg. Furthermore, agalacotsylated IgG exhibits reduced binding to Fc&#947;RIIB (<xref rid="B38" ref-type="bibr">38</xref>). Taken together, these data suggest that IgG profiles in IBD are skewed toward a pro-inflammatory phenotype, as observed in other antibody-mediated autoimmune diseases (<xref rid="B19" ref-type="bibr">19</xref>). Strikingly, five genes known to regulate IgG glycosylation show robust association with IBD (<italic toggle="yes">IKZF1, LAMB1, MGAT3, IL6ST</italic>, and <italic toggle="yes">BACH2</italic>) (<xref rid="B42" ref-type="bibr">42</xref>), including genes encoding galactosyltransferases (<xref rid="B41" ref-type="bibr">41</xref>). Given the association between pathological IL-23R signaling and IBD, and the observation that IL-23-derived Th17 immunity promotes IgG class-switching and inflammatory glycosyl patterns (<xref rid="B267" ref-type="bibr">267</xref>), these pathways may reinforce one another for the augmentation of pathology in the GI tract.</p><p>While the majority of studies focusing on Fc&#947;R signaling in GI immunity have focused on MNP and DC biology (<xref rid="B200" ref-type="bibr">200</xref>, <xref rid="B217" ref-type="bibr">217</xref>, <xref rid="B248" ref-type="bibr">248</xref>, <xref rid="B268" ref-type="bibr">268</xref>), relatively little is known about how Fc&#947;R signaling in neutrophils may contribute to intestinal pathology. Neutrophils are massively expanded in IBD (<xref rid="B155" ref-type="bibr">155</xref>) and express Fc&#947;RIIA and Fc&#947;RIIIB, as well as lower levels of Fc&#947;RIIB, making them candidates to directly promote IgG-mediated inflammation. Furthermore, the emergence of pANCA IgG in two-thirds of UC patients directly implicates neutrophils in the ongoing intestinal humoral response (<xref rid="B240" ref-type="bibr">240</xref>&#8211;<xref rid="B242" ref-type="bibr">242</xref>). Indeed, increased <italic toggle="yes">FCGR3B</italic> gene copy number is associated with susceptibility to UC, directly implicating the Fc&#947;R-neutrophil axis in IBD (<xref rid="B269" ref-type="bibr">269</xref>). The mechanisms by which this axis leads to disease susceptibility, however, remain unexplored.</p></sec><sec><title>IgG in Inflammation-Associated Intestinal Cancer</title><p>IBD is associated with a significant risk of developing colorectal cancer. Endogenous and therapeutic monoclonal antibody responses can contribute to tumor rejection <italic toggle="yes">in vivo</italic> through a variety of mechanisms, including DC-mediated T cell activation and NK cell-mediated ADCC (<xref rid="B270" ref-type="bibr">270</xref>, <xref rid="B271" ref-type="bibr">271</xref>). Indeed, in the gut, anti-tumor immunity is impaired in the absence of functional IgG responses (<xref rid="B268" ref-type="bibr">268</xref>). Consistent with its ability to induce cross-presentation, FcRn-deficient DCs from the MLN of colitogenic mice were impaired in their ability to induce IFN&#947; production by OT-I cells <italic toggle="yes">in vitro</italic> (<xref rid="B149" ref-type="bibr">149</xref>), while MLN CD8 T cells from FcRn-deficient mice were equally impaired in their ability to produce granzyme B and IFN&#947; following <italic toggle="yes">ex vivo</italic> re-stimulation. In the context of tumorigenesis, DC-specific FcRn expression protected against the development of colorectal cancer and lung metastases in the <italic toggle="yes">Apc</italic><sup><italic toggle="yes">min</italic></sup><sup>/+</sup> and DSS/azoxymethane (AOM) models via the homeostatic mucosal activation of endogenous tumor-reactive CD8 T cells (<xref rid="B268" ref-type="bibr">268</xref>). This protection was dually dependent on cross-presentation and IgG-IC-driven IL-12 production by DCs. In summary, Fc&#947;R-driven immune responses have the potential to contribute to both pathological and protective inflammation in IBD and cancer.</p></sec></sec><sec id="s7"><title>Fc&#947;R Pathways in the Treatment of Intestinal Disease</title><sec><title>Targeting Fc&#947;R Signaling in IBD</title><p>Our demonstration of the mechanism by which anti-commensal IgG might drive intestinal inflammation in UC also has therapeutic implications for IBD, particularly given the finding that high levels of colonic IgG and activating Fc&#947;R receptor transcripts are associated with resistance to TNF blockade (<xref rid="B248" ref-type="bibr">248</xref>). Strategies aimed at reducing the production of pathogenic IgG or blocking its effector function via Fc&#947;Rs, including B cell depletion, plasmapheresis, and IVIg administration, are commonly used in several inflammatory disorders but their application to IBD has not been studied extensively. No randomized control trials exist for IVIg but a meta-analysis identified a handful of case reports which indicated that IVIg can induce a rapid improvement in steroid resistant CD (<xref rid="B272" ref-type="bibr">272</xref>, <xref rid="B273" ref-type="bibr">273</xref>), and there are reports of utility in UC (<xref rid="B274" ref-type="bibr">274</xref>). A single randomized controlled trial exists for the anti-CD20 antibody rituximab in UC, where the number of patients included precludes any robust conclusions (<xref rid="B275" ref-type="bibr">275</xref>). In UC, of 16 patients who failed to respond to standard therapies, half demonstrated a response at 4 weeks compared to 2 of 8 placebo-treated patients, although this was not maintained to 12 weeks in a further half of patients. However, this study was substantially underpowered, given that studies examining the efficacy of anti-TNF therapies contain hundreds of patients (<xref rid="B234" ref-type="bibr">234</xref>). The efficacy of rituximab in depleting mucosal B cells in this study is unclear, given the use of CD20 expression itself to determine depletion, which may be masked by rituximab. Rituximab leads to pan-B cell depletion, which can exacerbate allo- and auto-immunity due to removal of regulatory B cells (<xref rid="B276" ref-type="bibr">276</xref>&#8211;<xref rid="B278" ref-type="bibr">278</xref>) and may be a sub-optimal therapeutic strategy, although rituximab does not appear to exacerbate UC in this instance. Finally, the experimental design of this study does not investigate the effect of repeated B cell depletion, which is associated with long-term treatment response in RA (<xref rid="B279" ref-type="bibr">279</xref>). Therefore, the question of whether B cell manipulation may be of benefit in UC has not been adequately addressed.</p><p>FcRn inhibitors are currently under development for use in autoimmune diseases, and effectively reduce serum IgG (<xref rid="B280" ref-type="bibr">280</xref>&#8211;<xref rid="B283" ref-type="bibr">283</xref>). Given the prominent role for FcRn in the GI tract, this may also influence IgG epithelial transport and immune complex-mediated local T cell activation within the mucosa of IBD patients.</p><p>As well as targeting IgG generation, therapeutic manipulation of Fc&#947;R signaling may also prove effective in IBD. Although small molecule SYK inhibitors were shown to be beneficial in RA patients (<xref rid="B284" ref-type="bibr">284</xref>), off-target side-effects are common given the widespread expression and function of SYK (<xref rid="B285" ref-type="bibr">285</xref>). Modulation of Fc&#947;RIIB activity is central to many newer therapies. Enforced co-localization of Fc&#947;RIIB with CD19 on B cells using an engineered anti-CD19 monoclonal antibody successfully suppressed humoral immunity in peripheral blood mononuclear cell (PBMC)-engrafted SCID mice (<xref rid="B286" ref-type="bibr">286</xref>). Furthermore, small preliminary studies have demonstrated efficacy of soluble human Fc&#947;RIIB in the treatment of ITP and SLE (<xref rid="B285" ref-type="bibr">285</xref>). However, a deeper understanding of the mechanisms of IgG-mediated inflammation in the GI tract are required for the development of sophisticated therapeutic strategies.</p></sec><sec><title>Fc&#947;R Influence on Therapeutic Intervention</title><p>Beyond targeting IgG-mediated inflammation therapeutically, it is known that Fc&#947;R polymorphisms can influence the efficacy of monoclonal antibody therapies in IBD. CD patients homozygous for the high affinity Fc&#947;RIIIA-V158 variant demonstrated improved biological responses (as determined by reduced CRP), and a trend toward improved clinical responses, to infliximab compared to Fc&#947;RIIIA-F158-bearing individuals (<xref rid="B287" ref-type="bibr">287</xref>, <xref rid="B288" ref-type="bibr">288</xref>). NK cells and PBMCs from Fc&#947;RIIIA-V158 homozygotes exhibited increased antibody binding and ADCC in response to infliximab. Furthermore, Fc&#947;R-dependent effector function has been implicated in mediating protective functions of infliximab at least partly via its ability to form anti-inflammatory immune complexes with trimeric TNF (<xref rid="B289" ref-type="bibr">289</xref>, <xref rid="B290" ref-type="bibr">290</xref>). Genetic variation in Fc&#947;RIIA can also influence responses to therapeutic monoclonal antibodies, for example the efficacy of rituximab therapy in B-cell lymphomas (<xref rid="B291" ref-type="bibr">291</xref>).</p><p>Fc&#947;R function also has a key role in the effector function of therapeutic monoclonal antibodies in tumor immunotherapy, including checkpoint blockade (<xref rid="B292" ref-type="bibr">292</xref>, <xref rid="B293" ref-type="bibr">293</xref>). The specific contributions of Fc&#947;R-mediated effector functions have been uncovered through the generation of Fc-optimized antibodies. Fc&#947;R-optimized anti-CD25 IgG shows improved ability to deplete intra-tumoral Tregs by bypassing the upregulation of Fc&#947;RIIB by tumor-associated macrophages and cDCs (<xref rid="B292" ref-type="bibr">292</xref>). Similarly, anti-CTLA4 IgG requires an Fc domain for activity (<xref rid="B294" ref-type="bibr">294</xref>), with hIgG2 antibodies driving Fc&#947;RIIA-mediated intra-tumoral Treg depletion in humanized mice (<xref rid="B293" ref-type="bibr">293</xref>). Strikingly, Fc&#947;RIIIA co-engagement on APCs by anti-CTLA4 IgG also augmented APC-T cell interaction and promoted pro-tumoricidal effector T cell responses (<xref rid="B295" ref-type="bibr">295</xref>).</p><p>These considerations extend to colorectal cancer, where patients treated with cetuximab, a monoclonal IgG1 antibody directed against EGFR, displayed improved survival in the presence of the high-affinity Fc&#947;RIIA-H131 variant (<xref rid="B296" ref-type="bibr">296</xref>). However, despite these advancements, a significant proportion of patients remain unresponsive to treatment (<xref rid="B293" ref-type="bibr">293</xref>) and further studies are required to determine the impact of these Fc&#947;R-mediated effector functions in immunotherapy.</p></sec></sec><sec sec-type="conclusions" id="s8"><title>Conclusion</title><p>Despite the identification of IgG positive cells in colonic biopsies more than 40 years ago by Baklien and Brandtzaeg (<xref rid="B9" ref-type="bibr">9</xref>) and the subsequent confirmation of the anti-microbial specificity of this mucosal IgG (<xref rid="B239" ref-type="bibr">239</xref>), research into the role of IgG antibodies in an otherwise IgA-dominated organ system has been relatively limited. However, the identification of <italic toggle="yes">FCGR2A</italic><sup>*</sup><italic toggle="yes">A519G</italic> (rs1801274) as the most-significant non-HLA genetic variant associated with UC in a Japanese GWAS (<xref rid="B13" ref-type="bibr">13</xref>), confirmed in candidate gene studies (odds ratio 0.70&#8211;0.84) (<xref rid="B297" ref-type="bibr">297</xref>, <xref rid="B298" ref-type="bibr">298</xref>) and in a subsequent meta-analysis of IBD GWAS (<xref rid="B14" ref-type="bibr">14</xref>), has brought the potential role of mucosal IgG in inflammation into focus.</p><p>We and others have shown that microbial IgG forms a core component of the intestinal inflammatory response, both in models of IBD, such as DSS-induced colitis, as well as mucosal infection, potentially identifying novel therapeutic strategies for IBD. However, the role of IgG and Fc&#947;Rs extend beyond local inflammatory responses and play essential roles in mucosal immune cell education, commensal regulation, oral tolerance, systemic immune protection, and cancer. Future studies will be required to elucidate the signals that determine the generation of these IgG responses in different settings and the mechanisms by which they contribute to local immunity.</p></sec><sec id="s9"><title>Author Contributions</title><p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>TC-D was supported by a Wellcome Trust Infection, Immunity, and Inflammation Programme Ph.D. fellowship. TC-D and MC are supported by a Medical Research Council New Investigator Research Grant (MR/N024907/1). MC is supported by the National Institute of Health Research (NIHR), the Cambridge Biomedical Research Centre, the NIHR Blood and Transplant Research Unit (NIHR BTRU-2014-10027), and an NIHR Research Professorship (RP-2017-08-ST2-002).</p></ack><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>LK</given-names></name><name name-style="western"><surname>O'Grady</surname><given-names>G</given-names></name><name name-style="western"><surname>Du</surname><given-names>P</given-names></name><name name-style="western"><surname>Egbuji</surname><given-names>JU</given-names></name><name name-style="western"><surname>Windsor</surname><given-names>JA</given-names></name><name name-style="western"><surname>Pullan</surname><given-names>AJ</given-names></name></person-group>. <article-title>Gastrointestinal system</article-title>. <source>Wiley Interdiscipl Rev.</source> (<year>2010</year>) <volume>2</volume>:<fpage>65</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1002/wsbm.19</pub-id><pub-id pub-id-type="pmid">20836011</pub-id><pub-id pub-id-type="pmcid">PMC4221587</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Harris</surname><given-names>NL</given-names></name></person-group>. <article-title>Interactions between commensal intestinal bacteria and the immune system</article-title>. <source>Nat Rev Immunol.</source> (<year>2004</year>) <volume>4</volume>:<fpage>478</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1038/nri1373</pub-id><pub-id pub-id-type="pmid">15173836</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooper</surname><given-names>LV</given-names></name><name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name><name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name></person-group>. <article-title>Interactions between the microbiota and the immune system</article-title>. <source>Science.</source> (<year>2012</year>) <volume>336</volume>:<fpage>1268</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1126/science.1223490</pub-id><pub-id pub-id-type="pmid">22674334</pub-id><pub-id pub-id-type="pmcid">PMC4420145</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hooper</surname><given-names>LV</given-names></name><name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name></person-group>. <article-title>Immune adaptations that maintain homeostasis with the intestinal microbiota</article-title>. <source>Nat Rev Immunol.</source> (<year>2010</year>) <volume>10</volume>:<fpage>159</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/nri2710</pub-id><pub-id pub-id-type="pmid">20182457</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomez</surname><given-names>de Ag&#252;ero M</given-names></name><name name-style="western"><surname>Ganal-Vonarburg</surname><given-names>SC</given-names></name><name name-style="western"><surname>Fuhrer</surname><given-names>T</given-names></name><name name-style="western"><surname>Rupp</surname><given-names>S</given-names></name><name name-style="western"><surname>Uchimura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><etal/></person-group><article-title>The maternal microbiota drives early postnatal innate immune development</article-title>. <source>Science.</source> (<year>2016</year>) <volume>351</volume>:<fpage>1296</fpage>&#8211;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad2571</pub-id><pub-id pub-id-type="pmid">26989247</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Seo</surname><given-names>S-U</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>MY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y-G</given-names></name><name name-style="western"><surname>Cascalho</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Humoral immunity in the gut selectively targets phenotypically virulent attaching-and-effacing bacteria for intraluminal elimination</article-title>. <source>Cell Host Microbe.</source> (<year>2015</year>) <volume>17</volume>:<fpage>617</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.04.001</pub-id><pub-id pub-id-type="pmid">25936799</pub-id><pub-id pub-id-type="pmcid">PMC4433422</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koch</surname><given-names>MA</given-names></name><name name-style="western"><surname>Reiner</surname><given-names>GL</given-names></name><name name-style="western"><surname>Lugo</surname><given-names>KA</given-names></name><name name-style="western"><surname>Kreuk</surname><given-names>LSM</given-names></name><name name-style="western"><surname>Stanbery</surname><given-names>AG</given-names></name><name name-style="western"><surname>Ansaldo</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life</article-title>. <source>Cell.</source> (<year>2016</year>) <volume>165</volume>:<fpage>827</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.055</pub-id><pub-id pub-id-type="pmid">27153495</pub-id><pub-id pub-id-type="pmcid">PMC4866587</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohsaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Venturelli</surname><given-names>N</given-names></name><name name-style="western"><surname>Buccigrosso</surname><given-names>TM</given-names></name><name name-style="western"><surname>Osganian</surname><given-names>SK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Blumberg</surname><given-names>RS</given-names></name><etal/></person-group>. <article-title>Maternal IgG immune complexes induce food allergen-specific tolerance in offspring</article-title>. <source>J Exp Med</source>. (<year>2017</year>) <volume>215</volume>:<fpage>91</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20171163</pub-id><pub-id pub-id-type="pmid">29158374</pub-id><pub-id pub-id-type="pmcid">PMC5748859</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baklien</surname><given-names>K</given-names></name><name name-style="western"><surname>Brandtzaeg</surname><given-names>P</given-names></name></person-group>. <article-title>Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon</article-title>. <source>Clin Exp Immunol.</source> (<year>1975</year>) <volume>22</volume>:<fpage>197</fpage>&#8211;<lpage>209</lpage>.<pub-id pub-id-type="pmid">1082398</pub-id><pub-id pub-id-type="pmcid">PMC1538296</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benckert</surname><given-names>J</given-names></name><name name-style="western"><surname>Schmolka</surname><given-names>N</given-names></name><name name-style="western"><surname>Kreschel</surname><given-names>C</given-names></name><name name-style="western"><surname>Zoller</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sturm</surname><given-names>A</given-names></name><name name-style="western"><surname>Wiedenmann</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The majority of intestinal IgA + and IgG + plasmablasts in the human gut are antigen-specific</article-title>. <source>J Clin Invest.</source> (<year>2011</year>) <volume>121</volume>:<fpage>1946</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1172/JCI44447</pub-id><pub-id pub-id-type="pmid">21490392</pub-id><pub-id pub-id-type="pmcid">PMC3083800</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodes</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Cong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Elson</surname><given-names>CO</given-names></name><name name-style="western"><surname>Mohamath</surname><given-names>R</given-names></name><name name-style="western"><surname>Landers</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Targan</surname><given-names>SR</given-names></name><etal/></person-group>. <article-title>Bacterial flagellin is a dominant antigen in Crohn disease</article-title>. <source>J Clin Invest.</source> (<year>2004</year>) <volume>113</volume>:<fpage>1296</fpage>&#8211;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200420295</pub-id><pub-id pub-id-type="pmid">15124021</pub-id><pub-id pub-id-type="pmcid">PMC398429</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>CA</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>G</given-names></name><name name-style="western"><surname>Lees</surname><given-names>CW</given-names></name><name name-style="western"><surname>Franke</surname><given-names>A</given-names></name><name name-style="western"><surname>D&#8242;Amato</surname><given-names>M</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>KD</given-names></name><etal/></person-group>. <article-title>Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47</article-title>. <source>Nat Genet.</source> (<year>2011</year>) <volume>43</volume>:<fpage>246</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1038/ng.764</pub-id><pub-id pub-id-type="pmid">21297633</pub-id><pub-id pub-id-type="pmcid">PMC3084597</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asano</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsushita</surname><given-names>T</given-names></name><name name-style="western"><surname>Umeno</surname><given-names>J</given-names></name><name name-style="western"><surname>Hosono</surname><given-names>N</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawaguchi</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population</article-title>. <source>Nat Genet.</source> (<year>2009</year>) <volume>41</volume>:<fpage>1325</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/ng.482</pub-id><pub-id pub-id-type="pmid">19915573</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jostins</surname><given-names>L</given-names></name><name name-style="western"><surname>Ripke</surname><given-names>S</given-names></name><name name-style="western"><surname>Weersma</surname><given-names>RK</given-names></name><name name-style="western"><surname>Duerr</surname><given-names>RH</given-names></name><name name-style="western"><surname>McGovern</surname><given-names>DP</given-names></name><name name-style="western"><surname>Hui</surname><given-names>KY</given-names></name><etal/></person-group>. <article-title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease</article-title>. <source>Nature.</source> (<year>2012</year>) <volume>491</volume>:<fpage>119</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/nature11582</pub-id><pub-id pub-id-type="pmid">23128233</pub-id><pub-id pub-id-type="pmcid">PMC3491803</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vidarsson</surname><given-names>G</given-names></name><name name-style="western"><surname>Dekkers</surname><given-names>G</given-names></name><name name-style="western"><surname>Rispens</surname><given-names>T</given-names></name></person-group>. <article-title>IgG subclasses and allotypes: from structure to effector functions</article-title>. <source>Front Immunol.</source> (<year>2014</year>) <volume>5</volume>:<fpage>520</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00520</pub-id><pub-id pub-id-type="pmid">25368619</pub-id><pub-id pub-id-type="pmcid">PMC4202688</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noris</surname><given-names>M</given-names></name><name name-style="western"><surname>Remuzzi</surname><given-names>G</given-names></name></person-group>. <article-title>Overview of complement activation and regulation</article-title>. <source>Semin Nephrol.</source> (<year>2013</year>) <volume>33</volume>:<fpage>479</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.semnephrol.2013.08.001</pub-id><pub-id pub-id-type="pmid">24161035</pub-id><pub-id pub-id-type="pmcid">PMC3820029</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Fcgamma receptors as regulators of immune responses</article-title>. <source>Nat Rev Immunol.</source> (<year>2008</year>) <volume>8</volume>:<fpage>34</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/nri2206</pub-id><pub-id pub-id-type="pmid">18064051</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>KGC</given-names></name><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name></person-group>. <article-title>FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications</article-title>. <source>Nat Rev Immunol.</source> (<year>2010</year>) <volume>10</volume>:<fpage>328</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/nri2762</pub-id><pub-id pub-id-type="pmid">20414206</pub-id><pub-id pub-id-type="pmcid">PMC4148599</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esp&#233;li</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KGC</given-names></name><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name></person-group>. <article-title>Fc&#947;RIIB and autoimmunity</article-title>. <source>Immunol Rev.</source> (<year>2016</year>) <volume>269</volume>:<fpage>194</fpage>&#8211;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12368</pub-id><pub-id pub-id-type="pmid">26683154</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></name><name name-style="western"><surname>DiLillo</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group><article-title>The role of Fc-Fc R interactions in IgG-mediated microbial neutralization</article-title>. <source>J Exp Med</source>. (<year>2015</year>) <volume>212</volume>:<fpage>1361</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151267</pub-id><pub-id pub-id-type="pmid">26282878</pub-id><pub-id pub-id-type="pmcid">PMC4548051</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mallery</surname><given-names>DL</given-names></name><name name-style="western"><surname>McEwan</surname><given-names>WA</given-names></name><name name-style="western"><surname>Bidgood</surname><given-names>SR</given-names></name><name name-style="western"><surname>Towers</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>CM</given-names></name><name name-style="western"><surname>James</surname><given-names>LC</given-names></name></person-group>. <article-title>Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2010</year>) <volume>107</volume>:<fpage>19985</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1014074107</pub-id><pub-id pub-id-type="pmid">21045130</pub-id><pub-id pub-id-type="pmcid">PMC2993423</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rath</surname><given-names>T</given-names></name><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Pyzik</surname><given-names>M</given-names></name><name name-style="western"><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>Regulation of immune responses by the neonatal Fc receptor and its therapeutic implications</article-title>. <source>Front Immunol.</source> (<year>2014</year>) <volume>5</volume>:<fpage>664</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00664</pub-id><pub-id pub-id-type="pmid">25601863</pub-id><pub-id pub-id-type="pmcid">PMC4283642</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Junghans</surname><given-names>RP</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>CL</given-names></name></person-group>. <article-title>The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor</article-title>. <source>Proc Natl Acad Sc USA.</source> (<year>1993</year>) <volume>93</volume>:<fpage>5512</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.11.5512</pub-id><pub-id pub-id-type="pmid">8643606</pub-id><pub-id pub-id-type="pmcid">PMC39277</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyzik</surname><given-names>M</given-names></name><name name-style="western"><surname>Rath</surname><given-names>T</given-names></name><name name-style="western"><surname>Lencer</surname><given-names>WI</given-names></name><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>FcRn: the architect behind the immune and nonimmune functions of IgG and Albumin</article-title>. <source>J Immunol.</source> (<year>2015</year>) <volume>194</volume>:<fpage>4595</fpage>&#8211;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1403014</pub-id><pub-id pub-id-type="pmid">25934922</pub-id><pub-id pub-id-type="pmcid">PMC4451002</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Claypool</surname><given-names>SM</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>JS</given-names></name><name name-style="western"><surname>Mizoguchi</surname><given-names>E</given-names></name><name name-style="western"><surname>Mizoguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Roopenian</surname><given-names>DC</given-names></name><etal/></person-group>. <article-title>Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells</article-title>. <source>Immunity.</source> (<year>2004</year>) <volume>20</volume>:<fpage>769</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2004.05.007</pub-id><pub-id pub-id-type="pmid">15189741</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>TT</given-names></name><name name-style="western"><surname>Bry</surname><given-names>L</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>JN</given-names></name><name name-style="western"><surname>Claypool</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria</article-title>. <source>J Clin Invest.</source> (<year>2006</year>) <volume>116</volume>:<fpage>2142</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27821</pub-id><pub-id pub-id-type="pmid">16841095</pub-id><pub-id pub-id-type="pmcid">PMC1501111</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharadwaj</surname><given-names>BD</given-names></name><name name-style="western"><surname>Stein</surname><given-names>M-P</given-names></name><name name-style="western"><surname>Volzer</surname><given-names>M</given-names></name><name name-style="western"><surname>Mold</surname><given-names>C</given-names></name><name name-style="western"><surname>Clos</surname><given-names>TWD</given-names></name></person-group><article-title>The major receptor for C-reactive protein on leukocytes is Fcg receptor II</article-title>. <source>J Exp Med.</source> (<year>1999</year>) <volume>190</volume>:<fpage>585</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1084/jem.190.4.585</pub-id><pub-id pub-id-type="pmid">10449529</pub-id><pub-id pub-id-type="pmcid">PMC2195602</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharadwaj</surname><given-names>D</given-names></name><name name-style="western"><surname>Mold</surname><given-names>C</given-names></name><name name-style="western"><surname>Markham</surname><given-names>E</given-names></name><name name-style="western"><surname>Du Clos</surname><given-names>TW</given-names></name></person-group>. <article-title>Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis</article-title>. <source>J Immunol.</source> (<year>2001</year>) <volume>166</volume>:<fpage>6735</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.11.6735</pub-id><pub-id pub-id-type="pmid">11359830</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pepys</surname><given-names>MB</given-names></name><name name-style="western"><surname>Booth</surname><given-names>SE</given-names></name><name name-style="western"><surname>Tennent</surname><given-names>GA</given-names></name><name name-style="western"><surname>Butler</surname><given-names>PJG</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DG</given-names></name></person-group>. <article-title>Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli</article-title>. <source>Clin Exp Immunol.</source> (<year>1994</year>) <volume>97</volume>:<fpage>152</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.1994.tb06594.x</pub-id><pub-id pub-id-type="pmid">8033412</pub-id><pub-id pub-id-type="pmcid">PMC1534802</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vermeire</surname><given-names>S</given-names></name><name name-style="western"><surname>Van Assche</surname><given-names>G</given-names></name><name name-style="western"><surname>Rutgeerts</surname><given-names>P</given-names></name></person-group>. <article-title>The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases</article-title>. <source>Nat Clin Pract Gastroenterol Hepatol.</source> (<year>2005</year>) <volume>2</volume>:<fpage>580</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ncpgasthep0359</pub-id><pub-id pub-id-type="pmid">16327837</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></name><name name-style="western"><surname>Iannascoli</surname><given-names>B</given-names></name><name name-style="western"><surname>England</surname><given-names>P</given-names></name><name name-style="western"><surname>Mancardi</surname><given-names>DA</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>N</given-names></name><name name-style="western"><surname>Jorieux</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses</article-title>. <source>Blood.</source> (<year>2009</year>) <volume>113</volume>:<fpage>3716</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-09-179754</pub-id><pub-id pub-id-type="pmid">19018092</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irani</surname><given-names>V</given-names></name><name name-style="western"><surname>Guy</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Andrew</surname><given-names>D</given-names></name><name name-style="western"><surname>Beeson</surname><given-names>JG</given-names></name><name name-style="western"><surname>Ramsland</surname><given-names>PA</given-names></name><name name-style="western"><surname>Richards</surname><given-names>JS</given-names></name></person-group>. <article-title>Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases</article-title>. <source>Mol Immunol.</source> (<year>2015</year>) <volume>67</volume>:<fpage>171</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2015.03.255</pub-id><pub-id pub-id-type="pmid">25900877</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Gunten</surname><given-names>S</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DF</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>RD</given-names></name><name name-style="western"><surname>Riedel</surname><given-names>S</given-names></name><name name-style="western"><surname>Miescher</surname><given-names>S</given-names></name><name name-style="western"><surname>Schaub</surname><given-names>A</given-names></name><etal/></person-group><article-title>Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass</article-title>. <source>J Allergy Clin Immunol.</source> (<year>2009</year>) <volume>123</volume>:<fpage>1</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2009.03.013</pub-id><pub-id pub-id-type="pmcid">PMC2777748</pub-id><pub-id pub-id-type="pmid">19443021</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stapleton</surname><given-names>NM</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>JT</given-names></name><name name-style="western"><surname>Stemerding</surname><given-names>AM</given-names></name><name name-style="western"><surname>Bjarnarson</surname><given-names>SP</given-names></name><name name-style="western"><surname>Verheul</surname><given-names>RC</given-names></name><name name-style="western"><surname>Gerritsen</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential</article-title>. <source>Nat Commun.</source> (<year>2011</year>) <volume>2</volume>:<fpage>599</fpage>&#8211;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms1608</pub-id><pub-id pub-id-type="pmid">22186895</pub-id><pub-id pub-id-type="pmcid">PMC3247843</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van</surname><given-names>der Neut Kolfschoten M</given-names></name><name name-style="western"><surname>Schuurman</surname><given-names>J</given-names></name><name name-style="western"><surname>Losen</surname><given-names>M</given-names></name><name name-style="western"><surname>Bleeker</surname><given-names>WK</given-names></name><name name-style="western"><surname>Mart&#237;nez-Mart&#237;nez</surname><given-names>P</given-names></name><name name-style="western"><surname>Vermeulen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange</article-title>. <source>Science.</source> (<year>2007</year>) <volume>317</volume>:<fpage>1554</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1126/science.1144603</pub-id><pub-id pub-id-type="pmid">17872445</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aalberse</surname><given-names>RC</given-names></name><name name-style="western"><surname>Schuurman</surname><given-names>J</given-names></name></person-group>. <article-title>IgG4 breaking the rules</article-title>. <source>Immunology.</source> (<year>2002</year>) <volume>105</volume>:<fpage>9</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1046/j.0019-2805.2001.01341.x</pub-id><pub-id pub-id-type="pmid">11849310</pub-id><pub-id pub-id-type="pmcid">PMC1782638</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaneko</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation</article-title>. <source>Science.</source> (<year>2006</year>) <volume>313</volume>:<fpage>670</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1126/science.1129594</pub-id><pub-id pub-id-type="pmid">16888140</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karsten</surname><given-names>CM</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>MK</given-names></name><name name-style="western"><surname>Figge</surname><given-names>J</given-names></name><name name-style="western"><surname>Kilchenstein</surname><given-names>R</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>PR</given-names></name><name name-style="western"><surname>Rosas</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc&#947;RIIB and dectin-1</article-title>. <source>Nat Med.</source> (<year>2012</year>) <volume>18</volume>:<fpage>1401</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2862</pub-id><pub-id pub-id-type="pmid">22922409</pub-id><pub-id pub-id-type="pmcid">PMC3492054</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>DiLillo</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></name><name name-style="western"><surname>Giddens</surname><given-names>JP</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L-X</given-names></name></person-group>. <article-title>Modulating IgG effector function by Fc glycan engineering</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2017</year>) <volume>114</volume>:<fpage>3485</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1702173114</pub-id><pub-id pub-id-type="pmid">28289219</pub-id><pub-id pub-id-type="pmcid">PMC5380036</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pincetic</surname><given-names>A</given-names></name><name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></name><name name-style="western"><surname>DiLillo</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Maamary</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TT</given-names></name><name name-style="western"><surname>Dahan</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Type I and type II Fc receptors regulate innate and adaptive immunity</article-title>. <source>Nat Immunol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>707</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2939</pub-id><pub-id pub-id-type="pmid">25045879</pub-id><pub-id pub-id-type="pmcid">PMC7430760</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauc</surname><given-names>G</given-names></name><name name-style="western"><surname>Huffman</surname><given-names>JE</given-names></name><name name-style="western"><surname>Pu&#269;i&#263;</surname><given-names>M</given-names></name><name name-style="western"><surname>Zgaga</surname><given-names>L</given-names></name><name name-style="western"><surname>Adamczyk</surname><given-names>B</given-names></name><name name-style="western"><surname>Mu&#381;ini&#263;</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers</article-title>. <source>PLoS Genet.</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003225</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003225</pub-id><pub-id pub-id-type="pmid">23382691</pub-id><pub-id pub-id-type="pmcid">PMC3561084</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theodoratou</surname><given-names>E</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>H</given-names></name><name name-style="western"><surname>Ventham</surname><given-names>NT</given-names></name><name name-style="western"><surname>Kolarich</surname><given-names>D</given-names></name><name name-style="western"><surname>Pu&#269;i&#263;-Bakovi&#263;</surname><given-names>M</given-names></name><name name-style="western"><surname>Zoldo&#353;</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>The role of glycosylation in IBD</article-title>. <source>Nat Rev Gastroenterol Hepatol.</source> (<year>2014</year>) <volume>11</volume>:<fpage>588</fpage>&#8211;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2014.78</pub-id><pub-id pub-id-type="pmid">24912389</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>JN</given-names></name><name name-style="western"><surname>Wormald</surname><given-names>MR</given-names></name><name name-style="western"><surname>Sim</surname><given-names>RB</given-names></name><name name-style="western"><surname>Rudd</surname><given-names>PM</given-names></name><name name-style="western"><surname>Dwek</surname><given-names>RA</given-names></name></person-group>. <article-title>The impact of glycosylation on the biological function and structure of human immunoglobulins</article-title>. <source>Annu Rev Immunol.</source> (<year>2007</year>) <volume>25</volume>:<fpage>21</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.25.022106.141702</pub-id><pub-id pub-id-type="pmid">17029568</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs</article-title>. <source>J Clin Immunol.</source> (<year>2010</year>) <volume>30</volume>:<fpage>9</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-010-9405-6</pub-id><pub-id pub-id-type="pmid">20480216</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></name><name name-style="western"><surname>Wermeling</surname><given-names>F</given-names></name><name name-style="western"><surname>Karlsson</surname><given-names>MCI</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Identification of a receptor required for the anti-inflammatory activity of IVIG</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2008</year>) <volume>105</volume>:<fpage>19571</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810163105</pub-id><pub-id pub-id-type="pmid">19036920</pub-id><pub-id pub-id-type="pmcid">PMC2604916</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Storkus</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Salter</surname><given-names>RD</given-names></name></person-group>. <article-title>Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells</article-title>. <source>J Immunol.</source> (<year>1999</year>) <volume>163</volume>:<fpage>5427</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">10553068</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malhotra</surname><given-names>R</given-names></name><name name-style="western"><surname>Wormald</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rudd</surname><given-names>PM</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>PB</given-names></name><name name-style="western"><surname>Dwek</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sim</surname><given-names>RB</given-names></name></person-group>. <article-title>Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein</article-title>. <source>Nat Med.</source> (<year>1995</year>) <volume>1</volume>:<fpage>237</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/nm0395-237</pub-id><pub-id pub-id-type="pmid">7585040</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGuckin</surname><given-names>MA</given-names></name><name name-style="western"><surname>Eri</surname><given-names>R</given-names></name><name name-style="western"><surname>Simms</surname><given-names>LA</given-names></name><name name-style="western"><surname>Florin</surname><given-names>THJ</given-names></name><name name-style="western"><surname>Radford-Smith</surname><given-names>G</given-names></name></person-group>. <article-title>Intestinal barrier dysfunction in inflammatory bowel diseases</article-title>. <source>Inflamm Bowel Dis.</source> (<year>2009</year>) <volume>15</volume>:<fpage>100</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.20539</pub-id><pub-id pub-id-type="pmid">18623167</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>LW</given-names></name><name name-style="western"><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Intestinal epithelial cells: regulators of barrier function and immune homeostasis</article-title>. <source>Nat Rev Immunol.</source> (<year>2014</year>) <volume>14</volume>:<fpage>141</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nri3608</pub-id><pub-id pub-id-type="pmid">24566914</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elinav</surname><given-names>E</given-names></name><name name-style="western"><surname>Strowig</surname><given-names>T</given-names></name><name name-style="western"><surname>Kau</surname><given-names>AL</given-names></name><name name-style="western"><surname>Henao-Mejia</surname><given-names>J</given-names></name><name name-style="western"><surname>Thaiss</surname><given-names>CA</given-names></name><name name-style="western"><surname>Booth</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis</article-title>. <source>Cell.</source> (<year>2011</year>) <volume>145</volume>:<fpage>745</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.04.022</pub-id><pub-id pub-id-type="pmid">21565393</pub-id><pub-id pub-id-type="pmcid">PMC3140910</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fulde</surname><given-names>M</given-names></name><name name-style="western"><surname>Sommer</surname><given-names>F</given-names></name><name name-style="western"><surname>Chassaing</surname><given-names>B</given-names></name><name name-style="western"><surname>van Vorst</surname><given-names>K</given-names></name><name name-style="western"><surname>Dupont</surname><given-names>A</given-names></name><name name-style="western"><surname>Hensel</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition</article-title>. <source>Nature</source>. (<year>2018</year>) <volume>560</volume>:<fpage>489</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0395-5</pub-id><pub-id pub-id-type="pmid">30089902</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>AE</given-names></name><name name-style="western"><surname>Shamardani</surname><given-names>K</given-names></name><name name-style="western"><surname>Lugo</surname><given-names>KA</given-names></name><name name-style="western"><surname>Deguine</surname><given-names>J</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>AW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BL</given-names></name><etal/></person-group>. <article-title>A map of toll-like receptor expression in the intestinal epithelium reveals distinct spatial, cell type-specific, and temporal patterns</article-title>. <source>Immunity.</source> (<year>2018</year>) <volume>49</volume>:<fpage>560</fpage>&#8211;<lpage>75</lpage>.e6. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.07.016</pub-id><pub-id pub-id-type="pmid">30170812</pub-id><pub-id pub-id-type="pmcid">PMC6152941</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>N</given-names></name><name name-style="western"><surname>Pott</surname><given-names>J</given-names></name><name name-style="western"><surname>Schiering</surname><given-names>C</given-names></name><name name-style="western"><surname>Krausgruber</surname><given-names>T</given-names></name><name name-style="western"><surname>Ilott</surname><given-names>NE</given-names></name><etal/></person-group>. <article-title>Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine</article-title>. <source>Mucosal Immunol.</source> (<year>2015</year>) <volume>8</volume>:<fpage>1226</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2015.13</pub-id><pub-id pub-id-type="pmid">25736457</pub-id><pub-id pub-id-type="pmcid">PMC4368110</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nowarski</surname><given-names>R</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>R</given-names></name><name name-style="western"><surname>Gagliani</surname><given-names>N</given-names></name><name name-style="western"><surname>de Zoete</surname><given-names>MR</given-names></name><name name-style="western"><surname>Palm</surname><given-names>NW</given-names></name><name name-style="western"><surname>Bailis</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Epithelial IL-18 equilibrium controls barrier function in colitis</article-title>. <source>Cell.</source> (<year>2015</year>) <volume>163</volume>:<fpage>1444</fpage>&#8211;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.10.072</pub-id><pub-id pub-id-type="pmid">26638073</pub-id><pub-id pub-id-type="pmcid">PMC4943028</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Lochner</surname><given-names>M</given-names></name><name name-style="western"><surname>Satoh-Takayama</surname><given-names>N</given-names></name><name name-style="western"><surname>Dulauroy</surname><given-names>S</given-names></name><name name-style="western"><surname>B&#233;rard</surname><given-names>M</given-names></name><name name-style="western"><surname>Kleinschek</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>ROR&#947;t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota</article-title>. <source>Nature immunology.</source> (<year>2011</year>) <volume>12</volume>:<fpage>320</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2002</pub-id><pub-id pub-id-type="pmid">21336274</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rimoldi</surname><given-names>M</given-names></name><name name-style="western"><surname>Chieppa</surname><given-names>M</given-names></name><name name-style="western"><surname>Salucci</surname><given-names>V</given-names></name><name name-style="western"><surname>Avogadri</surname><given-names>F</given-names></name><name name-style="western"><surname>Sonzogni</surname><given-names>A</given-names></name><name name-style="western"><surname>Sampietro</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells</article-title>. <source>Nat Immunol.</source> (<year>2005</year>) <volume>6</volume>:<fpage>507</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/ni1192</pub-id><pub-id pub-id-type="pmid">15821737</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Santini</surname><given-names>PA</given-names></name><name name-style="western"><surname>Polydorides</surname><given-names>AD</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>A</given-names></name><name name-style="western"><surname>Estrella</surname><given-names>J</given-names></name><etal/></person-group><article-title>Intestinal bacteria trigger T cell-independent Immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL</article-title>. <source>Immunity.</source> (<year>2007</year>) <volume>26</volume>:<fpage>812</fpage>&#8211;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.014</pub-id><pub-id pub-id-type="pmid">17570691</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>JH</given-names></name><name name-style="western"><surname>Brant</surname><given-names>SR</given-names></name></person-group>. <article-title>Recent insights into the genetics of inflammatory bowel disease</article-title>. <source>Gastroenterology.</source> (<year>2011</year>) <volume>140</volume>:<fpage>1704</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.02.046</pub-id><pub-id pub-id-type="pmid">21530736</pub-id><pub-id pub-id-type="pmcid">PMC4947143</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>J</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>CM</given-names></name><name name-style="western"><surname>Luo</surname><given-names>XM</given-names></name></person-group>. <article-title>Leaky gut as a danger signal for autoimmune diseases</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>598</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00598</pub-id><pub-id pub-id-type="pmid">28588585</pub-id><pub-id pub-id-type="pmcid">PMC5440529</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coccia</surname><given-names>M</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Schiering</surname><given-names>C</given-names></name><name name-style="western"><surname>Asquith</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Becher</surname><given-names>B</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>IL-1&#946; mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells</article-title>. <source>J Exp Med.</source> (<year>2012</year>) <volume>209</volume>:<fpage>1595</fpage>&#8211;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20111453</pub-id><pub-id pub-id-type="pmid">22891275</pub-id><pub-id pub-id-type="pmcid">PMC3428945</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duerr</surname><given-names>RH</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>KD</given-names></name><name name-style="western"><surname>Brant</surname><given-names>SR</given-names></name><name name-style="western"><surname>Rioux</surname><given-names>JD</given-names></name><name name-style="western"><surname>Silverberg</surname><given-names>MS</given-names></name><name name-style="western"><surname>Daly</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>A genome-wide association study identifies IL23R as an inflammatory bowel disease gene</article-title>. <source>Science.</source> (<year>2006</year>) <volume>314</volume>:<fpage>1461</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1126/science.1135245</pub-id><pub-id pub-id-type="pmid">17068223</pub-id><pub-id pub-id-type="pmcid">PMC4410764</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></name><name name-style="western"><surname>Atarashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Manel</surname><given-names>N</given-names></name><name name-style="western"><surname>Brodie</surname><given-names>EL</given-names></name><name name-style="western"><surname>Shima</surname><given-names>T</given-names></name><name name-style="western"><surname>Karaoz</surname><given-names>U</given-names></name><etal/></person-group>. <article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title>. <source>Cell.</source> (<year>2009</year>) <volume>139</volume>:<fpage>485</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><pub-id pub-id-type="pmid">19836068</pub-id><pub-id pub-id-type="pmcid">PMC2796826</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neurath</surname><given-names>MF</given-names></name></person-group>. <article-title>Cytokines in inflammatory bowel disease</article-title>. <source>Nat Rev Immunol.</source> (<year>2014</year>) <volume>14</volume>:<fpage>329</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/nri3661</pub-id><pub-id pub-id-type="pmid">24751956</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sano</surname><given-names>T</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Hall</surname><given-names>JA</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A</given-names></name><name name-style="western"><surname>Gavzy</surname><given-names>SJ</given-names></name><etal/></person-group>. <article-title>An IL-23R/IL-22 circuit regulates epithelial serum amyloid a to promote local effector Th17 responses</article-title>. <source>Cell.</source> (<year>2015</year>) <volume>163</volume>:<fpage>381</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.08.061</pub-id><pub-id pub-id-type="pmid">26411290</pub-id><pub-id pub-id-type="pmcid">PMC4621768</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Withers</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hepworth</surname><given-names>MR</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Mackley</surname><given-names>EC</given-names></name><name name-style="western"><surname>Halford</surname><given-names>EE</given-names></name><name name-style="western"><surname>Dutton</surname><given-names>EE</given-names></name><etal/></person-group>. <article-title>Transient inhibition of ROR-&#947;t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells</article-title>. <source>Nat Med.</source> (<year>2016</year>) <volume>22</volume>:<fpage>319</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4046</pub-id><pub-id pub-id-type="pmid">26878233</pub-id><pub-id pub-id-type="pmcid">PMC4948756</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jovanovic</surname><given-names>DV</given-names></name><name name-style="western"><surname>Di Battista</surname><given-names>JA</given-names></name><name name-style="western"><surname>Martel-Pelletier</surname><given-names>J</given-names></name><name name-style="western"><surname>Jolicoeur</surname><given-names>FC</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages</article-title>. <source>J Immunol.</source> (<year>1998</year>) <volume>160</volume>:<fpage>3513</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="pmid">9531313</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korn</surname><given-names>T</given-names></name><name name-style="western"><surname>Bettelli</surname><given-names>E</given-names></name><name name-style="western"><surname>Oukka</surname><given-names>M</given-names></name><name name-style="western"><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group>. <article-title>IL-17 and Th17 Cells</article-title>. <source>Annu Rev Immunol.</source> (<year>2009</year>) <volume>27</volume>:<fpage>485</fpage>&#8211;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132710</pub-id><pub-id pub-id-type="pmid">19132915</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veldhoen</surname><given-names>M</given-names></name></person-group>. <article-title>Interleukin 17 is a chief orchestrator of immunity</article-title>. <source>Nat Immunol.</source> (<year>2017</year>) <volume>18</volume>:<fpage>612</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3742</pub-id><pub-id pub-id-type="pmid">28518156</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>H</given-names></name><name name-style="western"><surname>Keith</surname><given-names>JW</given-names></name><name name-style="western"><surname>Samilo</surname><given-names>DW</given-names></name><name name-style="western"><surname>Carter</surname><given-names>RA</given-names></name><name name-style="western"><surname>Leiner</surname><given-names>IM</given-names></name><name name-style="western"><surname>Pamer</surname><given-names>EG</given-names></name></person-group>. <article-title>Innate Lymphocyte/Ly6C(hi) monocyte crosstalk promotes klebsiella pneumoniae clearance</article-title>. <source>Cell.</source> (<year>2016</year>) <volume>165</volume>:<fpage>679</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.03.017</pub-id><pub-id pub-id-type="pmid">27040495</pub-id><pub-id pub-id-type="pmcid">PMC4842125</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laan</surname><given-names>M</given-names></name><name name-style="western"><surname>Cui</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Hoshino</surname><given-names>H</given-names></name><name name-style="western"><surname>L&#246;tvall</surname><given-names>J</given-names></name><name name-style="western"><surname>Sj&#246;strand</surname><given-names>M</given-names></name><name name-style="western"><surname>Gruenert</surname><given-names>DC</given-names></name><etal/></person-group>. <article-title>Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways</article-title>. <source>J Immunol.</source> (<year>1999</year>) <volume>162</volume>:<fpage>2347</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">9973514</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parsonage</surname><given-names>G</given-names></name><name name-style="western"><surname>Filer</surname><given-names>A</given-names></name><name name-style="western"><surname>Bik</surname><given-names>M</given-names></name><name name-style="western"><surname>Hardie</surname><given-names>D</given-names></name><name name-style="western"><surname>Lax</surname><given-names>S</given-names></name><name name-style="western"><surname>Howlett</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha</article-title>. <source>Arthritis Res Ther.</source> (<year>2008</year>) <volume>10</volume>:<fpage>R47</fpage>&#8211;<lpage>R47</lpage>. <pub-id pub-id-type="doi">10.1186/ar2406</pub-id><pub-id pub-id-type="pmid">18433499</pub-id><pub-id pub-id-type="pmcid">PMC2453767</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Pawlaczyk</surname><given-names>K</given-names></name><name name-style="western"><surname>Breborowicz</surname><given-names>A</given-names></name><name name-style="western"><surname>Scheuren</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuzlan-Pawlaczyk</surname><given-names>M</given-names></name><name name-style="western"><surname>Wisniewska</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO chemokine from mesothelial cells</article-title>. <source>J Immunol.</source> (<year>2000</year>) <volume>165</volume>:<fpage>5814</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.165.10.5814</pub-id><pub-id pub-id-type="pmid">11067941</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolls</surname><given-names>JK</given-names></name><name name-style="western"><surname>McCray</surname><given-names>PB</given-names></name><name name-style="western"><surname>Chan</surname><given-names>YR</given-names></name></person-group>. <article-title>Cytokine-mediated regulation of antimicrobial proteins</article-title>. <source>Nat Rev Immunol.</source> (<year>2008</year>) <volume>8</volume>:<fpage>829</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/nri2433</pub-id><pub-id pub-id-type="pmid">18949018</pub-id><pub-id pub-id-type="pmcid">PMC2901862</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Tato</surname><given-names>CM</given-names></name><name name-style="western"><surname>Joyce-Shaikh</surname><given-names>B</given-names></name><name name-style="western"><surname>Gulan</surname><given-names>F</given-names></name><name name-style="western"><surname>Cayatte</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability</article-title>. <source>Immunity.</source> (<year>2015</year>) <volume>43</volume>:<fpage>727</fpage>&#8211;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.09.003</pub-id><pub-id pub-id-type="pmid">26431948</pub-id><pub-id pub-id-type="pmcid">PMC6044435</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maxwell</surname><given-names>JR</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Brown</surname><given-names>WA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CL</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>FR</given-names></name><name name-style="western"><surname>Fiorino</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Differential Roles for Interleukin-23 and Interleukin-17 in intestinal immunoregulation</article-title>. <source>Immunity.</source> (<year>2015</year>) <volume>43</volume>:<fpage>739</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.019</pub-id><pub-id pub-id-type="pmid">26431947</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Dai</surname><given-names>D</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Growth factor FGF2 cooperates with Interleukin-17 to repair intestinal epithelial damage</article-title>. <source>Immunity.</source> (<year>2015</year>) <volume>43</volume>:<fpage>488</fpage>&#8211;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.024</pub-id><pub-id pub-id-type="pmid">26320657</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name><name name-style="western"><surname>Hisamatsu</surname><given-names>T</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Chinen</surname><given-names>H</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Sato</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis</article-title>. <source>J Clin Invest.</source> (<year>2008</year>) <volume>118</volume>:<fpage>2269</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1172/JCI34610</pub-id><pub-id pub-id-type="pmid">18497880</pub-id><pub-id pub-id-type="pmcid">PMC2391067</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>R</given-names></name><name name-style="western"><surname>Shin-Ya</surname><given-names>M</given-names></name><name name-style="western"><surname>Kishida</surname><given-names>T</given-names></name><name name-style="western"><surname>Urano</surname><given-names>A</given-names></name><name name-style="western"><surname>Takada</surname><given-names>R</given-names></name><name name-style="western"><surname>Sakagami</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice</article-title>. <source>Clin Exp Immunol.</source> (<year>2006</year>) <volume>146</volume>:<fpage>330</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03214.x</pub-id><pub-id pub-id-type="pmid">17034586</pub-id><pub-id pub-id-type="pmcid">PMC1942055</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neurath</surname><given-names>MF</given-names></name><name name-style="western"><surname>Weigmann</surname><given-names>B</given-names></name><name name-style="western"><surname>Finotto</surname><given-names>S</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>J</given-names></name><name name-style="western"><surname>Nieuwenhuis</surname><given-names>E</given-names></name><name name-style="western"><surname>Iijima</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease</article-title>. <source>J Exp Med.</source> (<year>2002</year>) <volume>195</volume>:<fpage>1129</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20011956</pub-id><pub-id pub-id-type="pmid">11994418</pub-id><pub-id pub-id-type="pmcid">PMC2193714</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name><name name-style="western"><surname>Leach</surname><given-names>MW</given-names></name><name name-style="western"><surname>Mauze</surname><given-names>S</given-names></name><name name-style="western"><surname>Menon</surname><given-names>S</given-names></name><name name-style="western"><surname>Barcomb Caddle</surname><given-names>L</given-names></name><name name-style="western"><surname>Coffman</surname><given-names>RL</given-names></name></person-group><article-title>Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells</article-title>. <source>Immunity.</source> (<year>1994</year>) <volume>1</volume>:<fpage>553</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/1074-7613(94)90045-0</pub-id><pub-id pub-id-type="pmid">7600284</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JC</given-names></name><name name-style="western"><surname>Lees</surname><given-names>CW</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>CA</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region</article-title>. <source>Nat Genet.</source> (<year>2009</year>) <volume>41</volume>:<fpage>1330</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/ng.483</pub-id><pub-id pub-id-type="pmid">19915572</pub-id><pub-id pub-id-type="pmcid">PMC2812019</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>JG</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Z</given-names></name><name name-style="western"><surname>Whary</surname><given-names>MT</given-names></name><name name-style="western"><surname>Erdman</surname><given-names>SE</given-names></name><name name-style="western"><surname>Horwitz</surname><given-names>BH</given-names></name></person-group>. <article-title>Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer</article-title>. <source>Mucosal Immunol.</source> (<year>2011</year>) <volume>4</volume>:<fpage>22</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2010.61</pub-id><pub-id pub-id-type="pmid">20944559</pub-id><pub-id pub-id-type="pmcid">PMC3939708</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glocker</surname><given-names>E-O</given-names></name><name name-style="western"><surname>Kotlarz</surname><given-names>D</given-names></name><name name-style="western"><surname>Boztug</surname><given-names>K</given-names></name><name name-style="western"><surname>Gertz</surname><given-names>EM</given-names></name><name name-style="western"><surname>Sch&#228;ffer</surname><given-names>AA</given-names></name><name name-style="western"><surname>Noyan</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Inflammatory bowel disease and mutations affecting the interleukin-10 receptor</article-title>. <source>N Engl J Med.</source> (<year>2009</year>) <volume>361</volume>:<fpage>2033</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0907206</pub-id><pub-id pub-id-type="pmid">19890111</pub-id><pub-id pub-id-type="pmcid">PMC2787406</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olszak</surname><given-names>T</given-names></name><name name-style="western"><surname>Neves</surname><given-names>JF</given-names></name><name name-style="western"><surname>Dowds</surname><given-names>CM</given-names></name><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>J</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>NO</given-names></name><etal/></person-group>. <article-title>Protective mucosal immunity mediated by epithelial CD1d and IL-10</article-title>. <source>Nature.</source> (<year>2014</year>) <volume>509</volume>:<fpage>497</fpage>&#8211;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nature13150</pub-id><pub-id pub-id-type="pmid">24717441</pub-id><pub-id pub-id-type="pmcid">PMC4132962</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosser</surname><given-names>EC</given-names></name><name name-style="western"><surname>Oleinika</surname><given-names>K</given-names></name><name name-style="western"><surname>Tonon</surname><given-names>S</given-names></name><name name-style="western"><surname>Doyle</surname><given-names>R</given-names></name><name name-style="western"><surname>Bosma</surname><given-names>A</given-names></name><name name-style="western"><surname>Carter</surname><given-names>NA</given-names></name><etal/></person-group>. <article-title>Regulatory B cells are induced by gut microbiota-driven interleukin-1&#946; and interleukin-6 production</article-title>. <source>Nat Med.</source> (<year>2014</year>) <volume>20</volume>:<fpage>1334</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3680</pub-id><pub-id pub-id-type="pmid">25326801</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sattler</surname><given-names>S</given-names></name><name name-style="western"><surname>Ling</surname><given-names>GS</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Hussaarts</surname><given-names>L</given-names></name><name name-style="western"><surname>Romaine</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut</article-title>. <source>Jf Autoimmun.</source> (<year>2014</year>) <volume>50</volume>:<fpage>107</fpage>&#8211;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaut.2014.01.032</pub-id><pub-id pub-id-type="pmid">24491821</pub-id><pub-id pub-id-type="pmcid">PMC4012142</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pabst</surname><given-names>O</given-names></name></person-group>. <article-title>New concepts in the generation and functions of IgA</article-title>. <source>Nat Rev Immunol.</source> (<year>2012</year>) <volume>12</volume>:<fpage>821</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/nri3322</pub-id><pub-id pub-id-type="pmid">23103985</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerutti</surname><given-names>A</given-names></name></person-group>. <article-title>The regulation of IgA class switching</article-title>. <source>Nat Rev Immunol.</source> (<year>2008</year>) <volume>8</volume>:<fpage>421</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nri2322</pub-id><pub-id pub-id-type="pmid">18483500</pub-id><pub-id pub-id-type="pmcid">PMC3062538</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bollinger</surname><given-names>RR</given-names></name><name name-style="western"><surname>Everett</surname><given-names>ML</given-names></name><name name-style="western"><surname>Wahl</surname><given-names>SD</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YH</given-names></name><name name-style="western"><surname>Orndorff</surname><given-names>PE</given-names></name><name name-style="western"><surname>Parker</surname><given-names>W</given-names></name></person-group>. <article-title>Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili</article-title>. <source>Mol Immunol.</source> (<year>2006</year>) <volume>43</volume>:<fpage>378</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2005.02.013</pub-id><pub-id pub-id-type="pmid">16310051</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moor</surname><given-names>K</given-names></name><name name-style="western"><surname>Diard</surname><given-names>M</given-names></name><name name-style="western"><surname>Sellin</surname><given-names>ME</given-names></name><name name-style="western"><surname>Felmy</surname><given-names>B</given-names></name><name name-style="western"><surname>Wotzka</surname><given-names>SY</given-names></name><name name-style="western"><surname>Toska</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>High-avidity IgA protects the intestine by enchaining growing bacteria</article-title>. <source>Nature.</source> (<year>2017</year>) <volume>544</volume>:<fpage>498</fpage>&#8211;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nature22058</pub-id><pub-id pub-id-type="pmid">28405025</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fransen</surname><given-names>F</given-names></name><name name-style="western"><surname>Zagato</surname><given-names>E</given-names></name><name name-style="western"><surname>Mazzini</surname><given-names>E</given-names></name><name name-style="western"><surname>Fosso</surname><given-names>B</given-names></name><name name-style="western"><surname>Manzari</surname><given-names>C</given-names></name><name name-style="western"><surname>El Aidy</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity</article-title>. <source>Immunity.</source> (<year>2015</year>) <volume>43</volume>:<fpage>527</fpage>&#8211;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.08.011</pub-id><pub-id pub-id-type="pmid">26362264</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#233;cuyer</surname><given-names>E</given-names></name><name name-style="western"><surname>Rakotobe</surname><given-names>S</given-names></name><name name-style="western"><surname>Lenglin&#233;-Garnier</surname><given-names>H</given-names></name><name name-style="western"><surname>Lebreton</surname><given-names>C</given-names></name><name name-style="western"><surname>Picard</surname><given-names>M</given-names></name><name name-style="western"><surname>Juste</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses</article-title>. <source>Immunity.</source> (<year>2014</year>) <volume>40</volume>:<fpage>608</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.03.009</pub-id><pub-id pub-id-type="pmid">24745335</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsuji</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Kitamura</surname><given-names>H</given-names></name><name name-style="western"><surname>Maruya</surname><given-names>M</given-names></name><name name-style="western"><surname>Kinoshita</surname><given-names>K</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></name><etal/></person-group>. <article-title>Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent Immunoglobulin A generation in the gut</article-title>. <source>Immunity.</source> (<year>2008</year>) <volume>29</volume>:<fpage>261</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.014</pub-id><pub-id pub-id-type="pmid">18656387</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masahata</surname><given-names>K</given-names></name><name name-style="western"><surname>Umemoto</surname><given-names>E</given-names></name><name name-style="western"><surname>Kayama</surname><given-names>H</given-names></name><name name-style="western"><surname>Kotani</surname><given-names>M</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S</given-names></name><name name-style="western"><surname>Kurakawa</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Generation of colonic IgA-secreting cells in the caecal patch</article-title>. <source>Nat Commun.</source> (<year>2014</year>) <volume>5</volume>:<fpage>3704</fpage>&#8211;<lpage>3704</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms4704</pub-id><pub-id pub-id-type="pmid">24718324</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milpied</surname><given-names>PJ</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>MG</given-names></name></person-group>. <article-title>High-affinity IgA needs TH17 cell functional plasticity</article-title>. <source>Nat Immunol.</source> (<year>2013</year>) <volume>14</volume>:<fpage>313</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2567</pub-id><pub-id pub-id-type="pmid">23507637</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mora</surname><given-names>JR</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>M</given-names></name><name name-style="western"><surname>Eksteen</surname><given-names>B</given-names></name><name name-style="western"><surname>Song</surname><given-names>S-Y</given-names></name><name name-style="western"><surname>Junt</surname><given-names>T</given-names></name><name name-style="western"><surname>Senman</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells</article-title>. <source>Science.</source> (<year>2006</year>) <volume>314</volume>:<fpage>1157</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1126/science.1132742</pub-id><pub-id pub-id-type="pmid">17110582</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reboldi</surname><given-names>A</given-names></name><name name-style="western"><surname>Arnon</surname><given-names>TI</given-names></name><name name-style="western"><surname>Rodda</surname><given-names>LB</given-names></name><name name-style="western"><surname>Atakilit</surname><given-names>A</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>D</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches</article-title>. <source>Science.</source> (<year>2016</year>) <volume>352</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf4822</pub-id><pub-id pub-id-type="pmid">27174992</pub-id><pub-id pub-id-type="pmcid">PMC4890166</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandtzaeg</surname><given-names>P</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>F-E</given-names></name></person-group>. <article-title>Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties</article-title>. <source>Immunol Rev.</source> (<year>2005</year>) <volume>206</volume>:<fpage>32</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1111/j.0105-2896.2005.00283.x</pub-id><pub-id pub-id-type="pmid">16048541</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pone</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Zan</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Al-Qahtani</surname><given-names>A</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Casali</surname><given-names>P</given-names></name></person-group>. <article-title>Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses</article-title>. <source>Crit Rev Immunol.</source> (<year>2010</year>) <volume>30</volume>:<fpage>1</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevImmunol.v30.i1.10</pub-id><pub-id pub-id-type="pmid">20370617</pub-id><pub-id pub-id-type="pmcid">PMC3038989</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pone</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Mai</surname><given-names>T</given-names></name><name name-style="western"><surname>White</surname><given-names>CA</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Sakakura</surname><given-names>JK</given-names></name><etal/></person-group>. <article-title>BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-&#954;B pathway</article-title>. <source>Nat Commun.</source> (<year>2012</year>) <volume>3</volume>:<fpage>767</fpage>&#8211;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms1769</pub-id><pub-id pub-id-type="pmid">22473011</pub-id><pub-id pub-id-type="pmcid">PMC3337981</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moor</surname><given-names>K</given-names></name><name name-style="western"><surname>Wotzka</surname><given-names>SY</given-names></name><name name-style="western"><surname>Toska</surname><given-names>A</given-names></name><name name-style="western"><surname>Diard</surname><given-names>M</given-names></name><name name-style="western"><surname>Hapfelmeier</surname><given-names>S</given-names></name><name name-style="western"><surname>Slack</surname><given-names>E</given-names></name></person-group>. <article-title>Peracetic acid treatment generates potent inactivated oral vaccines from a broad range of culturable bacterial species</article-title>. <source>Front Immunol.</source> (<year>2016</year>) <volume>7</volume>:<fpage>34</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00034</pub-id><pub-id pub-id-type="pmid">26904024</pub-id><pub-id pub-id-type="pmcid">PMC4749699</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maaser</surname><given-names>C</given-names></name><name name-style="western"><surname>Housley</surname><given-names>MP</given-names></name><name name-style="western"><surname>Iimura</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JR</given-names></name><name name-style="western"><surname>Vallance</surname><given-names>BA</given-names></name><name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Clearance of <italic toggle="yes">Citrobacter rodentium</italic> requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies</article-title>. <source>Infect Immun.</source> (<year>2004</year>) <volume>72</volume>:<fpage>3315</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.6.3315-3324.2004</pub-id><pub-id pub-id-type="pmid">15155635</pub-id><pub-id pub-id-type="pmcid">PMC415672</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panda</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tan</surname><given-names>NS</given-names></name><name name-style="western"><surname>Ho</surname><given-names>B</given-names></name><name name-style="western"><surname>Ding</surname><given-names>JL</given-names></name></person-group>. <article-title>Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria</article-title>. <source>EMBO J.</source> (<year>2013</year>) <volume>32</volume>:<fpage>2905</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2013.199</pub-id><pub-id pub-id-type="pmid">24002211</pub-id><pub-id pub-id-type="pmcid">PMC3831310</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabanyi</surname><given-names>I</given-names></name><name name-style="western"><surname>Muller</surname><given-names>PA</given-names></name><name name-style="western"><surname>Feighery</surname><given-names>L</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>TY</given-names></name><name name-style="western"><surname>Costa-Pinto</surname><given-names>FA</given-names></name><name name-style="western"><surname>Mucida</surname><given-names>D</given-names></name></person-group>. <article-title>Neuro-immune interactions drive tissue programming in intestinal macrophages</article-title>. <source>Cell.</source> (<year>2016</year>) <volume>164</volume>:<fpage>378</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.12.023</pub-id><pub-id pub-id-type="pmid">26777404</pub-id><pub-id pub-id-type="pmcid">PMC4733406</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gross</surname><given-names>M</given-names></name><name name-style="western"><surname>Salame</surname><given-names>T-M</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Guardians of the gut &#8211; murine intestinal macrophages and dendritic cells</article-title>. <source>Front Immunol.</source> (<year>2015</year>) <volume>6</volume>:<fpage>254</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2015.00254</pub-id><pub-id pub-id-type="pmid">26082775</pub-id><pub-id pub-id-type="pmcid">PMC4451680</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>PA</given-names></name><name name-style="western"><surname>Koscs&#243;</surname><given-names>B</given-names></name><name name-style="western"><surname>Rajani</surname><given-names>GM</given-names></name><name name-style="western"><surname>Stevanovic</surname><given-names>K</given-names></name><name name-style="western"><surname>Berres</surname><given-names>ML</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>D</given-names></name><etal/></person-group><article-title>Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility</article-title>. <source>Cell.</source> (<year>2014</year>) <volume>158</volume>:<fpage>300</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.04.050</pub-id><pub-id pub-id-type="pmid">25036630</pub-id><pub-id pub-id-type="pmcid">PMC4149228</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bain</surname><given-names>CC</given-names></name><name name-style="western"><surname>Bravo-Blas</surname><given-names>A</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Perdiguero</surname><given-names>EG</given-names></name><name name-style="western"><surname>Geissmann</surname><given-names>F</given-names></name><name name-style="western"><surname>Henri</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice</article-title>. <source>Nat Immunol.</source> (<year>2014</year>) <volume>15</volume>:<fpage>929</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2967</pub-id><pub-id pub-id-type="pmid">25151491</pub-id><pub-id pub-id-type="pmcid">PMC4169290</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>KA</given-names></name><name name-style="western"><surname>Stappenbeck</surname><given-names>TS</given-names></name></person-group>. <article-title>Peripheral education of the immune system by the colonic microbiota</article-title>. <source>Semin Immunol.</source> (<year>2013</year>) <volume>25</volume>:<fpage>364</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2013.10.002</pub-id><pub-id pub-id-type="pmid">24169518</pub-id><pub-id pub-id-type="pmcid">PMC3864652</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thaiss</surname><given-names>CA</given-names></name><name name-style="western"><surname>Zmora</surname><given-names>N</given-names></name><name name-style="western"><surname>Levy</surname><given-names>M</given-names></name><name name-style="western"><surname>Elinav</surname><given-names>E</given-names></name></person-group>. <article-title>The microbiome and innate immunity</article-title>. <source>Nature.</source> (<year>2016</year>) <volume>535</volume>:<fpage>65</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature18847</pub-id><pub-id pub-id-type="pmid">27383981</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>PV</given-names></name><name name-style="western"><surname>Hao</surname><given-names>L</given-names></name><name name-style="western"><surname>Offermanns</surname><given-names>S</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>. <article-title>The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2014</year>) <volume>111</volume>:<fpage>2247</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1322269111</pub-id><pub-id pub-id-type="pmid">24390544</pub-id><pub-id pub-id-type="pmcid">PMC3926023</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krause</surname><given-names>P</given-names></name><name name-style="western"><surname>Morris</surname><given-names>V</given-names></name><name name-style="western"><surname>Greenbaum</surname><given-names>JA</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bjoerheden</surname><given-names>U</given-names></name><name name-style="western"><surname>Mikulski</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis</article-title>. <source>Nat Commun.</source> (<year>2015</year>) <volume>6</volume>:<fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms8055</pub-id><pub-id pub-id-type="pmid">25959063</pub-id><pub-id pub-id-type="pmcid">PMC4428691</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zigmond</surname><given-names>E</given-names></name><name name-style="western"><surname>Varol</surname><given-names>C</given-names></name><name name-style="western"><surname>Farache</surname><given-names>J</given-names></name><name name-style="western"><surname>Elmaliah</surname><given-names>E</given-names></name><name name-style="western"><surname>Satpathy</surname><given-names>AT</given-names></name><name name-style="western"><surname>Friedlander</surname><given-names>G</given-names></name><etal/></person-group><article-title>Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells</article-title>. <source>Immunity.</source> (<year>2012</year>) <volume>37</volume>:<fpage>1076</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.08.026</pub-id><pub-id pub-id-type="pmid">23219392</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denning</surname><given-names>TL</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y-C</given-names></name><name name-style="western"><surname>Patel</surname><given-names>SR</given-names></name><name name-style="western"><surname>Williams</surname><given-names>IR</given-names></name><name name-style="western"><surname>Pulendran</surname><given-names>B</given-names></name></person-group>. <article-title>Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses</article-title>. <source>Nat Immunol.</source> (<year>2007</year>) <volume>8</volume>:<fpage>1086</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1038/ni1511</pub-id><pub-id pub-id-type="pmid">17873879</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bain</surname><given-names>CC</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name name-style="western"><surname>Gudjonsson</surname><given-names>S</given-names></name><name name-style="western"><surname>Jansson</surname><given-names>O</given-names></name><name name-style="western"><surname>Grip</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors</article-title>. <source>Mucosal Immunol.</source><volume>6</volume>:<fpage>498</fpage>&#8211;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.89</pub-id><pub-id pub-id-type="pmid">22990622</pub-id><pub-id pub-id-type="pmcid">PMC3629381</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnold</surname><given-names>IC</given-names></name><name name-style="western"><surname>Mathisen</surname><given-names>S</given-names></name><name name-style="western"><surname>Schulthess</surname><given-names>J</given-names></name><name name-style="western"><surname>Danne</surname><given-names>C</given-names></name><name name-style="western"><surname>Hegazy</surname><given-names>AN</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name></person-group>. <article-title>CD11c+ monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23</article-title>. <source>Mucosal Immunol.</source> (<year>2015</year>) <volume>9</volume>: <fpage>352</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2015.65</pub-id><pub-id pub-id-type="pmid">26242598</pub-id><pub-id pub-id-type="pmcid">PMC4650208</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asano</surname><given-names>K</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Ushiki</surname><given-names>M</given-names></name><name name-style="western"><surname>Monya</surname><given-names>M</given-names></name><name name-style="western"><surname>Aihara</surname><given-names>F</given-names></name><name name-style="western"><surname>Kuboki</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Intestinal CD169+ macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes</article-title>. <source>Nat Commun.</source> (<year>2015</year>) <volume>6</volume>:<fpage>7802</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8802</pub-id><pub-id pub-id-type="pmid">26193821</pub-id><pub-id pub-id-type="pmcid">PMC4518321</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buonocore</surname><given-names>S</given-names></name><name name-style="western"><surname>Ahern</surname><given-names>PP</given-names></name><name name-style="western"><surname>Uhlig</surname><given-names>HH</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></name><name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name><name name-style="western"><surname>Maloy</surname><given-names>KJ</given-names></name><etal/></person-group>. <article-title>Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology</article-title>. <source>Nature.</source> (<year>2010</year>) <volume>464</volume>:<fpage>1371</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature08949</pub-id><pub-id pub-id-type="pmid">20393462</pub-id><pub-id pub-id-type="pmcid">PMC3796764</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longman</surname><given-names>RS</given-names></name><name name-style="western"><surname>Diehl</surname><given-names>GE</given-names></name><name name-style="western"><surname>Victorio</surname><given-names>DA</given-names></name><name name-style="western"><surname>Huh</surname><given-names>JR</given-names></name><name name-style="western"><surname>Galan</surname><given-names>C</given-names></name><name name-style="western"><surname>Miraldi</surname><given-names>ER</given-names></name><etal/></person-group><article-title>CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22</article-title>. <source>J Exp Med</source>. (<year>2014</year>) <volume>211</volume>:<fpage>1571</fpage><pub-id pub-id-type="doi">10.1084/jem.20140678</pub-id><pub-id pub-id-type="pmid">25024136</pub-id><pub-id pub-id-type="pmcid">PMC4113938</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seo</surname><given-names>S-U</given-names></name><name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name><name name-style="western"><surname>Mu&#241;oz-Planillo</surname><given-names>R</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y-G</given-names></name><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Koizumi</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Distinct commensals induce Interleukin-1&#946; via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury</article-title>. <source>Immunity.</source> (<year>2015</year>) <volume>42</volume>:<fpage>744</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.03.004</pub-id><pub-id pub-id-type="pmid">25862092</pub-id><pub-id pub-id-type="pmcid">PMC4408263</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varol</surname><given-names>C</given-names></name><name name-style="western"><surname>Mildner</surname><given-names>A</given-names></name><name name-style="western"><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Macrophages: development and tissue specialization</article-title>. <source>Annu Rev Immunol.</source> (<year>2015</year>) <volume>33</volume>:<fpage>643</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-032414-112220</pub-id><pub-id pub-id-type="pmid">25861979</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamoutounour</surname><given-names>S</given-names></name><name name-style="western"><surname>Henri</surname><given-names>S</given-names></name><name name-style="western"><surname>Lelouard</surname><given-names>H</given-names></name><name name-style="western"><surname>de Bovis</surname><given-names>B</given-names></name><name name-style="western"><surname>de Haar</surname><given-names>C</given-names></name><name name-style="western"><surname>van</surname><given-names>der Woude CJ</given-names></name><etal/></person-group>. <article-title>CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis</article-title>. <source>Eur J Immunol.</source> (<year>2012</year>) <volume>42</volume>:<fpage>3150</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201242847</pub-id><pub-id pub-id-type="pmid">22936024</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Wermeling</surname><given-names>F</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway</article-title>. <source>Nature.</source> (<year>2011</year>) <volume>475</volume>:<fpage>110</fpage>&#8211;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/nature10134</pub-id><pub-id pub-id-type="pmid">21685887</pub-id><pub-id pub-id-type="pmcid">PMC3694429</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pricop</surname><given-names>L</given-names></name><name name-style="western"><surname>Redecha</surname><given-names>P</given-names></name><name name-style="western"><surname>Teillaud</surname><given-names>JL</given-names></name><name name-style="western"><surname>Frey</surname><given-names>J</given-names></name><name name-style="western"><surname>Fridman</surname><given-names>WH</given-names></name><name name-style="western"><surname>Sautes-Fridman</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Differential modulation of stimulatory and inhibitory Fc receptors on human monocytes by Th1 and Th2 cytokines</article-title>. <source>J Immunol.</source> (<year>2001</year>) <volume>166</volume>:<fpage>531</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.1.531</pub-id><pub-id pub-id-type="pmid">11123333</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samuelsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Towers</surname><given-names>TL</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor</article-title>. <source>Science.</source> (<year>2001</year>) <volume>291</volume>:<fpage>484</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.291.5503.484</pub-id><pub-id pub-id-type="pmid">11161202</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TT</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>The role and function of Fc&#947; receptors on myeloid cells</article-title>. <source>Microbiol Spectr.</source> (<year>2016</year>) <volume>4</volume>:<fpage>1</fpage>&#8211;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/microbiolspec.MCHD-0045-2016</pub-id><pub-id pub-id-type="pmid">28087938</pub-id><pub-id pub-id-type="pmcid">PMC5240797</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guilliams</surname><given-names>M</given-names></name><name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></name><name name-style="western"><surname>Saeys</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hammad</surname><given-names>H</given-names></name><name name-style="western"><surname>Lambrecht</surname><given-names>BN</given-names></name></person-group>. <article-title>The function of Fc&#947; receptors in dendritic cells and macrophages</article-title>. <source>Nat Rev Immunol.</source> (<year>2014</year>) <volume>14</volume>:<fpage>94</fpage>&#8211;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1038/nri3582</pub-id><pub-id pub-id-type="pmid">24445665</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhodapkar</surname><given-names>KM</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>D</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>J</given-names></name><name name-style="western"><surname>Kukreja</surname><given-names>A</given-names></name><name name-style="western"><surname>Matayeva</surname><given-names>E</given-names></name><name name-style="western"><surname>Veri</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Selective blockade of the inhibitory Fcg receptor (FcgRIIB) in human dendritic cells and monocytes induces a type I interferon response program</article-title>. <source>J Exp Med</source>. (<year>2007</year>) <volume>204</volume>:<fpage>1359</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20062545</pub-id><pub-id pub-id-type="pmid">17502666</pub-id><pub-id pub-id-type="pmcid">PMC2118610</pub-id></mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakema</surname><given-names>JE</given-names></name><name name-style="western"><surname>Tuk</surname><given-names>CW</given-names></name><name name-style="western"><surname>van Vliet</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Bruijns</surname><given-names>SC</given-names></name><name name-style="western"><surname>Vos</surname><given-names>JB</given-names></name><name name-style="western"><surname>Letsiou</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs</article-title>. <source>J Immunol.</source> (<year>2015</year>) <volume>194</volume>:<fpage>1856</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1303126</pub-id><pub-id pub-id-type="pmid">25582855</pub-id></mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>den Dunnen</surname><given-names>J</given-names></name><name name-style="western"><surname>Vogelpoel</surname><given-names>LTC</given-names></name><name name-style="western"><surname>Wypych</surname><given-names>T</given-names></name><name name-style="western"><surname>Muller</surname><given-names>FJM</given-names></name><name name-style="western"><surname>de Boer</surname><given-names>L</given-names></name><name name-style="western"><surname>Kuijpers</surname><given-names>TW</given-names></name><etal/></person-group><article-title>IgG opsonization of bacteria promotes Th17 responses via synergy between TLRs and Fc&#947;RIIa in human dendritic cells</article-title>. <source>Blood.</source> (<year>2012</year>) <volume>120</volume>:<fpage>112</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2011-12-399931</pub-id><pub-id pub-id-type="pmid">22649103</pub-id></mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogelpoel</surname><given-names>LTC</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>IS</given-names></name><name name-style="western"><surname>Rispens</surname><given-names>T</given-names></name><name name-style="western"><surname>Muller</surname><given-names>FJM</given-names></name><name name-style="western"><surname>van Capel</surname><given-names>TMM</given-names></name><name name-style="western"><surname>Turina</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages</article-title>. <source>Nat Commun.</source> (<year>2014</year>) <volume>5</volume>:<fpage>5444</fpage>&#8211;<lpage>5444</lpage>. <pub-id pub-id-type="doi">10.1038/ncomms6444</pub-id><pub-id pub-id-type="pmid">25392121</pub-id><pub-id pub-id-type="pmcid">PMC4243215</pub-id></mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janczy</surname><given-names>JR</given-names></name><name name-style="western"><surname>Ciraci</surname><given-names>C</given-names></name><name name-style="western"><surname>Haasken</surname><given-names>S</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Olivier</surname><given-names>AK</given-names></name><name name-style="western"><surname>Cassel</surname><given-names>SL</given-names></name><etal/></person-group>. <article-title>Immune complexes inhibit IL-1 secretion and inflammasome activation</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>193</volume>:<fpage>5190</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1400628</pub-id><pub-id pub-id-type="pmid">25320279</pub-id><pub-id pub-id-type="pmcid">PMC4225162</pub-id></mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Immune complex/Ig negatively regulate TLR4-triggered inflammatory response in macrophages through Fc gamma RIIb-dependent PGE2 production</article-title>. <source>J Immunol.</source> (<year>2009</year>) <volume>182</volume>:<fpage>554</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.182.1.554</pub-id><pub-id pub-id-type="pmid">19109188</pub-id></mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coombes</surname><given-names>JL</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name></person-group>. <article-title>Dendritic cells in intestinal immune regulation</article-title>. <source>Nat Rev Immunol.</source> (<year>2008</year>) <volume>8</volume>:<fpage>435</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1038/nri2335</pub-id><pub-id pub-id-type="pmid">18500229</pub-id><pub-id pub-id-type="pmcid">PMC2674208</pub-id></mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guilliams</surname><given-names>M</given-names></name><name name-style="western"><surname>Ginhoux</surname><given-names>F</given-names></name><name name-style="western"><surname>Jakubzick</surname><given-names>C</given-names></name><name name-style="western"><surname>Naik</surname><given-names>SH</given-names></name><name name-style="western"><surname>Onai</surname><given-names>N</given-names></name><name name-style="western"><surname>Schraml</surname><given-names>BU</given-names></name><etal/></person-group>. <article-title>Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny</article-title>. <source>Nat Rev Immunol.</source> (<year>2014</year>) <volume>14</volume>:<fpage>571</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nri3712</pub-id><pub-id pub-id-type="pmid">25033907</pub-id><pub-id pub-id-type="pmcid">PMC4638219</pub-id></mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Persson</surname><given-names>E</given-names></name><name name-style="western"><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name name-style="western"><surname>Semmrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Rivollier</surname><given-names>A</given-names></name><name name-style="western"><surname>H&#228;gerbrand</surname><given-names>K</given-names></name><name name-style="western"><surname>Marsal</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>IRF4 transcription-factor-dependent CD103+CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation</article-title>. <source>Immunity.</source> (<year>2013</year>) <volume>38</volume>:<fpage>958</fpage>&#8211;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.009</pub-id><pub-id pub-id-type="pmid">23664832</pub-id></mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Langarica</surname><given-names>A</given-names></name><name name-style="western"><surname>M&#252;ller Luda</surname><given-names>K</given-names></name><name name-style="western"><surname>Persson</surname><given-names>EK</given-names></name><name name-style="western"><surname>Cook</surname><given-names>CN</given-names></name><name name-style="western"><surname>Bobat</surname><given-names>S</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>JL</given-names></name><etal/></person-group>. <article-title>CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin</article-title>. <source>Mucosal Immunol.</source> (<year>2017</year>) <volume>11</volume>:<fpage>681</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2017.105</pub-id><pub-id pub-id-type="pmid">29346347</pub-id><pub-id pub-id-type="pmcid">PMC5912514</pub-id></mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerovic</surname><given-names>V</given-names></name><name name-style="western"><surname>Houston</surname><given-names>SA</given-names></name><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Aumeunier</surname><given-names>A</given-names></name><name name-style="western"><surname>Yrlid</surname><given-names>U</given-names></name><name name-style="western"><surname>Mowat</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells</article-title>. <source>Mucosal Immunol.</source> (<year>2013</year>) <volume>6</volume>:<fpage>104</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.53</pub-id><pub-id pub-id-type="pmid">22718260</pub-id></mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>CL</given-names></name><name name-style="western"><surname>Bain</surname><given-names>CC</given-names></name><name name-style="western"><surname>Wright</surname><given-names>PB</given-names></name><name name-style="western"><surname>Sichien</surname><given-names>D</given-names></name><name name-style="western"><surname>Kotarsky</surname><given-names>K</given-names></name><name name-style="western"><surname>Persson</surname><given-names>EK</given-names></name><etal/></person-group>. <article-title>CCR2+CD103&#8211; intestinal dendritic cells develop from DC-committed precursors and induce interleukin-17 production by T cells</article-title>. <source>Mucosal Immunol.</source> (<year>2015</year>) <volume>8</volume>:<fpage>327</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2014.70</pub-id><pub-id pub-id-type="pmid">25138666</pub-id><pub-id pub-id-type="pmcid">PMC4270738</pub-id></mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kinnebrew</surname><given-names>MA</given-names></name><name name-style="western"><surname>Buffie</surname><given-names>CG</given-names></name><name name-style="western"><surname>Diehl</surname><given-names>GE</given-names></name><name name-style="western"><surname>Zenewicz</surname><given-names>LA</given-names></name><name name-style="western"><surname>Leiner</surname><given-names>I</given-names></name><name name-style="western"><surname>Hohl</surname><given-names>TM</given-names></name><etal/></person-group>. <article-title>Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense</article-title>. <source>Immunity.</source> (<year>2012</year>) <volume>36</volume>:<fpage>276</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.011</pub-id><pub-id pub-id-type="pmid">22306017</pub-id><pub-id pub-id-type="pmcid">PMC3288454</pub-id></mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mundy</surname><given-names>R</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>TT</given-names></name><name name-style="western"><surname>Dougan</surname><given-names>G</given-names></name><name name-style="western"><surname>Frankel</surname><given-names>G</given-names></name><name name-style="western"><surname>Wiles</surname><given-names>S</given-names></name></person-group>. <article-title><italic toggle="yes">Citrobacter rodentium</italic> of mice and man</article-title>. <source>Cell. Microbiol.</source> (<year>2005</year>) <volume>7</volume>:<fpage>1697</fpage>&#8211;<lpage>706</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00625.x</pub-id><pub-id pub-id-type="pmid">16309456</pub-id></mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satpathy</surname><given-names>AT</given-names></name><name name-style="western"><surname>Brise&#241;o</surname><given-names>CG</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Ng</surname><given-names>D</given-names></name><name name-style="western"><surname>Manieri</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kc</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens</article-title>. <source>Nat Immunol.</source> (<year>2013</year>) <volume>14</volume>:<fpage>937</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2679</pub-id><pub-id pub-id-type="pmid">23913046</pub-id><pub-id pub-id-type="pmcid">PMC3788683</pub-id></mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coombes</surname><given-names>JL</given-names></name><name name-style="western"><surname>Siddiqui</surname><given-names>KRR</given-names></name><name name-style="western"><surname>Arancibia-C&#225;rcamo</surname><given-names>CV</given-names></name><name name-style="western"><surname>Hall</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C-M</given-names></name><name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism</article-title>. <source>J Exp Med.</source> (<year>2007</year>) <volume>204</volume>:<fpage>1757</fpage>&#8211;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20070590</pub-id><pub-id pub-id-type="pmid">17620361</pub-id><pub-id pub-id-type="pmcid">PMC2118683</pub-id></mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boruchov</surname><given-names>AM</given-names></name><name name-style="western"><surname>Heller</surname><given-names>G</given-names></name><name name-style="western"><surname>Veri</surname><given-names>M-C</given-names></name><name name-style="western"><surname>Bonvini</surname><given-names>E</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name><name name-style="western"><surname>Young</surname><given-names>JW</given-names></name></person-group>. <article-title>Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions</article-title>. <source>J Clin Invest.</source> (<year>2005</year>) <volume>115</volume>:<fpage>2914</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1172/JCI24772</pub-id><pub-id pub-id-type="pmid">16167082</pub-id><pub-id pub-id-type="pmcid">PMC1201664</pub-id></mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhodapkar</surname><given-names>KM</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>JL</given-names></name><name name-style="western"><surname>Ehlers</surname><given-names>M</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>DK</given-names></name><name name-style="western"><surname>Bonvini</surname><given-names>E</given-names></name><name name-style="western"><surname>Koenig</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells</article-title>. <source>Proc Natl. Acad Sci USA.</source> (<year>2005</year>) <volume>102</volume>:<fpage>2910</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0500014102</pub-id><pub-id pub-id-type="pmid">15703291</pub-id><pub-id pub-id-type="pmcid">PMC549508</pub-id></mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Jong</surname><given-names>JMH</given-names></name><name name-style="western"><surname>Schuurhuis</surname><given-names>DH</given-names></name><name name-style="western"><surname>Ioan-Facsinay</surname><given-names>A</given-names></name><name name-style="western"><surname>Welling</surname><given-names>MM</given-names></name><name name-style="western"><surname>Camps</surname><given-names>MGM</given-names></name><name name-style="western"><surname>Van Der Voort</surname><given-names>EIH</given-names></name><etal/></person-group>. <article-title>Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake <italic toggle="yes">in vivo</italic></article-title>. <source>Immunology.</source> (<year>2006</year>) <volume>119</volume>:<fpage>499</fpage>&#8211;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2567.2006.02464.x</pub-id><pub-id pub-id-type="pmid">16995881</pub-id><pub-id pub-id-type="pmcid">PMC2265814</pub-id></mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Regnault</surname><given-names>A</given-names></name><name name-style="western"><surname>Lankar</surname><given-names>D</given-names></name><name name-style="western"><surname>Lacabanne</surname><given-names>V</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></name><name name-style="western"><surname>Rescigno</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization</article-title>. <source>J Exp Med.</source> (<year>1999</year>) <volume>189</volume>:<fpage>371</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1084/jem.189.2.371</pub-id><pub-id pub-id-type="pmid">9892619</pub-id><pub-id pub-id-type="pmcid">PMC2192989</pub-id></mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Montfoort</surname><given-names>N</given-names></name><name name-style="western"><surname>t Hoen</surname><given-names>PAC</given-names></name><name name-style="western"><surname>Mangsbo</surname><given-names>SM</given-names></name><name name-style="western"><surname>Camps</surname><given-names>MGM</given-names></name><name name-style="western"><surname>Boross</surname><given-names>P</given-names></name><name name-style="western"><surname>Melief</surname><given-names>CJM</given-names></name><etal/></person-group><article-title>Fc receptor IIb strongly regulates Fc receptor-facilitated T cell activation by dendritic cells</article-title>. <source>J Immunol.</source> (<year>2012</year>) <volume>189</volume>:<fpage>92</fpage>&#8211;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1103703</pub-id><pub-id pub-id-type="pmid">22649202</pub-id></mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name><name name-style="western"><surname>Aronin</surname><given-names>CEP</given-names></name><name name-style="western"><surname>Mathews</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>NY</given-names></name><name name-style="western"><surname>Smith</surname><given-names>KGC</given-names></name><name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name></person-group>. <article-title>Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes</article-title>. <source>Nat Med.</source> (<year>2014</year>) <volume>20</volume>:<fpage>1458</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3709</pub-id><pub-id pub-id-type="pmid">25384086</pub-id><pub-id pub-id-type="pmcid">PMC4283039</pub-id></mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>SW</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>TT</given-names></name><name name-style="western"><surname>Aveson</surname><given-names>VG</given-names></name><name name-style="western"><surname>Platzer</surname><given-names>B</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>JT</given-names></name><etal/></person-group>. <article-title>Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2011</year>) <volume>108</volume>:<fpage>9927</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1019037108</pub-id><pub-id pub-id-type="pmid">21628593</pub-id><pub-id pub-id-type="pmcid">PMC3116387</pub-id></mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ley</surname><given-names>K</given-names></name><name name-style="western"><surname>Hoffman</surname><given-names>HM</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name><name name-style="western"><surname>Cassatella</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zychlinsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Hedrick</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>Neutrophils: new insights and open questions</article-title>. <source>Sci Immunol</source>. (<year>2018</year>) <volume>3</volume>:<fpage>eaat4579</fpage>.<pub-id pub-id-type="pmid">30530726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.aat4579</pub-id></mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puga</surname><given-names>I</given-names></name><name name-style="western"><surname>Cols</surname><given-names>M</given-names></name><name name-style="western"><surname>Barra</surname><given-names>CM</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Cassis</surname><given-names>L</given-names></name><name name-style="western"><surname>Gentile</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen</article-title>. <source>Nat Immunol.</source> (<year>2012</year>) <volume>13</volume>:<fpage>170</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2194</pub-id><pub-id pub-id-type="pmid">22197976</pub-id><pub-id pub-id-type="pmcid">PMC3262910</pub-id></mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beauvillain</surname><given-names>C</given-names></name><name name-style="western"><surname>Delneste</surname><given-names>Y</given-names></name><name name-style="western"><surname>Scotet</surname><given-names>M</given-names></name><name name-style="western"><surname>Peres</surname><given-names>A</given-names></name><name name-style="western"><surname>Gascan</surname><given-names>H</given-names></name><name name-style="western"><surname>Guermonprez</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Neutrophils efficiently cross-prime naive T cells <italic toggle="yes">in vivo</italic></article-title>. <source>Blood.</source> (<year>2007</year>) <volume>110</volume>:<fpage>2965</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-12-063826</pub-id><pub-id pub-id-type="pmid">17562875</pub-id></mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Culshaw</surname><given-names>S</given-names></name><name name-style="western"><surname>Millington</surname><given-names>OR</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>JM</given-names></name><name name-style="western"><surname>McInnes</surname><given-names>IB</given-names></name></person-group>. <article-title>Murine neutrophils present Class II restricted antigen</article-title>. <source>Immunol Lett.</source> (<year>2008</year>) <volume>118</volume>:<fpage>49</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2008.02.008</pub-id><pub-id pub-id-type="pmid">18400308</pub-id><pub-id pub-id-type="pmcid">PMC2430030</pub-id></mixed-citation></ref><ref id="B154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vono</surname><given-names>M</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><name name-style="western"><surname>Norrby-Teglund</surname><given-names>A</given-names></name><name name-style="western"><surname>Koup</surname><given-names>RA</given-names></name><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Lor&#233;</surname><given-names>K</given-names></name></person-group>. <article-title>Neutrophils acquire the capacity for antigen presentation to memory CD4 + T cells <italic toggle="yes">in vitro</italic> and <italic toggle="yes">ex vivo</italic></article-title>. <source>Blood.</source> (<year>2017</year>) <volume>129</volume>:<fpage>1991</fpage>&#8211;<lpage>2001</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2016-10-744441</pub-id><pub-id pub-id-type="pmid">28143882</pub-id><pub-id pub-id-type="pmcid">PMC5383872</pub-id></mixed-citation></ref><ref id="B155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fournier</surname><given-names>BM</given-names></name><name name-style="western"><surname>Parkos</surname><given-names>CA</given-names></name></person-group>. <article-title>The role of neutrophils during intestinal inflammation</article-title>. <source>Mucosal Immunol.</source> (<year>2012</year>) <volume>5</volume>:<fpage>354</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.24</pub-id><pub-id pub-id-type="pmid">22491176</pub-id></mixed-citation></ref><ref id="B156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaser</surname><given-names>A</given-names></name><name name-style="western"><surname>Zeissig</surname><given-names>S</given-names></name><name name-style="western"><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>Inflammatory bowel disease</article-title>. <source>Annu Rev Immunol.</source> (<year>2010</year>) <volume>28</volume>:<fpage>573</fpage>&#8211;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101225</pub-id><pub-id pub-id-type="pmid">20192811</pub-id><pub-id pub-id-type="pmcid">PMC4620040</pub-id></mixed-citation></ref><ref id="B157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broggi</surname><given-names>A</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Granucci</surname><given-names>F</given-names></name><name name-style="western"><surname>Zanoni</surname><given-names>I</given-names></name></person-group>. <article-title>IFN-&#955; suppresses intestinal inflammation by non-translational regulation of neutrophil function</article-title>. <source>Nat Immunol.</source> (<year>2017</year>) <volume>18</volume>:<fpage>1084</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3821</pub-id><pub-id pub-id-type="pmid">28846084</pub-id><pub-id pub-id-type="pmcid">PMC5701513</pub-id></mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buell</surname><given-names>MG</given-names></name><name name-style="western"><surname>Berin</surname><given-names>MC</given-names></name></person-group>. <article-title>Neutrophil-independence of the initiation of colonic injury</article-title>. <source>Digest Dis Sci.</source> (<year>1994</year>) <volume>39</volume>:<fpage>2575</fpage>&#8211;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1007/BF02087693</pub-id><pub-id pub-id-type="pmid">7995182</pub-id></mixed-citation></ref><ref id="B159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qualls</surname><given-names>JE</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>AM</given-names></name><name name-style="western"><surname>Van Rooijen</surname><given-names>N</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>DA</given-names></name></person-group>. <article-title>Suppression of experimental colitis by intestinal mononuclear phagocytes</article-title>. <source>J Leukoc Biol.</source> (<year>2006</year>) <volume>80</volume>:<fpage>802</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1205734</pub-id><pub-id pub-id-type="pmid">16888083</pub-id></mixed-citation></ref><ref id="B160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zindl</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lai</surname><given-names>JF</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YK</given-names></name><name name-style="western"><surname>Maynard</surname><given-names>CL</given-names></name><name name-style="western"><surname>Harbour</surname><given-names>SN</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2013</year>) <volume>110</volume>:<fpage>12768</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1300318110</pub-id><pub-id pub-id-type="pmid">23781104</pub-id><pub-id pub-id-type="pmcid">PMC3732935</pub-id></mixed-citation></ref><ref id="B161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casanova-Acebes</surname><given-names>M</given-names></name><name name-style="western"><surname>Nicol&#225;s-&#193;vila</surname><given-names>JA</given-names></name><name name-style="western"><surname>Li</surname><given-names>JL</given-names></name><name name-style="western"><surname>Garc&#237;a-Silva</surname><given-names>S</given-names></name><name name-style="western"><surname>Balachander</surname><given-names>A</given-names></name><name name-style="western"><surname>Rubio-Ponce</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Neutrophils instruct homeostatic and pathological states in naive tissues</article-title>. <source>J Exp Med</source>. (<year>2018</year>) <volume>215</volume>:<fpage>2778</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20181468</pub-id><pub-id pub-id-type="pmid">30282719</pub-id><pub-id pub-id-type="pmcid">PMC6219739</pub-id></mixed-citation></ref><ref id="B162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ericson</surname><given-names>JA</given-names></name><name name-style="western"><surname>Duffau</surname><given-names>P</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Ortiz-Lopez</surname><given-names>A</given-names></name><name name-style="western"><surname>Rothamel</surname><given-names>K</given-names></name><name name-style="western"><surname>Rifkin</surname><given-names>IR</given-names></name><etal/></person-group>. <article-title>Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e108553</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0108553</pub-id><pub-id pub-id-type="pmid">25279834</pub-id><pub-id pub-id-type="pmcid">PMC4184787</pub-id></mixed-citation></ref><ref id="B163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimmerjahn</surname><given-names>F</given-names></name><name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></name><name name-style="western"><surname>Horiuchi</surname><given-names>K</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>FcgammaRIV: a novel FcR with distinct IgG subclass specificity</article-title>. <source>Immunity.</source> (<year>2005</year>) <volume>23</volume>:<fpage>41</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2005.05.010</pub-id><pub-id pub-id-type="pmid">16039578</pub-id></mixed-citation></ref><ref id="B164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willcocks</surname><given-names>LC</given-names></name><name name-style="western"><surname>Lyons</surname><given-names>PA</given-names></name><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>JI</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Newland</surname><given-names>SA</given-names></name><etal/></person-group>. <article-title>Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake</article-title>. <source>J Exp Med.</source> (<year>2008</year>) <volume>205</volume>:<fpage>1573</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20072413</pub-id><pub-id pub-id-type="pmid">18559452</pub-id><pub-id pub-id-type="pmcid">PMC2442635</pub-id></mixed-citation></ref><ref id="B165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sur Chowdhury</surname><given-names>C</given-names></name><name name-style="western"><surname>Giaglis</surname><given-names>S</given-names></name><name name-style="western"><surname>Walker</surname><given-names>UA</given-names></name><name name-style="western"><surname>Buser</surname><given-names>A</given-names></name><name name-style="western"><surname>Hahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Hasler</surname><given-names>P</given-names></name></person-group><article-title>Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility</article-title>. <source>Arthritis Res Ther.</source> (<year>2014</year>) <volume>16</volume>:<fpage>R122</fpage><pub-id pub-id-type="doi">10.1186/ar4579</pub-id><pub-id pub-id-type="pmid">24928093</pub-id><pub-id pub-id-type="pmcid">PMC4229860</pub-id></mixed-citation></ref><ref id="B166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>SD</given-names></name><name name-style="western"><surname>Voyich</surname><given-names>JM</given-names></name><name name-style="western"><surname>Buhl</surname><given-names>CL</given-names></name><name name-style="western"><surname>Stahl</surname><given-names>RM</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name></person-group>. <article-title>Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2002</year>) <volume>99</volume>:<fpage>6901</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.092148299</pub-id><pub-id pub-id-type="pmid">11983860</pub-id><pub-id pub-id-type="pmcid">PMC124501</pub-id></mixed-citation></ref><ref id="B167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadik</surname><given-names>CD</given-names></name><name name-style="western"><surname>Kim</surname><given-names>ND</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luster</surname><given-names>AD</given-names></name></person-group>. <article-title>Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and Fc&#947;R signaling</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2012</year>) <volume>109</volume>:<fpage>E3177</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213797109</pub-id><pub-id pub-id-type="pmid">23112187</pub-id><pub-id pub-id-type="pmcid">PMC3503206</pub-id></mixed-citation></ref><ref id="B168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coxon</surname><given-names>A</given-names></name><name name-style="western"><surname>Cullere</surname><given-names>X</given-names></name><name name-style="western"><surname>Knight</surname><given-names>S</given-names></name><name name-style="western"><surname>Sethi</surname><given-names>S</given-names></name><name name-style="western"><surname>Wakelin</surname><given-names>MW</given-names></name><name name-style="western"><surname>Stavrakis</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation</article-title>. <source>Immunity.</source> (<year>2001</year>) <volume>14</volume>:<fpage>693</fpage>&#8211;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00150-9</pub-id><pub-id pub-id-type="pmid">11420040</pub-id></mixed-citation></ref><ref id="B169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayadas</surname><given-names>TN</given-names></name><name name-style="western"><surname>Tsokos</surname><given-names>GC</given-names></name><name name-style="western"><surname>Tsuboi</surname><given-names>N</given-names></name></person-group>. <article-title>Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury</article-title>. <source>Circulation.</source> (<year>2009</year>) <volume>120</volume>:<fpage>2012</fpage>&#8211;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.771170</pub-id><pub-id pub-id-type="pmid">19917895</pub-id><pub-id pub-id-type="pmcid">PMC2782878</pub-id></mixed-citation></ref><ref id="B170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Brown</surname><given-names>EJ</given-names></name></person-group>. <article-title>CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: requirement for Fc gamma RIII and tyrosine phosphorylation</article-title>. <source>J Cell Biol.</source> (<year>1994</year>) <volume>125</volume>:<fpage>1407</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.125.6.1407</pub-id><pub-id pub-id-type="pmid">7515890</pub-id><pub-id pub-id-type="pmcid">PMC2290913</pub-id></mixed-citation></ref><ref id="B171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salmon</surname><given-names>JE</given-names></name><name name-style="western"><surname>Edberg</surname><given-names>JC</given-names></name><name name-style="western"><surname>Kimberly</surname><given-names>RP</given-names></name></person-group>. <article-title>Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities</article-title>. <source>J Clin Invest.</source> (<year>1990</year>) <volume>85</volume>:<fpage>1287</fpage>&#8211;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1172/JCI114566</pub-id><pub-id pub-id-type="pmid">1690757</pub-id><pub-id pub-id-type="pmcid">PMC296565</pub-id></mixed-citation></ref><ref id="B172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koene</surname><given-names>HR</given-names></name><name name-style="western"><surname>Kleijer</surname><given-names>M</given-names></name><name name-style="western"><surname>Roos</surname><given-names>D</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>M</given-names></name><name name-style="western"><surname>Von</surname><given-names>dem Borne AE</given-names></name></person-group>. <article-title>Fc gamma RIIIB gene duplication: evidence for presence and expression of three distinct Fc gamma RIIIB genes in NA(1+,2+)SH(+) individuals</article-title>. <source>Blood.</source> (<year>1998</year>) <volume>91</volume>:<fpage>673</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9427724</pub-id></mixed-citation></ref><ref id="B173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>NA</given-names></name><name name-style="western"><surname>Harnett</surname><given-names>MM</given-names></name></person-group><article-title>Dissection of the signalling mechanisms underlying Fc&#947; RIIB-mediated apoptosis of mature B-cells</article-title>. <source>Biochem Soc Trans</source>. (<year>2004</year>) <volume>32</volume>(<issue>Pt 6</issue>):<fpage>973</fpage>-<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1042/BST0320973</pub-id><pub-id pub-id-type="pmid">15506939</pub-id></mixed-citation></ref><ref id="B174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cutler</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Brownlie</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Fairfax</surname><given-names>K</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>KE</given-names></name><name name-style="western"><surname>Severinson</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis</article-title>. <source>Nat Immunol.</source> (<year>2007</year>) <volume>8</volume>:<fpage>419</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/ni1440</pub-id><pub-id pub-id-type="pmid">17322888</pub-id></mixed-citation></ref><ref id="B175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKenzie</surname><given-names>ANJ</given-names></name><name name-style="western"><surname>Spits</surname><given-names>H</given-names></name><name name-style="western"><surname>Eberl</surname><given-names>G</given-names></name></person-group>. <article-title>Innate lymphoid cells in inflammation and immunity</article-title>. <source>Immunity.</source> (<year>2014</year>) <volume>41</volume>:<fpage>366</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.09.006</pub-id><pub-id pub-id-type="pmid">25238094</pub-id></mixed-citation></ref><ref id="B176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artis</surname><given-names>D</given-names></name><name name-style="western"><surname>Spits</surname><given-names>H</given-names></name></person-group>. <article-title>The biology of innate lymphoid cells</article-title>. <source>Nature.</source><volume>517</volume>:<fpage>293</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1038/nature14189</pub-id><pub-id pub-id-type="pmid">25592534</pub-id></mixed-citation></ref><ref id="B177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klose</surname><given-names>CSN</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>EA</given-names></name><name name-style="western"><surname>Schwierzeck</surname><given-names>V</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>K</given-names></name><name name-style="western"><surname>Hoyler</surname><given-names>T</given-names></name><name name-style="western"><surname>d'Hargues</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A T-bet gradient controls the fate and function of CCR6-ROR&#947;t+ innate lymphoid cells</article-title>. <source>Nature.</source> (<year>2013</year>) <volume>494</volume>:<fpage>261</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature11813</pub-id><pub-id pub-id-type="pmid">23334414</pub-id></mixed-citation></ref><ref id="B178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Cella</surname><given-names>M</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>KG</given-names></name><name name-style="western"><surname>Garlanda</surname><given-names>C</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>GD</given-names></name><name name-style="western"><surname>Nukaya</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch</article-title>. <source>Nat Immunol.</source> (<year>2012</year>) <volume>13</volume>:<fpage>144</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/ni.2187</pub-id><pub-id pub-id-type="pmid">22101730</pub-id><pub-id pub-id-type="pmcid">PMC3468413</pub-id></mixed-citation></ref><ref id="B179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanos</surname><given-names>SL</given-names></name><name name-style="western"><surname>Bui</surname><given-names>VL</given-names></name><name name-style="western"><surname>Mortha</surname><given-names>A</given-names></name><name name-style="western"><surname>Oberle</surname><given-names>K</given-names></name><name name-style="western"><surname>Heners</surname><given-names>C</given-names></name><name name-style="western"><surname>Johner</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells</article-title>. <source>Nat Immunol.</source> (<year>2009</year>) <volume>10</volume>:<fpage>83</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1684</pub-id><pub-id pub-id-type="pmid">19029903</pub-id><pub-id pub-id-type="pmcid">PMC4217274</pub-id></mixed-citation></ref><ref id="B180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zook</surname><given-names>EC</given-names></name><name name-style="western"><surname>Kee</surname><given-names>BL</given-names></name></person-group>. <article-title>Development of innate lymphoid cells</article-title>. <source>Nat Immunol.</source> (<year>2016</year>) <volume>17</volume>:<fpage>775</fpage>&#8211;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3481</pub-id><pub-id pub-id-type="pmid">27328007</pub-id></mixed-citation></ref><ref id="B181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eberl</surname><given-names>G</given-names></name><name name-style="western"><surname>Marmon</surname><given-names>S</given-names></name><name name-style="western"><surname>Sunshine</surname><given-names>M-J</given-names></name><name name-style="western"><surname>Rennert</surname><given-names>PD</given-names></name><name name-style="western"><surname>Choi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name></person-group>. <article-title>An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells</article-title>. <source>Nat Immunol.</source> (<year>2004</year>) <volume>5</volume>:<fpage>64</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/ni1022</pub-id><pub-id pub-id-type="pmid">14691482</pub-id></mixed-citation></ref><ref id="B182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hepworth</surname><given-names>MR</given-names></name><name name-style="western"><surname>Fung</surname><given-names>TC</given-names></name><name name-style="western"><surname>Masur</surname><given-names>SH</given-names></name><name name-style="western"><surname>Kelsen</surname><given-names>JR</given-names></name><name name-style="western"><surname>McConnell</surname><given-names>FM</given-names></name><name name-style="western"><surname>Dubrot</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells</article-title>. <source>Science.</source> (<year>2015</year>) <volume>348</volume>:<fpage>1031</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa4812</pub-id><pub-id pub-id-type="pmid">25908663</pub-id><pub-id pub-id-type="pmcid">PMC4449822</pub-id></mixed-citation></ref><ref id="B183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hepworth</surname><given-names>MR</given-names></name><name name-style="western"><surname>Monticelli</surname><given-names>LA</given-names></name><name name-style="western"><surname>Fung</surname><given-names>TC</given-names></name><name name-style="western"><surname>Ziegler</surname><given-names>CGK</given-names></name><name name-style="western"><surname>Grunberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria</article-title>. <source>Nature.</source> (<year>2013</year>) <volume>498</volume>:<fpage>113</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature12240</pub-id><pub-id pub-id-type="pmid">23698371</pub-id><pub-id pub-id-type="pmcid">PMC3699860</pub-id></mixed-citation></ref><ref id="B184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takatori</surname><given-names>H</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>Y</given-names></name><name name-style="western"><surname>Watford</surname><given-names>WT</given-names></name><name name-style="western"><surname>Tato</surname><given-names>CM</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>G</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></name><etal/></person-group>. <article-title>Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22</article-title>. <source>J Exp Med.</source> (<year>2009</year>) <volume>206</volume>:<fpage>35</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20072713</pub-id><pub-id pub-id-type="pmid">19114665</pub-id><pub-id pub-id-type="pmcid">PMC2626689</pub-id></mixed-citation></ref><ref id="B185"><label>185.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Valdez</surname><given-names>PA</given-names></name><name name-style="western"><surname>Danilenko</surname><given-names>DM</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sa</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens</article-title>. <source>Nat Med.</source> (<year>2008</year>) <volume>14</volume>:<fpage>282</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nm1720</pub-id><pub-id pub-id-type="pmid">18264109</pub-id></mixed-citation></ref><ref id="B186"><label>186.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Obata</surname><given-names>T</given-names></name><name name-style="western"><surname>Kunisawa</surname><given-names>J</given-names></name><name name-style="western"><surname>Sato</surname><given-names>S</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>II</given-names></name><name name-style="western"><surname>Lamichhane</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Innate lymphoid cells regulate intestinal epithelial cell glycosylation</article-title>. <source>Science.</source> (<year>2014</year>) <volume>345</volume>:<fpage>1254009</fpage>. <pub-id pub-id-type="doi">10.1126/science.1254009</pub-id><pub-id pub-id-type="pmid">25214634</pub-id><pub-id pub-id-type="pmcid">PMC4774895</pub-id></mixed-citation></ref><ref id="B187"><label>187.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanash</surname><given-names>AM</given-names></name><name name-style="western"><surname>Dudakov</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hua</surname><given-names>G</given-names></name><name name-style="western"><surname>O'Connor</surname><given-names>MH</given-names></name><name name-style="western"><surname>Young</surname><given-names>LF</given-names></name><name name-style="western"><surname>Singer</surname><given-names>NV</given-names></name><etal/></person-group>. <article-title>Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease</article-title>. <source>Immunity.</source> (<year>2012</year>) <volume>37</volume>:<fpage>339</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.028</pub-id><pub-id pub-id-type="pmid">22921121</pub-id><pub-id pub-id-type="pmcid">PMC3477611</pub-id></mixed-citation></ref><ref id="B188"><label>188.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindemans</surname><given-names>CA</given-names></name><name name-style="western"><surname>Calafiore</surname><given-names>M</given-names></name><name name-style="western"><surname>Mertelsmann</surname><given-names>AM</given-names></name><name name-style="western"><surname>O'Connor</surname><given-names>MH</given-names></name><name name-style="western"><surname>Dudakov</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jenq</surname><given-names>RR</given-names></name><etal/></person-group>. <article-title>Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration</article-title>. <source>Nature.</source> (<year>2015</year>) <volume>528</volume>:<fpage>560</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nature16460</pub-id><pub-id pub-id-type="pmid">26649819</pub-id><pub-id pub-id-type="pmcid">PMC4720437</pub-id></mixed-citation></ref><ref id="B189"><label>189.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pham</surname><given-names>TAN</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S</given-names></name><name name-style="western"><surname>Goulding</surname><given-names>D</given-names></name><name name-style="western"><surname>Arasteh</surname><given-names>JM</given-names></name><name name-style="western"><surname>Stares</surname><given-names>MD</given-names></name><name name-style="western"><surname>Browne</surname><given-names>HP</given-names></name><etal/></person-group>. <article-title>Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen</article-title>. <source>Cell Host and Microbe.</source> (<year>2014</year>) <volume>16</volume>:<fpage>504</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2014.08.017</pub-id><pub-id pub-id-type="pmid">25263220</pub-id><pub-id pub-id-type="pmcid">PMC4190086</pub-id></mixed-citation></ref><ref id="B190"><label>190.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pickert</surname><given-names>G</given-names></name><name name-style="western"><surname>Neufert</surname><given-names>C</given-names></name><name name-style="western"><surname>Leppkes</surname><given-names>M</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wittkopf</surname><given-names>N</given-names></name><name name-style="western"><surname>Warntjen</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing</article-title>. <source>J Exp Med.</source> (<year>2009</year>) <volume>206</volume>:<fpage>1465</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20082683</pub-id><pub-id pub-id-type="pmid">19564350</pub-id><pub-id pub-id-type="pmcid">PMC2715097</pub-id></mixed-citation></ref><ref id="B191"><label>191.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sonnenberg</surname><given-names>GF</given-names></name><name name-style="western"><surname>Monticelli</surname><given-names>LA</given-names></name><name name-style="western"><surname>Alenghat</surname><given-names>T</given-names></name><name name-style="western"><surname>Fung</surname><given-names>TC</given-names></name><name name-style="western"><surname>Hutnick</surname><given-names>Na</given-names></name><name name-style="western"><surname>Kunisawa</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria</article-title>. <source>Science.</source> (<year>2012</year>) <volume>336</volume>:<fpage>1321</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.1222551</pub-id><pub-id pub-id-type="pmid">22674331</pub-id><pub-id pub-id-type="pmcid">PMC3659421</pub-id></mixed-citation></ref><ref id="B192"><label>192.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griseri</surname><given-names>T</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>BS</given-names></name><name name-style="western"><surname>Schiering</surname><given-names>C</given-names></name><name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name></person-group>. <article-title>Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation</article-title>. <source>Immunity.</source> (<year>2012</year>) <volume>37</volume>:<fpage>1116</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2012.08.025</pub-id><pub-id pub-id-type="pmid">23200826</pub-id><pub-id pub-id-type="pmcid">PMC3664922</pub-id></mixed-citation></ref><ref id="B193"><label>193.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearson</surname><given-names>C</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>EE</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>B</given-names></name><name name-style="western"><surname>Schaupp</surname><given-names>A-L</given-names></name><name name-style="western"><surname>Huskens</surname><given-names>N</given-names></name><name name-style="western"><surname>Griseri</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation</article-title>. <source>eLife.</source> (<year>2016</year>) <volume>5</volume>:<fpage>e10066</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.10066</pub-id><pub-id pub-id-type="pmid">26780670</pub-id><pub-id pub-id-type="pmcid">PMC4733039</pub-id></mixed-citation></ref><ref id="B194"><label>194.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Gilfillan</surname><given-names>S</given-names></name><name name-style="western"><surname>Robinette</surname><given-names>ML</given-names></name><name name-style="western"><surname>Newberry</surname><given-names>RD</given-names></name><name name-style="western"><surname>Stappenbeck</surname><given-names>TS</given-names></name><etal/></person-group>. <article-title>Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation</article-title>. <source>J Exp Med.</source> (<year>2015</year>) <volume>212</volume>:<fpage>1869</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151403</pub-id><pub-id pub-id-type="pmid">26458769</pub-id><pub-id pub-id-type="pmcid">PMC4612098</pub-id></mixed-citation></ref><ref id="B195"><label>195.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Metes</surname><given-names>D</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>LK</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>WH</given-names></name><name name-style="western"><surname>Sulica</surname><given-names>A</given-names></name><name name-style="western"><surname>Herberman</surname><given-names>RB</given-names></name><name name-style="western"><surname>Morel</surname><given-names>PA</given-names></name></person-group>. <article-title>Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene</article-title>. <source>Blood.</source> (<year>1998</year>) <volume>91</volume>:<fpage>2369</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="pmid">9516136</pub-id></mixed-citation></ref><ref id="B196"><label>196.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vivier</surname><given-names>E</given-names></name><name name-style="western"><surname>Tomasello</surname><given-names>E</given-names></name><name name-style="western"><surname>Baratin</surname><given-names>M</given-names></name><name name-style="western"><surname>Walzer</surname><given-names>T</given-names></name><name name-style="western"><surname>Ugolini</surname><given-names>S</given-names></name></person-group>. <article-title>Functions of natural killer cells</article-title>. <source>Nat Immunol.</source> (<year>2008</year>) <volume>9</volume>:<fpage>503</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/ni1582</pub-id><pub-id pub-id-type="pmid">18425107</pub-id></mixed-citation></ref><ref id="B197"><label>197.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bryceson</surname><given-names>YT</given-names></name><name name-style="western"><surname>March</surname><given-names>ME</given-names></name><name name-style="western"><surname>Ljunggren</surname><given-names>H-G</given-names></name><name name-style="western"><surname>Long</surname><given-names>EO</given-names></name></person-group>. <article-title>Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion</article-title>. <source>Blood</source>. (<year>2006</year>) <volume>107</volume>:<fpage>159</fpage>&#8211;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2005-04-1351</pub-id><pub-id pub-id-type="pmid">16150947</pub-id><pub-id pub-id-type="pmcid">PMC1895346</pub-id></mixed-citation></ref><ref id="B198"><label>198.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srivastava</surname><given-names>S</given-names></name><name name-style="western"><surname>Pelloso</surname><given-names>D</given-names></name><name name-style="western"><surname>Feng</surname><given-names>H</given-names></name><name name-style="western"><surname>Voiles</surname><given-names>L</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>D</given-names></name><name name-style="western"><surname>Haskova</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin</article-title>. <source>Cancer Immunol Immunother.</source> (<year>2013</year>) <volume>62</volume>:<fpage>1073</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s00262-013-1403-0</pub-id><pub-id pub-id-type="pmid">23604103</pub-id><pub-id pub-id-type="pmcid">PMC3707624</pub-id></mixed-citation></ref><ref id="B199"><label>199.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prehn</surname><given-names>JL</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>LS</given-names></name><name name-style="western"><surname>Landers</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yu</surname><given-names>QT</given-names></name><name name-style="western"><surname>Michelsen</surname><given-names>KS</given-names></name><name name-style="western"><surname>Targan</surname><given-names>SR</given-names></name></person-group>. <article-title>The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells</article-title>. <source>J Immunol.</source> (<year>2007</year>) <volume>178</volume>:<fpage>4033</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.178.7.4033</pub-id><pub-id pub-id-type="pmid">17371957</pub-id></mixed-citation></ref><ref id="B200"><label>200.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hisamatsu</surname><given-names>T</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaito</surname><given-names>D</given-names></name><name name-style="western"><surname>Yoneno</surname><given-names>K</given-names></name><name name-style="western"><surname>Kitazume</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through Fc&#947;R-mediated CD14 macrophage activation</article-title>. <source>Gut.</source> (<year>2013</year>) <volume>62</volume>:<fpage>1734</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2012-303063</pub-id><pub-id pub-id-type="pmid">23013725</pub-id></mixed-citation></ref><ref id="B201"><label>201.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allan</surname><given-names>DS</given-names></name><name name-style="western"><surname>Kirkham</surname><given-names>CL</given-names></name><name name-style="western"><surname>Aguilar</surname><given-names>OA</given-names></name><name name-style="western"><surname>Qu</surname><given-names>LC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P</given-names></name><name name-style="western"><surname>Fine</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>An <italic toggle="yes">in vitro</italic> model of innate lymphoid cell function and differentiation</article-title>. <source>Mucosal Immunol.</source> (<year>2014</year>) <volume>8</volume>: <fpage>340</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2014.71</pub-id><pub-id pub-id-type="pmid">25138665</pub-id></mixed-citation></ref><ref id="B202"><label>202.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koues</surname><given-names>OI</given-names></name><name name-style="western"><surname>Collins</surname><given-names>PL</given-names></name><name name-style="western"><surname>Cella</surname><given-names>M</given-names></name><name name-style="western"><surname>Robinette</surname><given-names>ML</given-names></name><name name-style="western"><surname>Porter</surname><given-names>SI</given-names></name><name name-style="western"><surname>Pyfrom</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells</article-title>. <source>Cell.</source> (<year>2016</year>) <volume>165</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.014</pub-id><pub-id pub-id-type="pmid">27156452</pub-id><pub-id pub-id-type="pmcid">PMC4874868</pub-id></mixed-citation></ref><ref id="B203"><label>203.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renz</surname><given-names>H</given-names></name><name name-style="western"><surname>Brandtzaeg</surname><given-names>P</given-names></name><name name-style="western"><surname>Hornef</surname><given-names>M</given-names></name></person-group>. <article-title>The impact of perinatal immune development on mucosal homeostasis and chronic inflammation</article-title>. <source>Nat Rev Immunol.</source> (<year>2012</year>) <volume>12</volume>:<fpage>9</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/nri3112</pub-id><pub-id pub-id-type="pmid">22158411</pub-id></mixed-citation></ref><ref id="B204"><label>204.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slack</surname><given-names>E</given-names></name><name name-style="western"><surname>Hapfelmeier</surname><given-names>S</given-names></name><name name-style="western"><surname>Stecher</surname><given-names>B</given-names></name><name name-style="western"><surname>Velykoredko</surname><given-names>Y</given-names></name><name name-style="western"><surname>Stoel</surname><given-names>M</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>MAE</given-names></name><etal/></person-group>. <article-title>Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism</article-title>. <source>Science.</source> (<year>2009</year>) <volume>325</volume>:<fpage>617</fpage>&#8211;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1126/science.1172747</pub-id><pub-id pub-id-type="pmid">19644121</pub-id><pub-id pub-id-type="pmcid">PMC3730530</pub-id></mixed-citation></ref><ref id="B205"><label>205.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>MY</given-names></name><name name-style="western"><surname>Cisalpino</surname><given-names>D</given-names></name><name name-style="western"><surname>Varadarajan</surname><given-names>S</given-names></name><name name-style="western"><surname>Hellman</surname><given-names>J</given-names></name><name name-style="western"><surname>Warren</surname><given-names>HS</given-names></name><name name-style="western"><surname>Cascalho</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens</article-title>. <source>Immunity.</source> (<year>2016</year>) <volume>44</volume>:<fpage>647</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.006</pub-id><pub-id pub-id-type="pmid">26944199</pub-id><pub-id pub-id-type="pmcid">PMC4794373</pub-id></mixed-citation></ref><ref id="B206"><label>206.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>NL</given-names></name><name name-style="western"><surname>Spoerri</surname><given-names>I</given-names></name><name name-style="western"><surname>Schopfer</surname><given-names>JF</given-names></name><name name-style="western"><surname>Nembrini</surname><given-names>C</given-names></name><name name-style="western"><surname>Merky</surname><given-names>P</given-names></name><name name-style="western"><surname>Massacand</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Mechanisms of neonatal mucosal antibody protection</article-title>. <source>J Immunol.</source> (<year>2006</year>) <volume>177</volume>:<fpage>6256</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6256</pub-id><pub-id pub-id-type="pmid">17056555</pub-id></mixed-citation></ref><ref id="B207"><label>207.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Heller</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z-ME</given-names></name><name name-style="western"><surname>Fish</surname><given-names>K</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y-X</given-names></name><etal/></person-group>. <article-title>The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells</article-title>. <source>Immunity.</source> (<year>2012</year>) <volume>36</volume>:<fpage>92</fpage>&#8211;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.11.011</pub-id><pub-id pub-id-type="pmid">22177117</pub-id><pub-id pub-id-type="pmcid">PMC3268875</pub-id></mixed-citation></ref><ref id="B208"><label>208.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></name><name name-style="western"><surname>J&#246;nsson</surname><given-names>F</given-names></name></person-group>. <article-title>Mouse and human FcR effector functions</article-title>. <source>Immunol Rev.</source> (<year>2015</year>) <volume>268</volume>:<fpage>25</fpage>&#8211;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12350</pub-id><pub-id pub-id-type="pmid">26497511</pub-id></mixed-citation></ref><ref id="B209"><label>209.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moor</surname><given-names>K</given-names></name><name name-style="western"><surname>Fadlallah</surname><given-names>J</given-names></name><name name-style="western"><surname>Toska</surname><given-names>A</given-names></name><name name-style="western"><surname>Sterlin</surname><given-names>D</given-names></name><name name-style="western"><surname>Balmer</surname><given-names>ML</given-names></name><name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry</article-title>. <source>Nat Protoc.</source> (<year>2016</year>) <volume>11</volume>:<fpage>1531</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2016.091</pub-id><pub-id pub-id-type="pmid">27466712</pub-id></mixed-citation></ref><ref id="B210"><label>210.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bry</surname><given-names>L</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen</article-title>. <source>J Immunol.</source> (<year>2004</year>) <volume>172</volume>:<fpage>433</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.172.1.433</pub-id><pub-id pub-id-type="pmid">14688352</pub-id></mixed-citation></ref><ref id="B211"><label>211.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simmons</surname><given-names>CP</given-names></name><name name-style="western"><surname>Clare</surname><given-names>S</given-names></name><name name-style="western"><surname>Ghaem-Maghami</surname><given-names>M</given-names></name><name name-style="western"><surname>Uren</surname><given-names>TK</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>J</given-names></name><name name-style="western"><surname>Huett</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen <italic toggle="yes">Citrobacter rodentium</italic></article-title>. <source>Infect Immun.</source> (<year>2003</year>) <volume>71</volume>:<fpage>5077</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.9.5077-5086.2003</pub-id><pub-id pub-id-type="pmid">12933850</pub-id><pub-id pub-id-type="pmcid">PMC187366</pub-id></mixed-citation></ref><ref id="B212"><label>212.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>YG</given-names></name><name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>MH</given-names></name><name name-style="western"><surname>Warner</surname><given-names>N</given-names></name><name name-style="western"><surname>Chen</surname><given-names>GY</given-names></name><name name-style="western"><surname>Franchi</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes</article-title>. <source>Immunity.</source> (<year>2011</year>) <volume>34</volume>:<fpage>769</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.04.013</pub-id><pub-id pub-id-type="pmid">21565531</pub-id><pub-id pub-id-type="pmcid">PMC3103637</pub-id></mixed-citation></ref><ref id="B213"><label>213.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schreiber</surname><given-names>HA</given-names></name><name name-style="western"><surname>Loschko</surname><given-names>J</given-names></name><name name-style="western"><surname>Karssemeijer</surname><given-names>RA</given-names></name><name name-style="western"><surname>Escolano</surname><given-names>A</given-names></name><name name-style="western"><surname>Meredith</surname><given-names>MM</given-names></name><name name-style="western"><surname>Mucida</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium</article-title>. <source>J Exp Med.</source> (<year>2013</year>) <volume>210</volume>:<fpage>2025</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20130903</pub-id><pub-id pub-id-type="pmid">24043764</pub-id><pub-id pub-id-type="pmcid">PMC3782042</pub-id></mixed-citation></ref><ref id="B214"><label>214.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohr</surname><given-names>E</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>AF</given-names></name><name name-style="western"><surname>Toellner</surname><given-names>K-M</given-names></name><name name-style="western"><surname>Bobat</surname><given-names>S</given-names></name><name name-style="western"><surname>Coughlan</surname><given-names>RE</given-names></name><name name-style="western"><surname>Bird</surname><given-names>RA</given-names></name><etal/></person-group>. <article-title>IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2010</year>) <volume>107</volume>:<fpage>17292</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1004879107</pub-id><pub-id pub-id-type="pmid">20855629</pub-id><pub-id pub-id-type="pmcid">PMC2951392</pub-id></mixed-citation></ref><ref id="B215"><label>215.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>SL</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Glimcher</surname><given-names>LH</given-names></name></person-group>. <article-title>T-bet regulates IgG class switching and pathogenic autoantibody production</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2002</year>) <volume>99</volume>:<fpage>5545</fpage>&#8211;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.082114899</pub-id><pub-id pub-id-type="pmid">11960012</pub-id><pub-id pub-id-type="pmcid">PMC122806</pub-id></mixed-citation></ref><ref id="B216"><label>216.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belzer</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>MC</given-names></name><name name-style="western"><surname>Bry</surname><given-names>L</given-names></name></person-group>. <article-title>The role of specific IgG and complement in combating a primary mucosal infection of the gut epithelium</article-title>. <source>Eur J Microbiol Immunol</source>. (<year>2011</year>) <volume>1</volume>:<fpage>311</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1556/EuJMI.1.2011.4.7</pub-id><pub-id pub-id-type="pmid">22485193</pub-id><pub-id pub-id-type="pmcid">PMC3319158</pub-id></mixed-citation></ref><ref id="B217"><label>217.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masuda</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Shiomi</surname><given-names>H</given-names></name><name name-style="western"><surname>Ikezawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Takagawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Fcgamma receptor regulation of Citrobacter rodentium infection</article-title>. <source>Infect Immun.</source> (<year>2008</year>) <volume>76</volume>:<fpage>1728</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01493-07</pub-id><pub-id pub-id-type="pmid">18227164</pub-id><pub-id pub-id-type="pmcid">PMC2292883</pub-id></mixed-citation></ref><ref id="B218"><label>218.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caballero-Flores</surname><given-names>G</given-names></name><name name-style="western"><surname>Sakamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>MY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hakim</surname><given-names>J</given-names></name><name name-style="western"><surname>Matus-Acu&#241;a</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk</article-title>. <source>Cell Host Microbe.</source> (<year>2019</year>) <volume>25</volume>:<fpage>313</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2018.12.015</pub-id><pub-id pub-id-type="pmid">30686564</pub-id><pub-id pub-id-type="pmcid">PMC6375740</pub-id></mixed-citation></ref><ref id="B219"><label>219.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben Suleiman</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Nishiumi</surname><given-names>S</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>H</given-names></name><name name-style="western"><surname>Mimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Nobutani</surname><given-names>K</given-names></name><etal/></person-group><article-title>Neonatal Fc receptor for IgG (FcRn) expressed in the gastric epithelium regulates bacterial infection in mice</article-title>. <source>Mucosal Immunol.</source> (<year>2012</year>) <volume>5</volume>:<fpage>87</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2011.53</pub-id><pub-id pub-id-type="pmid">22089027</pub-id><pub-id pub-id-type="pmcid">PMC3964614</pub-id></mixed-citation></ref><ref id="B220"><label>220.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baba</surname><given-names>TW</given-names></name><name name-style="western"><surname>Liska</surname><given-names>V</given-names></name><name name-style="western"><surname>Hofmann-Lehmann</surname><given-names>R</given-names></name><name name-style="western"><surname>Vlasak</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ayehunie</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection</article-title>. <source>Nat Med.</source> (<year>2000</year>) <volume>6</volume>:<fpage>200</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/72309</pub-id><pub-id pub-id-type="pmid">10655110</pub-id></mixed-citation></ref><ref id="B221"><label>221.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mascola</surname><given-names>JR</given-names></name><name name-style="western"><surname>Stiegler</surname><given-names>G</given-names></name><name name-style="western"><surname>VanCott</surname><given-names>TC</given-names></name><name name-style="western"><surname>Katinger</surname><given-names>H</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>CB</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies</article-title>. <source>Nat Med.</source> (<year>2000</year>) <volume>6</volume>:<fpage>207</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1038/72318</pub-id><pub-id pub-id-type="pmid">10655111</pub-id></mixed-citation></ref><ref id="B222"><label>222.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bournazos</surname><given-names>S</given-names></name><name name-style="western"><surname>Klein</surname><given-names>F</given-names></name><name name-style="western"><surname>Pietzsch</surname><given-names>J</given-names></name><name name-style="western"><surname>Seaman</surname><given-names>MS</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name><name name-style="western"><surname>Ravetch</surname><given-names>JV</given-names></name></person-group>. <article-title>Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for <italic toggle="yes">in vivo</italic> activity</article-title>. <source>Cell.</source> (<year>2014</year>) <volume>158</volume>:<fpage>1243</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.08.023</pub-id><pub-id pub-id-type="pmid">25215485</pub-id><pub-id pub-id-type="pmcid">PMC4167398</pub-id></mixed-citation></ref><ref id="B223"><label>223.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>S-Y</given-names></name><name name-style="western"><surname>Pegu</surname><given-names>A</given-names></name><name name-style="western"><surname>Rudicell</surname><given-names>RS</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z-Y</given-names></name><name name-style="western"><surname>Joyce</surname><given-names>MG</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Enhanced neonatal Fc receptor function improves protection against primate SHIV infection</article-title>. <source>Nature.</source> (<year>2014</year>) <volume>514</volume>:<fpage>642</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature13612</pub-id><pub-id pub-id-type="pmid">25119033</pub-id><pub-id pub-id-type="pmcid">PMC4433741</pub-id></mixed-citation></ref><ref id="B224"><label>224.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ackerman</surname><given-names>ME</given-names></name><name name-style="western"><surname>Das</surname><given-names>J</given-names></name><name name-style="western"><surname>Pittala</surname><given-names>S</given-names></name><name name-style="western"><surname>Broge</surname><given-names>T</given-names></name><name name-style="western"><surname>Linde</surname><given-names>C</given-names></name><name name-style="western"><surname>Suscovich</surname><given-names>TJ</given-names></name><etal/></person-group>. <article-title>Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV</article-title>. <source>Nat Med.</source> (<year>2018</year>) <volume>24</volume>:<fpage>1590</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-018-0161-0</pub-id><pub-id pub-id-type="pmid">30177821</pub-id><pub-id pub-id-type="pmcid">PMC6482471</pub-id></mixed-citation></ref><ref id="B225"><label>225.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westerman</surname><given-names>LE</given-names></name><name name-style="western"><surname>McClure</surname><given-names>HM</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Almond</surname><given-names>JW</given-names></name><name name-style="western"><surname>Glass</surname><given-names>RI</given-names></name></person-group>. <article-title>Serum IgG mediates mucosal immunity against rotavirus infection</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2005</year>) <volume>102</volume>:<fpage>7268</fpage>&#8211;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0502437102</pub-id><pub-id pub-id-type="pmid">15883382</pub-id><pub-id pub-id-type="pmcid">PMC1129131</pub-id></mixed-citation></ref><ref id="B226"><label>226.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>JH</given-names></name></person-group>. <article-title>The genetics and immunopathogenesis of inflammatory bowel disease</article-title>. <source>Nat Rev Immunol.</source> (<year>2008</year>) <volume>8</volume>:<fpage>458</fpage>&#8211;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/nri2340</pub-id><pub-id pub-id-type="pmid">18500230</pub-id></mixed-citation></ref><ref id="B227"><label>227.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xavier</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Podolsky</surname><given-names>DK</given-names></name></person-group>. <article-title>Unravelling the pathogenesis of inflammatory bowel disease</article-title>. <source>Nature.</source> (<year>2007</year>) <volume>448</volume>:<fpage>427</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nature06005</pub-id><pub-id pub-id-type="pmid">17653185</pub-id></mixed-citation></ref><ref id="B228"><label>228.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burton</surname><given-names>PR</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>DG</given-names></name><name name-style="western"><surname>Cardon</surname><given-names>LR</given-names></name><name name-style="western"><surname>Craddock</surname><given-names>N</given-names></name><name name-style="western"><surname>Deloukas</surname><given-names>P</given-names></name><name name-style="western"><surname>Duncanson</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants</article-title>. <source>Nat Genet.</source> (<year>2007</year>) <volume>39</volume>:<fpage>1329</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2007.17</pub-id><pub-id pub-id-type="pmid">17952073</pub-id><pub-id pub-id-type="pmcid">PMC2680141</pub-id></mixed-citation></ref><ref id="B229"><label>229.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elson</surname><given-names>CO</given-names></name><name name-style="western"><surname>Cong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>CT</given-names></name><name name-style="western"><surname>Schoeb</surname><given-names>TR</given-names></name><name name-style="western"><surname>McClanahan</surname><given-names>TK</given-names></name><name name-style="western"><surname>Fick</surname><given-names>RB</given-names></name><etal/></person-group>. <article-title>Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice</article-title>. <source>Gastroenterology.</source> (<year>2007</year>) <volume>132</volume>:<fpage>2359</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.03.104</pub-id><pub-id pub-id-type="pmid">17570211</pub-id></mixed-citation></ref><ref id="B230"><label>230.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hue</surname><given-names>S</given-names></name><name name-style="western"><surname>Ahern</surname><given-names>P</given-names></name><name name-style="western"><surname>Buonocore</surname><given-names>S</given-names></name><name name-style="western"><surname>Kullberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Cua</surname><given-names>DJ</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>BS</given-names></name><etal/></person-group>. <article-title>Interleukin-23 drives innate and T cell-mediated intestinal inflammation</article-title>. <source>J Exp Med.</source> (<year>2006</year>) <volume>203</volume>:<fpage>2473</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20061099</pub-id><pub-id pub-id-type="pmid">17030949</pub-id><pub-id pub-id-type="pmcid">PMC2118132</pub-id></mixed-citation></ref><ref id="B231"><label>231.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kullberg</surname><given-names>MC</given-names></name><name name-style="western"><surname>Jankovic</surname><given-names>D</given-names></name><name name-style="western"><surname>Feng</surname><given-names>CG</given-names></name><name name-style="western"><surname>Hue</surname><given-names>S</given-names></name><name name-style="western"><surname>Gorelick</surname><given-names>PL</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>BS</given-names></name><etal/></person-group>. <article-title>IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis</article-title>. <source>J Exp Med.</source> (<year>2006</year>) <volume>203</volume>:<fpage>2485</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20061082</pub-id><pub-id pub-id-type="pmid">17030948</pub-id><pub-id pub-id-type="pmcid">PMC2118119</pub-id></mixed-citation></ref><ref id="B232"><label>232.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van</surname><given-names>den Brande JMH</given-names></name><name name-style="western"><surname>Braat</surname><given-names>H</given-names></name><name name-style="western"><surname>Van</surname><given-names>den Brink GR</given-names></name><name name-style="western"><surname>Versteeg</surname><given-names>HH</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hoedemaeker</surname><given-names>I</given-names></name><etal/></person-group><article-title>Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease</article-title>. <source>Gastroenterology.</source> (<year>2003</year>) <volume>124</volume>:<fpage>1774</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/S0016-5085(03)00382-2</pub-id><pub-id pub-id-type="pmid">12806611</pub-id></mixed-citation></ref><ref id="B233"><label>233.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mannon</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Fuss</surname><given-names>IJ</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>L</given-names></name><name name-style="western"><surname>Elson</surname><given-names>CO</given-names></name><name name-style="western"><surname>Sandborn</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Present</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Anti-interleukin-12 antibody for active Crohn's disease</article-title>. <source>N Engl J Med.</source> (<year>2004</year>) <volume>351</volume>:<fpage>2069</fpage>&#8211;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa033402</pub-id><pub-id pub-id-type="pmid">15537905</pub-id></mixed-citation></ref><ref id="B234"><label>234.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandborn</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Gasink</surname><given-names>C</given-names></name><name name-style="western"><surname>Gao</surname><given-names>L-L</given-names></name><name name-style="western"><surname>Blank</surname><given-names>MA</given-names></name><name name-style="western"><surname>Johanns</surname><given-names>J</given-names></name><name name-style="western"><surname>Guzzo</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Ustekinumab induction and maintenance therapy in refractory Crohn's disease</article-title>. <source>N Engl J Med.</source> (<year>2012</year>) <volume>367</volume>:<fpage>1519</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1203572</pub-id><pub-id pub-id-type="pmid">23075178</pub-id></mixed-citation></ref><ref id="B235"><label>235.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolaczkowska</surname><given-names>E</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name></person-group>. <article-title>Neutrophil recruitment and function in health and inflammation</article-title>. <source>Nat Rev Immunol.</source> (<year>2013</year>) <volume>13</volume>:<fpage>159</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/nri3399</pub-id><pub-id pub-id-type="pmid">23435331</pub-id></mixed-citation></ref><ref id="B236"><label>236.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XO</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><etal/></person-group>. <article-title>Critical regulation of early Th17 cell differentiation by Interleukin-1 signaling</article-title>. <source>Immunity.</source> (<year>2009</year>) <volume>30</volume>:<fpage>576</fpage>&#8211;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.007</pub-id><pub-id pub-id-type="pmid">19362022</pub-id><pub-id pub-id-type="pmcid">PMC2705871</pub-id></mixed-citation></ref><ref id="B237"><label>237.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoreschi</surname><given-names>K</given-names></name><name name-style="western"><surname>Laurence</surname><given-names>A</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X-P</given-names></name><name name-style="western"><surname>Tato</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mandy</surname><given-names>JM</given-names></name><name name-style="western"><surname>Konkel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Generation of pathogenic Th17 cells in the absence of TGF-B signaling</article-title>. <source>Nature.</source> (<year>2010</year>) <volume>467</volume>:<fpage>967</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/nature09447</pub-id><pub-id pub-id-type="pmid">20962846</pub-id><pub-id pub-id-type="pmcid">PMC3108066</pub-id></mixed-citation></ref><ref id="B238"><label>238.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Revu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Henkel</surname><given-names>M</given-names></name><name name-style="western"><surname>Rittenhouse</surname><given-names>N</given-names></name><name name-style="western"><surname>Menk</surname><given-names>A</given-names></name><name name-style="western"><surname>Delgoffe</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>IL-23 and IL-1&#946; drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation</article-title>. <source>Cell Rep.</source> (<year>2018</year>) <volume>22</volume>:<fpage>2642</fpage>&#8211;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.044</pub-id><pub-id pub-id-type="pmid">29514093</pub-id><pub-id pub-id-type="pmcid">PMC5884137</pub-id></mixed-citation></ref><ref id="B239"><label>239.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macpherson</surname><given-names>A</given-names></name><name name-style="western"><surname>Khoo</surname><given-names>UY</given-names></name><name name-style="western"><surname>Forgacs</surname><given-names>I</given-names></name><name name-style="western"><surname>Philpott-Howard</surname><given-names>J</given-names></name><name name-style="western"><surname>Bjarnason</surname><given-names>I</given-names></name></person-group>. <article-title>Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria</article-title>. <source>Gut.</source> (<year>1996</year>) <volume>38</volume>:<fpage>365</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1136/gut.38.3.365</pub-id><pub-id pub-id-type="pmid">8675088</pub-id><pub-id pub-id-type="pmcid">PMC1383064</pub-id></mixed-citation></ref><ref id="B240"><label>240.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuna</surname><given-names>AT</given-names></name></person-group>. <article-title>Serological markers of inflammatory bowel disease</article-title>. <source>Biochem Med.</source> (<year>2013</year>) <volume>23</volume>:<fpage>28</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.11613/BM.2013.006</pub-id><pub-id pub-id-type="pmid">23457764</pub-id><pub-id pub-id-type="pmcid">PMC3900099</pub-id></mixed-citation></ref><ref id="B241"><label>241.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quinton</surname><given-names>JF</given-names></name><name name-style="western"><surname>Sendid</surname><given-names>B</given-names></name><name name-style="western"><surname>Reumaux</surname><given-names>D</given-names></name><name name-style="western"><surname>Duthilleul</surname><given-names>P</given-names></name><name name-style="western"><surname>Cortot</surname><given-names>A</given-names></name><name name-style="western"><surname>Grandbastien</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role</article-title>. <source>Gut.</source> (<year>1998</year>) <volume>42</volume>:<fpage>788</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1136/gut.42.6.788</pub-id><pub-id pub-id-type="pmid">9691915</pub-id><pub-id pub-id-type="pmcid">PMC1727156</pub-id></mixed-citation></ref><ref id="B242"><label>242.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teegen</surname><given-names>B</given-names></name><name name-style="western"><surname>Niemann</surname><given-names>S</given-names></name><name name-style="western"><surname>Probst</surname><given-names>C</given-names></name><name name-style="western"><surname>Schlumberger</surname><given-names>W</given-names></name><name name-style="western"><surname>St&#246;cker</surname><given-names>W</given-names></name><name name-style="western"><surname>Komorowski</surname><given-names>L</given-names></name></person-group>. <article-title>DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis</article-title>. <source>Ann N Y Acad Sci.</source> (<year>2009</year>) <volume>1173</volume>:<fpage>161</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04752.x</pub-id><pub-id pub-id-type="pmid">19758145</pub-id></mixed-citation></ref><ref id="B243"><label>243.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hibi</surname><given-names>T</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Brown</surname><given-names>WR</given-names></name><name name-style="western"><surname>Toda</surname><given-names>K</given-names></name><name name-style="western"><surname>Takaishi</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease</article-title>. <source>Gut.</source> (<year>1994</year>) <volume>35</volume>:<fpage>224</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/gut.35.2.224</pub-id><pub-id pub-id-type="pmid">8307474</pub-id><pub-id pub-id-type="pmcid">PMC1374498</pub-id></mixed-citation></ref><ref id="B244"><label>244.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gillis</surname><given-names>C</given-names></name><name name-style="western"><surname>Gouel-Ch&#233;ron</surname><given-names>A</given-names></name><name name-style="western"><surname>J&#246;nsson</surname><given-names>F</given-names></name><name name-style="western"><surname>Bruhns</surname><given-names>P</given-names></name></person-group>. <article-title>Contribution of human Fc&#947;Rs to disease with evidence from human polymorphisms and transgenic animal studies</article-title>. <source>Frontiers in Immunology.</source> (<year>2014</year>) <volume>5</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00254</pub-id><pub-id pub-id-type="pmid">24910634</pub-id><pub-id pub-id-type="pmcid">PMC4038777</pub-id></mixed-citation></ref><ref id="B245"><label>245.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warmerdam</surname><given-names>PA</given-names></name><name name-style="western"><surname>van</surname><given-names>de Winkel JG</given-names></name><name name-style="western"><surname>Gosselin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Capel</surname><given-names>PJ</given-names></name></person-group>. <article-title>Molecular basis for a polymorphism of human Fc gamma receptor II (CD32)</article-title>. <source>J Exp Med.</source> (<year>1990</year>) <volume>172</volume>:<fpage>19</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1084/jem.172.1.19</pub-id><pub-id pub-id-type="pmid">2141627</pub-id><pub-id pub-id-type="pmcid">PMC2188138</pub-id></mixed-citation></ref><ref id="B246"><label>246.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van</surname><given-names>der Heijden J</given-names></name><name name-style="western"><surname>Nagelkerke</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Geissler</surname><given-names>J</given-names></name><name name-style="western"><surname>Rispens</surname><given-names>T</given-names></name><name name-style="western"><surname>van</surname><given-names>den Berg TK</given-names></name><etal/></person-group><article-title>Haplotypes of FcgammaRIIa and FcgammaRIIIb polymorphic variants influence IgG-mediated responses in neutrophils</article-title>. <source>J Immunol.</source> (<year>2014</year>) <volume>192</volume>:<fpage>2715</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1203570</pub-id><pub-id pub-id-type="pmid">24554771</pub-id></mixed-citation></ref><ref id="B247"><label>247.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chuen Khor</surname><given-names>C</given-names></name><name name-style="western"><surname>Davila</surname><given-names>S</given-names></name><name name-style="western"><surname>Breunis</surname><given-names>WB</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y-C</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>C</given-names></name><name name-style="western"><surname>Wright</surname><given-names>VJ</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease</article-title>. <source>Nat Genet.</source> (<year>2011</year>) <volume>43</volume>:<fpage>1241</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ng.981</pub-id><pub-id pub-id-type="pmid">22081228</pub-id></mixed-citation></ref><ref id="B248"><label>248.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castro-Dopico</surname><given-names>T</given-names></name><name name-style="western"><surname>Dennison</surname><given-names>TW</given-names></name><name name-style="western"><surname>Ferdinand</surname><given-names>JR</given-names></name><name name-style="western"><surname>Mathews</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>A</given-names></name><name name-style="western"><surname>Clift</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis</article-title>. <source>Immunity</source>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.02.006.</pub-id> [Epub ahead of print].<pub-id pub-id-type="pmid">30876876</pub-id><pub-id pub-id-type="pmcid">PMC6477154</pub-id></mixed-citation></ref><ref id="B249"><label>249.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>SW</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Lencer</surname><given-names>WI</given-names></name><name name-style="western"><surname>Blumberg</surname><given-names>RS</given-names></name></person-group>. <article-title>An FcRn-Dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice</article-title>. <source>Gastroenterology.</source> (<year>2009</year>) <volume>137</volume>:<fpage>174656</fpage>.e1741. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.07.059</pub-id><pub-id pub-id-type="pmid">19664634</pub-id><pub-id pub-id-type="pmcid">PMC2787451</pub-id></mixed-citation></ref><ref id="B250"><label>250.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Floto</surname><given-names>RA</given-names></name><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name><name name-style="western"><surname>Heilbronn</surname><given-names>KR</given-names></name><name name-style="western"><surname>Rosner</surname><given-names>DR</given-names></name><name name-style="western"><surname>MacAry</surname><given-names>PA</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts</article-title>. <source>Nat Med.</source> (<year>2005</year>) <volume>11</volume>:<fpage>1056</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nm1288</pub-id><pub-id pub-id-type="pmid">16170323</pub-id></mixed-citation></ref><ref id="B251"><label>251.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kono</surname><given-names>H</given-names></name><name name-style="western"><surname>Kyogoku</surname><given-names>C</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsuchiya</surname><given-names>N</given-names></name><name name-style="western"><surname>Honda</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling</article-title>. <source>Hum Mol Genet.</source> (<year>2005</year>) <volume>14</volume>:<fpage>2881</fpage>&#8211;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddi320</pub-id><pub-id pub-id-type="pmid">16115811</pub-id></mixed-citation></ref><ref id="B252"><label>252.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Xia</surname><given-names>M</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus- associated polymorphism Fc &#947; RIIB-T232</article-title>. <source>J Exp Med.</source> (<year>2016</year>) <volume>213</volume>:<fpage>2707</fpage>&#8211;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20160528</pub-id><pub-id pub-id-type="pmid">27799621</pub-id><pub-id pub-id-type="pmcid">PMC5110019</pub-id></mixed-citation></ref><ref id="B253"><label>253.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyogoku</surname><given-names>C</given-names></name><name name-style="western"><surname>Dijstelbloem</surname><given-names>HM</given-names></name><name name-style="western"><surname>Tsuchiya</surname><given-names>N</given-names></name><name name-style="western"><surname>Hatta</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kato</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility</article-title>. <source>Arthritis Rheum.</source> (<year>2002</year>) <volume>46</volume>:<fpage>1242</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/art.10257</pub-id><pub-id pub-id-type="pmid">12115230</pub-id></mixed-citation></ref><ref id="B254"><label>254.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willcocks</surname><given-names>LC</given-names></name><name name-style="western"><surname>Carr</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Niederer</surname><given-names>HA</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>TF</given-names></name><name name-style="western"><surname>Williams</surname><given-names>TN</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2010</year>) <volume>107</volume>:<fpage>7881</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0915133107</pub-id><pub-id pub-id-type="pmid">20385827</pub-id><pub-id pub-id-type="pmcid">PMC2867866</pub-id></mixed-citation></ref><ref id="B255"><label>255.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name><name name-style="western"><surname>Willcocks</surname><given-names>L</given-names></name><name name-style="western"><surname>Urban</surname><given-names>B</given-names></name><name name-style="western"><surname>Langhorne</surname><given-names>J</given-names></name><name name-style="western"><surname>Williams</surname><given-names>TN</given-names></name><name name-style="western"><surname>Peshu</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2007</year>) <volume>104</volume>:<fpage>7169</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0608889104</pub-id><pub-id pub-id-type="pmid">17435165</pub-id><pub-id pub-id-type="pmcid">PMC1855357</pub-id></mixed-citation></ref><ref id="B256"><label>256.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morgan</surname><given-names>AW</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>B</given-names></name><name name-style="western"><surname>Ponchel</surname><given-names>F</given-names></name><name name-style="western"><surname>Montague</surname><given-names>BM</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>PP</given-names></name><etal/></person-group>. <article-title>Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups</article-title>. <source>Arthritis Rheum.</source> (<year>2000</year>) <volume>43</volume>:<fpage>2328</fpage>&#8211;<lpage>34</lpage>. <pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1529-0131(200010)43:10&amp;#x0003c;2328::AID-ANR21&amp;#x0003e;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">11037893</pub-id></mixed-citation></ref><ref id="B257"><label>257.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tutuncu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kavanaugh</surname><given-names>A</given-names></name><name name-style="western"><surname>Zvaifler</surname><given-names>N</given-names></name><name name-style="western"><surname>Corr</surname><given-names>M</given-names></name><name name-style="western"><surname>Deutsch</surname><given-names>R</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>D</given-names></name></person-group>. <article-title>Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents</article-title>. <source>Arthritis Rheum.</source> (<year>2005</year>) <volume>52</volume>:<fpage>2693</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/art.21266</pub-id><pub-id pub-id-type="pmid">16142749</pub-id></mixed-citation></ref><ref id="B258"><label>258.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niederer</surname><given-names>HA</given-names></name><name name-style="western"><surname>Willcocks</surname><given-names>LC</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>TF</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Lau</surname><given-names>YL</given-names></name><name name-style="western"><surname>Williams</surname><given-names>TN</given-names></name><etal/></person-group>. <article-title>Copy number, linkage disequilibrium and disease association in the FCGR locus</article-title>. <source>Hum Mol Genet</source>. (<year>2010</year>) <volume>19</volume>:<fpage>3282</fpage>&#8211;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq216</pub-id><pub-id pub-id-type="pmid">20508037</pub-id><pub-id pub-id-type="pmcid">PMC2908468</pub-id></mixed-citation></ref><ref id="B259"><label>259.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>AW</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>MP</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>KB</given-names></name><name name-style="western"><surname>Yu</surname><given-names>WH</given-names></name><name name-style="western"><surname>Schoen</surname><given-names>MK</given-names></name><name name-style="western"><surname>Dunphy</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology</article-title>. <source>Cell.</source> (<year>2015</year>) <volume>163</volume>:<fpage>988</fpage>&#8211;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.10.027</pub-id><pub-id pub-id-type="pmid">26544943</pub-id><pub-id pub-id-type="pmcid">PMC5490491</pub-id></mixed-citation></ref><ref id="B260"><label>260.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lofano</surname><given-names>G</given-names></name><name name-style="western"><surname>Gorman</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Yousif</surname><given-names>AS</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W-H</given-names></name><name name-style="western"><surname>Fox</surname><given-names>JM</given-names></name><name name-style="western"><surname>Dugast</surname><given-names>A-S</given-names></name><etal/></person-group>. <article-title>Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement</article-title>. <source>Sci Immunol.</source> (<year>2018</year>) <volume>3</volume>:<fpage>eaat7796</fpage>. <pub-id pub-id-type="doi">10.1126/sciimmunol.aat7796</pub-id><pub-id pub-id-type="pmid">30120121</pub-id><pub-id pub-id-type="pmcid">PMC6298214</pub-id></mixed-citation></ref><ref id="B261"><label>261.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>LL</given-names></name><name name-style="western"><surname>Chung</surname><given-names>AW</given-names></name><name name-style="western"><surname>Rosebrock</surname><given-names>TR</given-names></name><name name-style="western"><surname>Ghebremichael</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>WH</given-names></name><name name-style="western"><surname>Grace</surname><given-names>PS</given-names></name><etal/></person-group>. <article-title>A functional role for antibodies in tuberculosis</article-title>. <source>Cell.</source> (<year>2016</year>) <volume>167</volume>:<fpage>433</fpage>&#8211;<lpage>43</lpage>.e414. <pub-id pub-id-type="doi">10.1016/j.cell.2016.08.072</pub-id><pub-id pub-id-type="pmid">27667685</pub-id><pub-id pub-id-type="pmcid">PMC5526202</pub-id></mixed-citation></ref><ref id="B262"><label>262.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernard</surname><given-names>NJ</given-names></name></person-group>. <article-title>Rheumatoid arthritis: changes in ACPA Fc glycosylation patterns prior to RA onset</article-title>. <source>Nat Rev Rheum.</source> (<year>2013</year>) <volume>9</volume>:<fpage>697</fpage>&#8211;<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1038/nrrheum.2013.162</pub-id><pub-id pub-id-type="pmid">24166244</pub-id></mixed-citation></ref><ref id="B263"><label>263.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vu&#269;kov&#239;c</surname><given-names>F</given-names></name><name name-style="western"><surname>Kri&#353;t&#239;c</surname><given-names>J</given-names></name><name name-style="western"><surname>Gudelj</surname><given-names>I</given-names></name><name name-style="western"><surname>Teruel</surname><given-names>M</given-names></name><name name-style="western"><surname>Keser</surname><given-names>T</given-names></name><name name-style="western"><surname>Pezer</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome</article-title>. <source>Arthritis Rheumatol.</source> (<year>2015</year>) <volume>67</volume>:<fpage>2978</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1002/art.39273</pub-id><pub-id pub-id-type="pmid">26200652</pub-id><pub-id pub-id-type="pmcid">PMC4626261</pub-id></mixed-citation></ref><ref id="B264"><label>264.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyoshi</surname><given-names>E</given-names></name><name name-style="western"><surname>Shinzaki</surname><given-names>S</given-names></name><name name-style="western"><surname>Fujii</surname><given-names>H</given-names></name><name name-style="western"><surname>Iijima</surname><given-names>H</given-names></name><name name-style="western"><surname>Kamada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takehara</surname><given-names>T</given-names></name></person-group>. <article-title>Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease</article-title>. <source>Proteomics.</source> (<year>2016</year>) <volume>10</volume>:<fpage>384</fpage>&#8211;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/prca.201500089</pub-id><pub-id pub-id-type="pmid">26427763</pub-id></mixed-citation></ref><ref id="B265"><label>265.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trbojevi&#263; Akma&#269;i&#263;</surname><given-names>I</given-names></name><name name-style="western"><surname>Ventham</surname><given-names>NT</given-names></name><name name-style="western"><surname>Theodoratou</surname><given-names>E</given-names></name><name name-style="western"><surname>Vu&#269;kovi&#263;</surname><given-names>F</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kri&#353;ti&#263;</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome</article-title>. <source>Inflamm Bowel Dis.</source> (<year>2015</year>) <volume>21</volume>:<fpage>1</fpage><pub-id pub-id-type="doi">10.1097/MIB.0000000000000372</pub-id><pub-id pub-id-type="pmid">25895110</pub-id><pub-id pub-id-type="pmcid">PMC4450892</pub-id></mixed-citation></ref><ref id="B266"><label>266.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quast</surname><given-names>I</given-names></name><name name-style="western"><surname>Keller</surname><given-names>CW</given-names></name><name name-style="western"><surname>Maurer</surname><given-names>MA</given-names></name><name name-style="western"><surname>Giddens</surname><given-names>JP</given-names></name><name name-style="western"><surname>Tackenberg</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>LX</given-names></name><etal/></person-group>. <article-title>Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity</article-title>. <source>J Clin Invest.</source> (<year>2015</year>) <volume>125</volume>:<fpage>4160</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1172/JCI82695</pub-id><pub-id pub-id-type="pmid">26436649</pub-id><pub-id pub-id-type="pmcid">PMC4639970</pub-id></mixed-citation></ref><ref id="B267"><label>267.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pfeifle</surname><given-names>R</given-names></name><name name-style="western"><surname>Rothe</surname><given-names>T</given-names></name><name name-style="western"><surname>Ipseiz</surname><given-names>N</given-names></name><name name-style="western"><surname>Scherer</surname><given-names>HU</given-names></name><name name-style="western"><surname>Culemann</surname><given-names>S</given-names></name><name name-style="western"><surname>Harre</surname><given-names>U</given-names></name><etal/></person-group><article-title>Regulation of autoantibody activity by the IL-23 &#8211; T H 17 axis determines the onset of autoimmune disease</article-title>. <source>Nat Immunol.</source> (<year>2016</year>) <volume>18</volume>:<fpage>104</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3579</pub-id><pub-id pub-id-type="pmid">27820809</pub-id><pub-id pub-id-type="pmcid">PMC5164937</pub-id></mixed-citation></ref><ref id="B268"><label>268.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Rath</surname><given-names>T</given-names></name><name name-style="western"><surname>Flak</surname><given-names>MB</given-names></name><name name-style="western"><surname>Arthur</surname><given-names>JC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Glickman</surname><given-names>JN</given-names></name><etal/></person-group>. <article-title>Neonatal Fc receptor expression in dendritic cells mediates protective immunity against Colorectal Cancer</article-title>. <source>Immunity.</source> (<year>2013</year>) <volume>39</volume>:<fpage>1095</fpage>&#8211;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.11.003</pub-id><pub-id pub-id-type="pmid">24290911</pub-id><pub-id pub-id-type="pmcid">PMC3902970</pub-id></mixed-citation></ref><ref id="B269"><label>269.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asano</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsumoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Umeno</surname><given-names>J</given-names></name><name name-style="western"><surname>Hirano</surname><given-names>A</given-names></name><name name-style="western"><surname>Esaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Hosono</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis</article-title>. <source>Inflamm Bowel Dis.</source> (<year>2013</year>) <volume>19</volume>:<fpage>2061</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0b013e318298118e</pub-id><pub-id pub-id-type="pmid">23917248</pub-id></mixed-citation></ref><ref id="B270"><label>270.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Spitzer</surname><given-names>MH</given-names></name><name name-style="western"><surname>Linde</surname><given-names>IL</given-names></name><name name-style="western"><surname>Burt</surname><given-names>BM</given-names></name><name name-style="western"><surname>Prestwood</surname><given-names>TR</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity</article-title>. <source>Nature.</source> (<year>2015</year>) <volume>521</volume>:<fpage>99</fpage>&#8211;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1038/nature14424</pub-id><pub-id pub-id-type="pmid">25924063</pub-id><pub-id pub-id-type="pmcid">PMC4877172</pub-id></mixed-citation></ref><ref id="B271"><label>271.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>de Andrade L</given-names></name><name name-style="western"><surname>Tay</surname><given-names>RE</given-names></name><name name-style="western"><surname>Pan</surname><given-names>D</given-names></name><name name-style="western"><surname>Luoma</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name><name name-style="western"><surname>Badrinath</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell&#8211;driven tumor immunity</article-title>. <source>Science.</source> (<year>2018</year>) <volume>359</volume>:<fpage>1537</fpage>&#8211;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1126/science.aao0505</pub-id><pub-id pub-id-type="pmid">29599246</pub-id><pub-id pub-id-type="pmcid">PMC6626532</pub-id></mixed-citation></ref><ref id="B272"><label>272.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogosnitzky</surname><given-names>M</given-names></name><name name-style="western"><surname>Danks</surname><given-names>R</given-names></name><name name-style="western"><surname>Holt</surname><given-names>D</given-names></name></person-group>. <article-title>Intravenous immunoglobulin for the treatment of Crohn's disease</article-title>. <source>Autoimmun Rev.</source> (<year>2012</year>) <volume>12</volume>:<fpage>275</fpage>&#8211;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2012.04.006</pub-id><pub-id pub-id-type="pmid">22579561</pub-id></mixed-citation></ref><ref id="B273"><label>273.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>S</given-names></name><name name-style="western"><surname>Terdiman</surname><given-names>J</given-names></name><name name-style="western"><surname>Gundling</surname><given-names>K</given-names></name><name name-style="western"><surname>Mahadevan</surname><given-names>U</given-names></name></person-group>. <article-title>Immunoglobulin therapy for refractory Crohn's disease</article-title>. <source>Ther Adv Gastroenterol.</source> (<year>2013</year>) <volume>7</volume>:<fpage>99</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1177/1756283X13504728</pub-id><pub-id pub-id-type="pmid">24587823</pub-id><pub-id pub-id-type="pmcid">PMC3903086</pub-id></mixed-citation></ref><ref id="B274"><label>274.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horton</surname><given-names>N</given-names></name><name name-style="western"><surname>Kochhar</surname><given-names>G</given-names></name><name name-style="western"><surname>Patel</surname><given-names>K</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>R</given-names></name><name name-style="western"><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Efficacy and factors associated with treatment response of intravenous immunoglobulin in inpatients with refractory <italic toggle="yes">Inflamm Bowel Dis</italic>.</article-title> (<year>2017</year>) <volume>23</volume>:<fpage>1080</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1097/MIB.0000000000001116</pub-id><pub-id pub-id-type="pmid">28452863</pub-id></mixed-citation></ref><ref id="B275"><label>275.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leiper</surname><given-names>K</given-names></name><name name-style="western"><surname>Martin</surname><given-names>K</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>A</given-names></name><name name-style="western"><surname>Subramanian</surname><given-names>S</given-names></name><name name-style="western"><surname>Watson</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Christmas</surname><given-names>SE</given-names></name><etal/></person-group>. <article-title>Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis</article-title>. <source>Gut.</source> (<year>2011</year>) <volume>60</volume>:<fpage>1520</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2010.225482</pub-id><pub-id pub-id-type="pmid">21471566</pub-id></mixed-citation></ref><ref id="B276"><label>276.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clatworthy</surname><given-names>MR</given-names></name><name name-style="western"><surname>Watson</surname><given-names>CJE</given-names></name><name name-style="western"><surname>Plotnek</surname><given-names>G</given-names></name><name name-style="western"><surname>Bardsley</surname><given-names>V</given-names></name><name name-style="western"><surname>Chaudhry</surname><given-names>AN</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>B-cell&#8211;depleting induction therapy and acute cellular rejection</article-title>. <source>N Engl J Med.</source> (<year>2009</year>) <volume>360</volume>:<fpage>2683</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc0808481</pub-id><pub-id pub-id-type="pmid">19535812</pub-id><pub-id pub-id-type="pmcid">PMC4143588</pub-id></mixed-citation></ref><ref id="B277"><label>277.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Borja</surname><given-names>F</given-names></name><name name-style="western"><surname>Bosma</surname><given-names>A</given-names></name><name name-style="western"><surname>Ng</surname><given-names>D</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>V</given-names></name><name name-style="western"><surname>Ehrenstein</surname><given-names>MR</given-names></name><name name-style="western"><surname>Isenberg</surname><given-names>DA</given-names></name><etal/></person-group>. <article-title>CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation</article-title>. <source>Sci Transl Med.</source> (<year>2013</year>) <volume>5</volume>:<fpage>173ra123</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3005407</pub-id><pub-id pub-id-type="pmid">23427243</pub-id></mixed-citation></ref><ref id="B278"><label>278.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menon</surname><given-names>M</given-names></name><name name-style="western"><surname>Blair</surname><given-names>PA</given-names></name><name name-style="western"><surname>Isenberg</surname><given-names>DA</given-names></name><name name-style="western"><surname>Mauri</surname><given-names>C</given-names></name></person-group>. <article-title>A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus</article-title>. <source>Immunity.</source> (<year>2016</year>) <volume>44</volume>:<fpage>683</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.012</pub-id><pub-id pub-id-type="pmid">26968426</pub-id><pub-id pub-id-type="pmcid">PMC4803914</pub-id></mixed-citation></ref><ref id="B279"><label>279.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>JCW</given-names></name><name name-style="western"><surname>Szczepanski</surname><given-names>L</given-names></name><name name-style="western"><surname>Szechinski</surname><given-names>J</given-names></name><name name-style="western"><surname>Filipowicz-Sosnowska</surname><given-names>A</given-names></name><name name-style="western"><surname>Emery</surname><given-names>P</given-names></name><name name-style="western"><surname>Close</surname><given-names>DR</given-names></name><etal/></person-group>. <article-title>Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis</article-title>. <source>N Engl J Med.</source> (<year>2004</year>) <volume>350</volume>:<fpage>2572</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa032534</pub-id><pub-id pub-id-type="pmid">15201414</pub-id></mixed-citation></ref><ref id="B280"><label>280.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiessling</surname><given-names>P</given-names></name><name name-style="western"><surname>Lledo-Garcia</surname><given-names>R</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Langdon</surname><given-names>G</given-names></name><name name-style="western"><surname>Tran</surname><given-names>D</given-names></name><name name-style="western"><surname>Bari</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study</article-title>. <source>Sci Transl Med.</source> (<year>2017</year>) <volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aan1208</pub-id><pub-id pub-id-type="pmid">29093180</pub-id></mixed-citation></ref><ref id="B281"><label>281.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>L</given-names></name><name name-style="western"><surname>Hillson</surname><given-names>JL</given-names></name><name name-style="western"><surname>Tiessen</surname><given-names>RG</given-names></name><name name-style="western"><surname>Bosje</surname><given-names>T</given-names></name><name name-style="western"><surname>van Iersel</surname><given-names>MP</given-names></name><name name-style="western"><surname>Nix</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>M281, an Anti-FcRn antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first-in-human study</article-title>. <source>Clin Pharm Ther.</source> (<year>2018</year>) <volume>105</volume>:<fpage>1031</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/cpt.1276</pub-id><pub-id pub-id-type="pmid">30402880</pub-id><pub-id pub-id-type="pmcid">PMC6587432</pub-id></mixed-citation></ref><ref id="B282"><label>282.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>B</given-names></name><name name-style="western"><surname>Kiessling</surname><given-names>A</given-names></name><name name-style="western"><surname>Lledo-Garcia</surname><given-names>R</given-names></name><name name-style="western"><surname>Dixon</surname><given-names>KL</given-names></name><name name-style="western"><surname>Christodoulou</surname><given-names>L</given-names></name><name name-style="western"><surname>Catley</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration</article-title>. <source>MABS.</source> (<year>2018</year>) <volume>10</volume>:<fpage>1111</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1080/19420862.2018.1505464</pub-id><pub-id pub-id-type="pmid">30130439</pub-id><pub-id pub-id-type="pmcid">PMC6291300</pub-id></mixed-citation></ref><ref id="B283"><label>283.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ulrichts</surname><given-names>P</given-names></name><name name-style="western"><surname>Guglietta</surname><given-names>A</given-names></name><name name-style="western"><surname>Dreier</surname><given-names>T</given-names></name><name name-style="western"><surname>van Bragt</surname><given-names>T</given-names></name><name name-style="western"><surname>Hanssens</surname><given-names>V</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans</article-title>. <source>J Clin Invest.</source> (<year>2018</year>) <volume>128</volume>:<fpage>4372</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1172/JCI97911</pub-id><pub-id pub-id-type="pmid">30040076</pub-id><pub-id pub-id-type="pmcid">PMC6159959</pub-id></mixed-citation></ref><ref id="B284"><label>284.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinblatt</surname><given-names>ME</given-names></name><name name-style="western"><surname>Kavanaugh</surname><given-names>A</given-names></name><name name-style="western"><surname>Genovese</surname><given-names>MC</given-names></name><name name-style="western"><surname>Musser</surname><given-names>TK</given-names></name><name name-style="western"><surname>Grossbard</surname><given-names>EB</given-names></name><name name-style="western"><surname>Magilavy</surname><given-names>DB</given-names></name></person-group>. <article-title>An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis</article-title>. <source>N Engl J Med.</source> (<year>2010</year>) <volume>363</volume>:<fpage>1303</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1000500</pub-id><pub-id pub-id-type="pmid">20879879</pub-id></mixed-citation></ref><ref id="B285"><label>285.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bosques</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Manning</surname><given-names>AM</given-names></name></person-group>. <article-title>Fc-gamma receptors: attractive targets for autoimmune drug discovery searching for intelligent therapeutic designs</article-title>. <source>Autoimmun Rev.</source> (<year>2016</year>) <volume>15</volume>:<fpage>1081</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2016.07.035</pub-id><pub-id pub-id-type="pmid">27491569</pub-id></mixed-citation></ref><ref id="B286"><label>286.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horton</surname><given-names>HM</given-names></name><name name-style="western"><surname>Chu</surname><given-names>SY</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>EC</given-names></name><name name-style="western"><surname>Pong</surname><given-names>E</given-names></name><name name-style="western"><surname>Cemerski</surname><given-names>S</given-names></name><name name-style="western"><surname>Leung</surname><given-names>IWL</given-names></name><etal/></person-group>. <article-title>Antibody-mediated coengagement of Fc&#947;RIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus</article-title>. <source>J Immunol.</source> (<year>2011</year>) <volume>186</volume>:<fpage>4223</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003412</pub-id><pub-id pub-id-type="pmid">21357255</pub-id></mixed-citation></ref><ref id="B287"><label>287.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Louis</surname><given-names>E</given-names></name><name name-style="western"><surname>El Ghoul</surname><given-names>Z</given-names></name><name name-style="western"><surname>Vermeire</surname><given-names>S</given-names></name><name name-style="western"><surname>Dall'Ozzo</surname><given-names>S</given-names></name><name name-style="western"><surname>Rutgeerts</surname><given-names>P</given-names></name><name name-style="western"><surname>Paintaud</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease</article-title>. <source>Aliment Pharmacol Ther.</source> (<year>2004</year>) <volume>19</volume>:<fpage>511</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2036.2004.01871.x</pub-id><pub-id pub-id-type="pmid">14987319</pub-id></mixed-citation></ref><ref id="B288"><label>288.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moroi</surname><given-names>R</given-names></name><name name-style="western"><surname>Endo</surname><given-names>K</given-names></name><name name-style="western"><surname>Kinouchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shiga</surname><given-names>H</given-names></name><name name-style="western"><surname>Kakuta</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kuroha</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity</article-title>. <source>Immunogenetics.</source> (<year>2013</year>) <volume>65</volume>:<fpage>265</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/s00251-013-0679-8</pub-id><pub-id pub-id-type="pmid">23358932</pub-id></mixed-citation></ref><ref id="B289"><label>289.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bloemendaal</surname><given-names>FM</given-names></name><name name-style="western"><surname>Koelink</surname><given-names>PJ</given-names></name><name name-style="western"><surname>van Schie</surname><given-names>KA</given-names></name><name name-style="western"><surname>Rispens</surname><given-names>T</given-names></name><name name-style="western"><surname>Peters</surname><given-names>CP</given-names></name><name name-style="western"><surname>Buskens</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>TNF-anti-TNF immune complexes inhibit IL-12/IL-23 secretion by inflammatory macrophages via an Fc-dependent mechanism</article-title>. <source>J Crohns Colitis.</source> (<year>2018</year>) <volume>12</volume>:<fpage>1122</fpage>&#8211;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjy075</pub-id><pub-id pub-id-type="pmid">29860435</pub-id></mixed-citation></ref><ref id="B290"><label>290.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McRae</surname><given-names>BL</given-names></name><name name-style="western"><surname>Levin</surname><given-names>AD</given-names></name><name name-style="western"><surname>Wildenberg</surname><given-names>ME</given-names></name><name name-style="western"><surname>Koelink</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Bousquet</surname><given-names>P</given-names></name><name name-style="western"><surname>Mikaelian</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Fc receptor-mediated effector function contributes to the therapeutic response of anti-TNF monoclonal antibodies in a mouse model of inflammatory bowel disease</article-title>. <source>J Crohns Colitis.</source> (<year>2016</year>) <volume>10</volume>:<fpage>69</fpage>&#8211;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjv179</pub-id><pub-id pub-id-type="pmid">26429698</pub-id></mixed-citation></ref><ref id="B291"><label>291.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>WK</given-names></name><name name-style="western"><surname>Levy</surname><given-names>R</given-names></name></person-group>. <article-title>Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma</article-title>. <source>J Clin Oncol.</source> (<year>2003</year>) <volume>21</volume>:<fpage>3940</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2003.05.013</pub-id><pub-id pub-id-type="pmid">12975461</pub-id></mixed-citation></ref><ref id="B292"><label>292.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arce Vargas</surname><given-names>F</given-names></name><name name-style="western"><surname>Furness</surname><given-names>AJS</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>I</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Mekkaoui</surname><given-names>L</given-names></name><name name-style="western"><surname>Lesko</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors</article-title>. <source>Immunity.</source> (<year>2017</year>) <volume>46</volume>:<fpage>577</fpage>&#8211;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2017.03.013</pub-id><pub-id pub-id-type="pmid">28410988</pub-id><pub-id pub-id-type="pmcid">PMC5437702</pub-id></mixed-citation></ref><ref id="B293"><label>293.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas</surname><given-names>FA</given-names></name><name name-style="western"><surname>Furness</surname><given-names>AJS</given-names></name><name name-style="western"><surname>Litchfield</surname><given-names>K</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>R</given-names></name><name name-style="western"><surname>Ghorani</surname><given-names>E</given-names></name><etal/></person-group><article-title>Fc effector function contributes to the activity of human anti-CTLA-4 antibodies</article-title>. <source>Cancer Cell.</source> (<year>2018</year>) <volume>33</volume>:<fpage>649</fpage>&#8211;<lpage>63</lpage>.e644. <pub-id pub-id-type="doi">10.1016/j.ccell.2018.02.010</pub-id><pub-id pub-id-type="pmid">29576375</pub-id><pub-id pub-id-type="pmcid">PMC5904288</pub-id></mixed-citation></ref><ref id="B294"><label>294.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ingram</surname><given-names>JR</given-names></name><name name-style="western"><surname>Blomberg</surname><given-names>OS</given-names></name><name name-style="western"><surname>Rashidian</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>L</given-names></name><name name-style="western"><surname>Garforth</surname><given-names>S</given-names></name><name name-style="western"><surname>Fedorov</surname><given-names>E</given-names></name></person-group>. <article-title>Anti &#8211; CTLA-4 therapy requires an Fc domain for efficacy</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2018</year>) <volume>115</volume>:<fpage>3912</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1801524115</pub-id><pub-id pub-id-type="pmid">29581255</pub-id><pub-id pub-id-type="pmcid">PMC5899492</pub-id></mixed-citation></ref><ref id="B295"><label>295.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waight</surname><given-names>JD</given-names></name><name name-style="western"><surname>Chand</surname><given-names>D</given-names></name><name name-style="western"><surname>Dietrich</surname><given-names>S</given-names></name><name name-style="western"><surname>Gombos</surname><given-names>R</given-names></name><name name-style="western"><surname>Horn</surname><given-names>T</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Selective Fc&#947;R Co-engagement on APCs modulates the activity of therapeutic antibodies targeting T cell antigens</article-title>. <source>Cancer Cell.</source> (<year>2018</year>) <volume>33</volume>:<fpage>1033</fpage>&#8211;<lpage>1047</lpage>.e1035. <pub-id pub-id-type="doi">10.1016/j.ccell.2018.05.005</pub-id><pub-id pub-id-type="pmid">29894690</pub-id><pub-id pub-id-type="pmcid">PMC6292441</pub-id></mixed-citation></ref><ref id="B296"><label>296.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name><name name-style="western"><surname>Tu</surname><given-names>D</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>LA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Fc-g receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancer</article-title>. <source>Clin Cancer Res.</source> (<year>2016</year>) <volume>22</volume>:<fpage>2435</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-0414</pub-id><pub-id pub-id-type="pmid">27179112</pub-id></mixed-citation></ref><ref id="B297"><label>297.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weersma</surname><given-names>RK</given-names></name><name name-style="western"><surname>Crusius</surname><given-names>JB</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>RL</given-names></name><name name-style="western"><surname>Koeleman</surname><given-names>BP</given-names></name><name name-style="western"><surname>Palomino-Morales</surname><given-names>R</given-names></name><name name-style="western"><surname>Wolfkamp</surname><given-names>S</given-names></name><etal/></person-group><article-title>Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations</article-title>. <source>Inflamm Bowel Dis.</source> (<year>2010</year>) <volume>16</volume>:<fpage>2080</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21342</pub-id><pub-id pub-id-type="pmid">20848524</pub-id></mixed-citation></ref><ref id="B298"><label>298.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>SK</given-names></name><name name-style="western"><surname>Jung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M</given-names></name><name name-style="western"><surname>Ye</surname><given-names>BD</given-names></name><name name-style="western"><surname>Song</surname><given-names>K</given-names></name></person-group>. <article-title>Association of FCGR2A, JAK2 or HNF4A variants with ulcerative colitis in Koreans</article-title>. <source>Dig Liver Dis.</source> (<year>2011</year>) <volume>43</volume>:<fpage>856</fpage>&#8211;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.dld.2011.07.006</pub-id><pub-id pub-id-type="pmid">21831733</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>ADCC</term><def><p>Antibody-dependent cell-mediated cytotoxicity</p></def></def-item><def-item><term>AHR</term><def><p>Aryl hydrocarbon receptor</p></def></def-item><def-item><term>AID</term><def><p>Activation-induced cytidine deaminase</p></def></def-item><def-item><term>APRIL</term><def><p>A proliferation-inducing ligand</p></def></def-item><def-item><term>BAFF</term><def><p>B cell activating factor</p></def></def-item><def-item><term>BCR</term><def><p>B cell receptor</p></def></def-item><def-item><term>CD</term><def><p>Crohn's disease</p></def></def-item><def-item><term>cDC</term><def><p>Classical/conventional DC</p></def></def-item><def-item><term>CRP</term><def><p>C reactive protein</p></def></def-item><def-item><term>DC</term><def><p>Dendritic cell</p></def></def-item><def-item><term>DSS</term><def><p>Dextran sodium sulfate</p></def></def-item><def-item><term>Fc&#947;R</term><def><p>Fc&#947; receptor</p></def></def-item><def-item><term>FcRn</term><def><p>Neonatal Fc receptor</p></def></def-item><def-item><term>GALT</term><def><p>Gut-associated lymphoid tissue</p></def></def-item><def-item><term>GI</term><def><p>Gastrointestinal tract</p></def></def-item><def-item><term>GlcNAc</term><def><p><italic toggle="yes">N-</italic>acetylglucosamine</p></def></def-item><def-item><term>GM-CSF</term><def><p>Granulocyte-macrophage colony-stimulating factor</p></def></def-item><def-item><term>GWAS</term><def><p>Genome wide association study</p></def></def-item><def-item><term>IBD</term><def><p>Inflammatory bowel disease</p></def></def-item><def-item><term>IC</term><def><p>Immune complex</p></def></def-item><def-item><term>IEC</term><def><p>Intestinal epithelial cell</p></def></def-item><def-item><term>IFN</term><def><p>Interferon</p></def></def-item><def-item><term>Ig</term><def><p>Immunoglobulin</p></def></def-item><def-item><term>IL</term><def><p>Interleukin</p></def></def-item><def-item><term>ILC</term><def><p>Innate lymphoid cell</p></def></def-item><def-item><term>ITAM</term><def><p>Immunoreceptor tyrosine-based activating motif</p></def></def-item><def-item><term>ITIM</term><def><p>Immunoreceptor tyrosine-based inhibitory motif</p></def></def-item><def-item><term>IVIg</term><def><p>Intravenous immunoglobulin</p></def></def-item><def-item><term>MHC</term><def><p>Major histocompatibility complex</p></def></def-item><def-item><term>MLN</term><def><p>Mesenteric lymph node</p></def></def-item><def-item><term>MNP</term><def><p>Mononuclear phagocyte</p></def></def-item><def-item><term>NOD</term><def><p>Nucleotide-binding oligomerization domain</p></def></def-item><def-item><term>NET</term><def><p>Neutrophil extracellular trap</p></def></def-item><def-item><term>NK</term><def><p>Natural killer</p></def></def-item><def-item><term>pANCA</term><def><p>Perinuclear anti-neutrophil cytoplasmic antibodies</p></def></def-item><def-item><term>PBMC</term><def><p>Peripheral blood mononuclear cell</p></def></def-item><def-item><term>PGE2</term><def><p>Prostaglandin E2</p></def></def-item><def-item><term>PI3K</term><def><p>Phosphatidylinositol3-kinase</p></def></def-item><def-item><term>pIgR</term><def><p>Polymeric immunoglobulin receptor</p></def></def-item><def-item><term>PRR</term><def><p>Pattern recognition receptor</p></def></def-item><def-item><term>RA</term><def><p>Rheumatoid arthritis</p></def></def-item><def-item><term>REGIII&#947;</term><def><p>Regenerating islet-derived protein III-&#947;</p></def></def-item><def-item><term>SAP</term><def><p>Serum</p></def></def-item><def-item><term>SCFA</term><def><p>Short chain fatty acid</p></def></def-item><def-item><term>SLE</term><def><p>Systemic lupus erythematosus</p></def></def-item><def-item><term>SNP</term><def><p>Single nucleotide polymorphism</p></def></def-item><def-item><term>SYK</term><def><p>Spleen tyrosine kinase</p></def></def-item><def-item><term>TLR</term><def><p>Toll-like receptor</p></def></def-item><def-item><term>Th</term><def><p>T helper cell</p></def></def-item><def-item><term>TNF</term><def><p>Tumor necrosis factor</p></def></def-item><def-item><term>Treg</term><def><p>Regulatory T cell</p></def></def-item><def-item><term>TRIM21</term><def><p>Tripartite motif-containing protein 21</p></def></def-item><def-item><term>UC</term><def><p>Ulcerative colitis.</p></def></def-item></def-list></glossary></back></article></pmc-articleset>